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Feeding the World sustainably in the 21st century and beyond is perhaps one of the biggest 
challenges mankind has faced. Plant based pig feeds contain significant quantities of 
phosphorus, essential for animal health and performance, but which is locked-up in phytic 
acid and associated phytate salts (only around 30 % digestible). Since the 1990’s, phytase 
enzymes have been added to non-ruminant feeds to enhance phytate digestibility. Recent 
evidence suggests that feeding super doses of phytase increases growth performance 
beyond that attributable to phosphorus release alone. In the UK, therapeutic levels of ZnO 
are often prescribed to prevent and treat post-weaning diarrhoea in newly weaned pigs, 
though some evidence suggests zinc may reduce the phosphorus releasing efficacy of 
phytase. Improving the efficiency of pig production, reducing environmental pollution and 
maximising the use of non-renewable resources may help contribute to a sustainable and 
secure global food chain. The objective of this study was to evaluate the optimal strategy 
for using phytase in weaner pig diets, in conjunction with pharmaceutical ZnO. Four live pig 
experiments were conducted to quantify the growth response to increasing dietary 
phosphorus, identify ‘extra phosphoric’ effects associated with phytase super dosing and to 
evaluate this response in ZnO medicated feed. Resulting recommendations are to super 
dose phytase (2000 - 8000 FTU/kg) for two weeks post-weaning; reducing to 1000 FTU/kg 
in the third week post-weaning to facilitate bone mineralisation. In this study, seemingly 
healthy pigs fed pharmaceutical ZnO at high levels (3100 mg/kg feed) showed reduced 
growth performance, possibly due to interactions between zinc and phosphorus. Further 
research into reducing levels of pharmaceutical ZnO in feed and the use of ZnO 
nanoparticles could help overcome these risks. There may also be justification for a higher 
inclusion of dietary digestible phosphorus in ZnO medicated diets post-weaning, especially 
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CHAPTER ONE  
General introduction 
1.0. The rising population  
Feeding the World in the 21st century and beyond is perhaps one of the biggest challenges 
mankind has ever faced. The population of humans has exhibited unprecedented expansion 
in the last two hundred years, increasing from one billion in 1804 to six billion by 1999 
(McQueen, 2000). Projected growth to the year 2100 by the United Nations (2011) suggests 
this trend will continue with an estimated increase to 10.1 billion. At the same time, there is 
a notable shift from those living in rural areas to urban environments (Figure 1). Those 
people living in urban areas tend to require more commercially prepared foods which are 
typically easier to transport but increase the requirements for grains, sugar and animal 
products, such as fats and proteins (McQueen, 2000).    
 
 
Figure 1: Global human population dynamics from 1961 – 2010 with trends indicated 
for rural and total populations, male and female economically active agricultural 
populations.              (Source: FAOSTAT, 2012).  
 
As the human population increases, so does the competition for natural resources such as 
nitrogen (N) and phosphorous (P), which are also attributed to both direct and indirect 
consequences on the global environment (Holdren and Ehlich, 1974). For example, N has 
been extracted from the air for industrial fertiliser and explosives since the invention of the 
Haber–Bosch process, in which, as Fritz Haber described in his 1920 Nobel Prize speech, 
“Gaseous nitrogen combines with gaseous hydrogen in simple quantitative proportions to 
produce gaseous ammonia” (Haber, 2002). It is this process, in combination with N 
mobilisation from processes like biomass burning, which contributes to huge amounts of N 
fixation in the terrestrial environment (Vitousek et al., 1997). This N can lead to acidification 
and eutrophication of water courses (Vitousek et al., 1997) and if it gets into drinking water 





In the same way, P, arguably one of six unconditional ingredients for life on earth (Wolfe-
Simon et al., 2011; Schoepp-Cothenet et al., 2011), follows a similar trend. In nature it tends 
to be found as the inorganic element which can be mined from the earth, or as organic 
constituents of animals and plants. In the latter case, it is largely found phosphorylating 
inositol in the form myo-inositolhexakisphosphate (IP6), where it can accumulate in the 
environment, contributing to eutrophication of watercourses (Turner et al., 2002). Pigs have 
very limited endogenous phytase production in the stomach and small intestines, instead 
relying on exogenous phytase to catalyse the dephosphorylation of IP6 (Schlemmer et al., 
2001). The result is that 60 - 70% of dietary P from phytate containing crops, is excreted in 
farm slurry or manure where exogenous phytase is not supplemented (Lenis and 
Jongbloed, 1999). This is partly in the form of phytic acid (IP6) or lower inositol phosphates 
from the incompletely digested cereals such as wheat and corn, with the remainder as 
inorganic P (Giles et al., 2011).  
   
Total daily P intakes from pig feeds in the UK are estimated to be 60 tonnes, 83% of which 
is fed to fattening pigs (Table 1). With this in mind, a partial solution to the problem of P 
digestibility in pigs and poultry was put in to commercial practice in the 1990’s in the form 
of dietary exogenous phytase enzymes (van Gorcom et al., 1991). These were initially 
derived from Aspergillus ficuum but have since been produced from a number of other 
sources including Eschericha coil and Peniophora lycii (Lei et al., 2013).  
 
Table 1: Estimated daily phosphorus usage by UK pigs from feed sources.  
















Pregnant  sows 339 2.7 2.3 5.1 13.8 4.7 
Lactating sows 68 8.0 3.2 7.1 56.9 3.9 
Boars/gilts 98 2.8 2.4 5.3 14.9 4.5 
All breeding pigs 505     10.0 
Weaners 1080 1.01 3.8 8.4 8.5 9.2 
Growers 1080 1.96 2.5 5.6 10.9 11.8 
Finishers 1080 2.5 2.4 5.3 13.3 14.4 
Bacon pigs 1080 2.8 2.2 4.9 13.7 14.8 
All fattening pigs 4319     50.1 







In pig feeds, rates of 500 FTU/kg of microbial phytase are efficient at improving P 
digestibility, allowing for a reduction of 0.77 g/kg to 1.0 g/kg inorganic P in feed (Adeola et 
al., 2006; Jones et al., 2010). At spring 2015 prices, this equates to a UK wide saving of 
£18000/day from the substitution of dicalcium phosphate with phytase. A plateau in 
improved P digestibility is observed above 1000 FTU/kg supplemented phytase (Jones et 
al., 2010). Despite little extra P digestibility past this dose, ‘extra phosphoric’ effects have 
been reported, including enhanced feed conversion efficiency (Cowieson et al., 2011). 
Following a comprehensive review of phytase enzymes in pig diets, Selle and Ravindran 
(2008) conclude that further work to develop nutritional frameworks for phytase 
supplemented diets is still needed. Based on current population projections, we must 
continue to develop sustainable production systems that provide healthy food from healthy 
animals to meet the nutritional needs of humans in the 21st century. The concept of phytase 
super-dosing may thus be a useful strategy to incorporate in pig production systems, 
alongside phase feeding to reduce dietary P usage (Kebreab et al., 2012). Investigating 
phytase super dosing at weaning is of particular interest, due to the high levels of dietary P, 
rapid growth and changing gut environment. 
 
1.3. Zinc oxide 
Typical requirements of dietary zinc for modern EU pig genotypes is estimated to be 100 – 
110 mg/kg feed (DM basis) for pigs around weaning, decreasing to 89 – 100 mg/kg feed 
(DM basis) during the first few weeks post-weaning (Whittemore et al., 2003; NRC, 2012). 
Pooled data from Europe (22 countries), however, suggests that the median level of zinc in 
piglet feeds is typically higher than this at 137 mg/kg feed (DM basis), close to the currently 
authorised total maximum content of zinc permitted in complete feed of 150 mg/kg 
(FEEDAP, 2014). At very high levels (1000 – 3000 mg/kg), zinc has been concluded to have 
therapeutic properties (FEEDAP, 2014) and pharmaceutical grade zinc oxide (ZnO) has 
therefore been licensed as a veterinary medicinal product for use in Europe. In the UK, 
PigZin Premix (Vm 19108/4000) and ZincoTec® (Vm 03941/4000) are both authorised for 
use in pig feeds on a veterinary prescription (Mounsey, 2016), and would normally be given 
either metaphylactically or therapeutically to prevent/treat post-weaning diarrhoea (PWD).  
 
The bioavailability of ZnO for pigs is not well defined, with some estimates as low as 20% 
(Poulsen and Larson, 1995), however, availability of ZnO is typically 50 - 80% (NRC, 2012) 
so that the amount absorbed and retained from a typical diet supplemented with 2000 mg/kg 
ZnO is 27 % and 24% respectively (Buff et al., 2005). Based on an average feed 
consumption of 500 g/day (over a period of three weeks post-weaning), there would be 
approximately 950 mg of excreted zinc per pig per day. In a recent Danish study, excess 
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zinc was confirmed to be accumulating in the environment from the application of pig 
slurries/manure from ZnO medicated feeds to arable land (Jensen et al., 2016). In addition 
to disrupting the soil ecosystem (Duan et al., 2016), excess zinc poses the risk of leaching 
into aquatic environments, posing a risk of toxicity in some fish species. A review by 
FEEDAP (2014) however, suggests that while species such as trout may be able to tolerate 
reasonable levels of zinc in the environment, levels >20 mg/kg bodyweight may be 
detrimental. In addition to these risks, pharmaceutical levels of Zn supplementation has 
been shown to reduce the efficacy of phytase for releasing dietary P for pigs (Augspurger 
et al., 2004). Based on the stated risks and antagonistic effects, it may be desirable to 
restrict the use of high doses of pharmaceutical ZnO in pig production to therapeutic 
applications in clinical cases only.  
    
1.4. Objective of the thesis 
Based on the premise that there is now a body of evidence suggesting that super dosing 
phytase enzymes can enhance young pig production performance beyond that attributable 
to the release of additional dietary P from phytate, the aim of this thesis is to evaluate the 
best strategy for using phytase in newly weaned pig diets. This is done in the context of 
weaning being a critical time in the life of the pig, with multiple sources of stress, potentially 
leading to a “growth check” and/or post-weaning diarrhoea. Phytase will therefore be 
assessed in line with pharmaceutical ZnO as a standard, which is commonly added to pig 
feed immediately post-weaning in the UK to prevent adverse weaning associated events 
(e.g. PWD). Specifically, the hypotheses being tested in this thesis are: 
 
1. Supplementing phytase in diets for weaned pigs at doses beyond that normally required 
for improving plant derived phytate phosphorus digestibility (super dosing) is an 
efficacious strategy for improving production performance in newly weaned pigs.  
 
2. Metaphylactically ZnO medicated diets for seemingly healthy newly weaned pigs may 
need supplementation of addition digestible phosphorus or phytase to ensure optimal 





























Figure 1.2: Schematic overview of the experiments conducted in this thesis. 
Experiment SM1 
- Dose response to digestible phosphorus level 
Experiment SM2 
- Dose response to phytase level 
Experiment SM3 
- Factorial experiment for level of P, dose of phytase and dose of ZnO 
- Dose response to digestible phosphorus level 
Experiment SM4 
- Assessment of BD Vacutainers for blood 
mineral quantification by ICP-MS 
Experiment SM5 
- Factorial experiment for dose of phytase and dose of ZnO (health/immune responses) 
- geNorm experiment to identify appropriate reference genes 
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CHAPTER TWO  
Literature review 
2.0. Introduction 
This chapter reviews published literature on the nutritional requirements of the pig post 
weaning in response to the complex physiological changes and stresses during this 
period. It examines past and current thinking around phytase enzyme inclusion in weaner 
pig diets, starting with the traditional approach of reducing environmental pollution by 
enhancing phosphorus digestibility, and concluding with areas for developing potential 
new approaches.  
 
2.1. Weaning 
The definition of weaning is one of complexity and as such, has been extensively 
debated. In simple terms, the Concise Oxford English Dictionary (2002) states: 
 
“wean1 v. – accustom (an infant or other young mammal) to food other than its mother’s 
milk” 
 
This implies that weaning is unique to mammals and fails to adequately describe the 
behavioural and physiological changes occurring at this time. A different approach to re-
define weaning was taken by Martin (1984), who also recognised the limitations of this 
definition and so proposed a general model based on the changes in parental care as a 
function of the age of the offspring (Figure 2.1). Counsilman and Lim (1985) agreed that 
the model proposed in Martin’s revised definition was a useful concept but objected to a 
change from the dictionary definition. Interestingly, their objection was based on a now 
out-dated definition they gave from the Shorter Oxford English Dictionary (1964, 3rd ed.) 




Figure 2.1: General relationship between the rate of parental investment and the 
age of the offspring. The period of weaning is bounded by the two principle points 
of inflection.                (Source: adapted from Martin, 1984). 
 
In response, Martin (1985) defended his argument that weaning could be termed as the 
period during ontogeny when the rate of parental investment drops most sharply. 
Furthermore, he criticised their focus on suckling, since his view was that parental care 
encompasses more than just providing milk. It is this point that complicates how we 
measure weaning; as Martin (1985) goes on to offer examples of parental care such as 
providing solid food, supporting social interactions and defence against predication. How 
exactly parental care is measured is therefore up for discussion but Martin (1985) also 
adds that weaning is accompanied by behavioural and physiological changes. Thus, 
Figure 2.1 would appear to be lacking in full detail. In defining the weaning process, 
several questions with regards to the length of transition and the general changes 
observed in weaner pigs must be answered.  
 
2.1.1. Weaning the young pig 
In pigs, weaning tends to be initiated by the sow, occurring gradually with a marked 
increase of supplemental feed intake from about week five and declining suckling periods 
until complete weaning at 11-12 weeks in indoor systems ( Bøe, 1991). This can be even 
longer in semi-natural environments, with mean weaning at around week 17 (Jensen and 
Recén, 1989). The difference between an indoor commercial system where temperature 



















Age of offspring 
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account for the variation in weaning length. However, in both studies it was noted that 
there was a cost-benefit conflict between mother and offspring. Sows increasingly 
terminated suckling as time progressed and preferred to be suckled lying down initially 
but progressively reverted to standing. This ties in with the prediction of Martin’s (1984) 
model that parental care sharply declines during the natural weaning process.    
 
In commercial and experimental situations it is rare that this gradual process is followed, 
rather, the young pig is abruptly separated from the dam at a set point in time. 
Segregated early weaning is a system commonly found in the USA where piglets are 
weaned by removal and separation from the sow at around seven – ten days of age. 
Performance data of early weaned pigs (at day seven) also lends weight to the idea that 
these systems are sub-optimal, with reportedly lighter piglets at six weeks (p<0.05), than 
those weaned at 14 or 28 days (Worobec et al., 1999).  
 
A similar study by Patience et al. (2000) found that at six weeks, pigs weaned at 12 days 
and kept on the same site as the sows were not heavier than those weaned at 21 days 
(p=0.05). While this is in good agreement with the results of Worobec et al. (1999), early 
weaned pigs (at day 12) that were moved off-site weighed more at day 56 (p<0.05) than 
those weaned at 21 days (Patience et al., 2000), indicating weaning age is only one of 
the factors affecting growth at this time. Furthermore, Patience et al. (1999) report that 
early weaning followed by rearing off-site continues with heavier pigs (p<0.01) at day 56 
than those weaned at 21 days. However, they also found that early weaned pigs 
remaining on-site end up lighter (p<0.01) than the later weaned pigs by 0.8 kg. Multisite 
production may then become a useful management tool for segregated early weaning. 
 
It is apparent from these studies that performance is multifactorial, however, growth 
performance is not the only measure applicable to finding the optimal age to separate 
sow and piglet. Pigs weaned at seven days have also been observed to perform more 
belly-nosing (p<0.05) on pen mates than those weaned later (Worobec et al., 1999), 
suggesting that behavioural changes should also be taken into account. Given the ethical 
considerations and abnormal behaviour exhibited by early weaned pigs, animal welfare 
legislations (The Welfare of Farmed Animals [England, 2007] and [Scotland, 2010] 
Regulations) require weaning to be postponed until at least 28 days of age or 21 days if 
the piglets are moved to clean and disinfected housing, which is separate to that of the 
sow. In practice, this means that the UK pig industry tends to abrupt wean around day 





Main et al. (2004) lends further support to the UK strategy of later weaning as they found 
that multisite production in early weaning systems is still no substitute for increasing 
weaning age to three weeks. In their series of trials, they weaned pigs at 12, 15, 18 or 
21 days of age and found a linear improvement in average daily gain (p<0.002) and day 
42 weight (p<0.001). They calculated that this resulted in an increase in weight sold per 
pig weaned of 1.80±0.12 kg for each day weaning was extended. Moreover, when they 
compared simple and complex diets (containing more lactose and plasma) with weaning 
age, there were no differences in daily gain or 42 day weight. Extending the weaning age 
past four weeks to six or even eight weeks raises another set of problems. Whereas 
early weaning is bad for the piglet, a collaborative study by DEFRA (2007) over a three 
year period, predicted that later weaning effectively reduced sow yearly litter size by four 
pigs. While some significant improvements to piglet performance were identified 
immediately post-weaning, they did not find any differences by the time the pigs reached 
slaughter weight. On balance, weaning at 21 - 28 days would appear to be an appropriate 
strategy that benefits both the piglet and the sow.   
   
2.2. Transition period 
The transition from milk to solid/semi-solid feed is clearly a key feature of weaning in 
mammals, resulting from the reduction of parental investment. Formulated solid feed fed 
post-weaning is lower in fat and denser in carbohydrates than milk due to the cereal 
content (Table 2.1). Liquid feeds can be fed as an alternative to dry feed but must be 
adjusted to ensure adequate dry matter (DM) provision. 
 
Table 2.1: The composition of sow milk, creep feed and starter diet 
Composition  Sow milk1 Creep feed2 Starter feed2 
Dry Matter % 20.7 88.0 88.0 
Fat % 10.4 13.0 6.5 
Protein % 4.8 20.0 21.5 
Lactose % 5.8 - - 
Digestible Energy (MJ) 6.1 15.0 15.0 
(Source: adapted from 1Atwood and Hartmann, 1992 and 2Primary Diets, not dated). 
 
There is evidence that pigs are able to influence their DM intakes by regulating their 
consumption of water in relation to the DM content of their feed (Geary et al., 1996).  This 
may be a natural response, since if feed is restricted post-weaning, the gut will not 
develop fully in terms of anatomy (smaller stomach and SI tract), morphology (shorter 
villi height and deeper crypts due to a lack of energy and physical stimulus) and will have 
lower digestive functionality due to reduced digestive enzyme activity (Kelly et al., 1991; 
Dong and Pluske, 2007).  Dry matter intakes during this weaning period are thus not only 
key to ensuring adequate nutrient provision, but influence how the gut develops.  
10 
 
2.2.1. Gut physiology 
Lining the whole gut lumen are long finger like projections called villi, which provide a 
large absorptive area for the transport of nutrients into the blood via the brush border 
membrane coating them (Mosenthin, 1998). Using scanning electron microscope images 
from birth to 21 days post-natal, Skrzypek et al. (2007) reported that duodenal villi at birth 
were folded (forming transversal furrows) but these disappeared as the length of villi 
increased and flattened. Jejunum villi also flattened out with active extrusion zones 
whereas, ileal villi started out flat with many large lysosomal vacuoles but had developed 
into different shapes by day seven, depending on the crossbreed examined. Polish 
Landrace / Pietrain showed a range from finger-like to tongue-like, but Duroc / Hampshire 
/ Wild Boar crossbreeds developed only short finger-like ileal villi. Even after weaning, 
Rubio et al. (2010) reports that in a 15 kg pig, the duodenal and jejunal villi height are 
similar but that ileal villi are significantly shorter. Rubio et al. (2010) also found 
differences in overall villus height and surface area between Landrace/Large White and 
Iberian breeds. Taken together with the results of Skrzypek et al. (2007), their work 
suggests different crossbreeds may be better at absorbing nutrients depending on how 
their GI tract develops. 
         
At the base between the villi are mucosal glands (crypts) which function to produce all 
the intestinal epithelia cells required to maintain a constant rate of cellular turnover 
(Kraehenbuhl et al., 1997). The emerging enterocytes are fully capable of producing a 
range of proteins as they emerge from the crypts (Fan et al., 2001) having already 
differentiated into one of four terminal cell types (Chandrasekaran et al., 1996). 
Protein/biological activity then increases the further the enterocytes migrate up the villus 
away from the villus/crypt junction (Brown et al., 1999; Fan et al., 2001), before cell death 
by apoptosis at the tip of the villi. The rate of migration up the villus is constant along the 
small intestines in the neonatal pig, however, the lifespan of these cell increases from 
around 4.7 days in the proximal segment to around 10.2 days in the distal region (Fan et 
al., 2001). Differences in regional functions may account for this discrepancy.  
 
During weaning, major histophysiological changes occur in the gut of the pig ( Lallès and 
Salmon, 1994, Pluske et al., 1997).  The most distinctive changes were described by 
Boudry et al. (2004) who killed piglets at two, five, eight and 15 days after weaning (day 
21), before dissecting and measuring various parts of their intestines. They found that 
villous height in the proximal jejunum significantly decreased by 40 % from two days 
post-weaning but began to recover by day 15 (77 % of pre-weaning height). Additionally, 
crypt depth in the proximal jejunum and distal ileum significantly increased by day five 
post-weaning. Even when weaning was postponed to weeks four and six, Miller et al. 
(1986) reported a shortening of villi and increasing crypt depth along the length of the 
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small intestines at day five. Similar results were presented by Spreeuwenberg et al.  
(2001) who also observed a significant decrease in the mean ratio of villus height to crypt 
depth (2.25 vs 1.80) over four days post-weaning.  
 
Since Skrzypek et al. (2007) found that villi had fully extended by 21 days post-partition, 
it is likely that the reduction in villus height is attributed to an increase loss of cells as 
they shed into the lumen. This may also explain the increase in crypt depth as they have 
to expand to keep up with cell proliferation to maintain villus height. While these physical 
changes to the tissue structure of the small intestines post-weaning may contribute to a 
reduced absorptive surface area (Pluske et al., 1997), changes to digestive function and 
absorption may be a more profound problem (Miller et al., 1986; Kelly et al., 1991).  
 
2.2.2. Digestive and absorptive functions 
The intestinal brush border membrane comprises of a microvilli layer lining the apical 
surface of enterocytes originating from the crypts (as previously described in section 
2.2.1), which acts to facilitate the transfer of nutrients from the gut lumen to the interstitial 
fluids and blood. The microvilli overlay a fibrillar cytoskeleton, which interacts as a 
support and regulatory structure (Holmes and Lobley, 1989) allowing intracellular entry 
of nutrients. These migrate through the cell to the basolateral membrane for absorption 
into the blood.  A potent cocktail of enzymes and proteins are secreted on the brush 
border membrane (Fan et al., 2001; Rubio et al., 2010), which aid in digestion (brush 
border enzymes) and absorption (transporters). Activity of the digestive enzymes vary 
depending on location along the small intestines, with the highest activity of lactase, 
sucrase, maltase and isomaltase found in the jejunum of 15 kg pigs (Rubio et al., 2010). 
Both aminopeptidase and alkaline phosphatase activity were highest in the mid-distal 
regions. The concentration of these enzymes were also shown to vary depending on 
breed (Rubio et al., 2010), not unlike the differences in gut morphology previously 
described.  
 
Passive absorption of nutrients occur by diffusion between epithelial cells via the tight 
junctions (Figure 2.2), as well as by endocytosis (Wijtten et al., 2011). Mineral ions and 
other nutrients (such as glucose and amino acids) can also move across the brush 




Figure 2.2: Pig nutrient absorption pathways through paracellular routes via tight 
junctions and intracellular routes by transporters in the small intestines.  
          (Source: Adapted from KEGG, 2013) 
 
Many of the active transport mechanisms are co-dependent on multiple nutrients. For 
example, glucose and phosphorous (to a certain extent) are dependent on the transport 
of sodium (Figure 2.2) via sodium-dependent glucose co-transporter member 1 (SGLT-
1) and type 2 sodium-dependent phosphorous co-transporter (NPT2b). Before weaning, 
there is a constant active transport of Ca and P across the brush border membrane, 
however, post-weaning this is dependent on calcitriol status (Schröder et al., 1998).  Just 
like the digestive enzymes, these active transporter genes are not constantly expressed 
along the length of the intestine (Figure 2.3), indicating they may have localised 




Figure 2.3: Heatmap of pig gene expression results of eight selected targets. 
Green and red indicate low and high gene expression respectively compared to 
the average expression.   (Source: Adapted from van der Wielen et al., 2014).  
 
Peptide transporter 1 (PepT1) shows the highest expression in the proximal and mid 
small intestines whereas, sodium-dependent glucose co-transporter member 1 (SGLT-
1) up-regulation tends to be confined to the jejunum only (Figure 2.3).  In contrast, gut 
hormones such as glucagon-like peptide-1 (GLP-1) and cholecystokinin (CCK) are 
expressed largely in the proximal small intestines but glucagon and peptide YY (PYY) 
are found mid to distal regions (Figure 2.3).  This localisation of transporter expression 
level is consistent with site dependent digestive enzyme activity (Rubio et al., 2010), 
chemosensing (Mace and Marshall, 2013) and nutrient absorption site (Table 2.2).  
 
Most of the nutrient absorption is localised to the duodenum and jejunum with the 
exception of magnesium, which is reported to be absorbed mainly from the hind gut 
(Table 2.2). New born pigs have also been shown to have a considerable net 
electrogenic ion transport across duodenal brush border membrane compared to those 
suckling or weaned (up to a 75% reduction in short circuit currents) and show a significant 
reduction in tissue conductance post-weaning (Schröder et al., 1998). This indicates that 
the tight junctions are more permeable post-weaning; confirmed by a significant increase 
in mannitol (used as a marker) transport from two days post-weaning (Spreeuwenberg 
















Table 2.2: Sites of mineral absorption in the porcine intestine 
Nutrient Major site of absorption Mechanism Source 
Phosphorous Jejunum Sodium dependent active 
transport, calcitriol and 
passive diffusion  
1, 2, 6 
Sodium Jejunum and ileum  Sodium-dependent 
transporters  
3, 6, 7, 11 
Calcium Active transport along 
duodenum and jejunum. 
Passive transport along 
whole tract.  
Calcitriol dependent active 
transport and passive 
transport in high Ca diets 
2, 4, 6 
Zinc Duodenum and jejunum Zinc specific transporters 
and peptide co-
transporters 
5, 6, 8 
Potassium Whole tract Passive diffusion via tight 
junctions 
6, 7, 11 
Iron Duodenum Active transporters and 
active transport of Heme 
6, 10 
Magnesium Colon and caecum Mainly passive diffusion, 
some via tight junctions 
but some active 
transporters  
6, 9 
1Saddoris et al. (2010); 2Schröder et al. (1998); 3 van der Wielen et al. (2014); 4Bronner 
(2003); 5Tacnet et al., (1993); 6KEGG (2013); 7Nabuurs et al. (1996); 8Hill et al. (1987); 
9Milinković-Tur et al. (2001); 10Furugouri and Kawabata (1976); 11Leddin (1991).  
   
Wijtten et al. (2011) reviewed the literature around intestinal barrier function post-
weaning and concluded that low feed intakes at weaning led to reduced villus height. 
Low feed intake also resulted in compromised proximal intestinal barrier function but 
weaning in general had no effects on distal barrier function. Supplementing solid feed 
during the suckling period has been shown to prevent the normal reduction in small 
intestine villus height and net fluid absorption four days post-weaning, compared with 
those left on the sow or weaned without supplemental feed (Nabuurs et al., 1996). In a 
different strategy, cow’s milk has previously been used to ensure nutrient supply was 
maintained immediately post-weaning and also effectively prevented villus atrophy 
(Pluske et al., 1996). Both approaches support the need for adequate nutrient provision 







2.2.3. Gut immunology  
The gastro-intestinal (GI) tract forms a complex interface where substances cross from 
the environment into the body. This is clearly vital for the absorption of nutrients but also 
exposes the animal to the risk of pathogens. The pig has evolved a layered defence 
system to protect against infection, consisting of physical barriers, generic innate 
mechanisms and specific pathogen acquired immunity. The physical intestinal barrier is 
composed of intestinal epithelial cells (as already discussed), their associated mucins 
(Oswald, 2006), diffuse intestinal intraepithelial lymphocytes (iIELs) and dendritic cells 
(Christ and Blumberg, 1997). These all play active roles in immunity above the 
basolateral membrane (Christ and Blumberg, 1997). They are able to sense antigens 
using pattern recognition receptors (PRR) such as Toll-like receptors (TLR), Nucleotide 
oligomerisation domain-like receptors (NLR) and RIG-I-like receptors (RLRs) (Bailey, 
2009; KEGG, 2014). Ligation of PRR can up-regulate the transcription of a variety of 
cytokines within the micro-environment (Oswald, 2006; Bailey, 2009; KEGG, 2014). 
These cytokines also act to signal other classes of immune cells (Table 2.3) and can 
induce an acute phase response. 
 
Table 2.3: Summary of cytokines and chemokines secreted from pig intestinal 
epithelial cells and their usual target for interaction 
(Source: Oswald, 2006) 
 
Mucosal layer thickness is greater in the ileum verses the jejunum or duodenum (Rubio 
et al., 2010), where in addition to the array of frontline defences, special M (microfold) 
cells are able to transport luminal antigens to the gut-associated lymphoid tissue (GALT), 
underlying the basolateral membrane (Jung et al., 2010). GALT, is formed of either 
isolated or aggregated lymphoid follicles (Peyer’s patches), with the former found in the 
jejunum and the latter in the ileum in the pig (Pabst and Rothkӧtter, 1999). Since the 
ileum contains larger continuous Peyer’s patches compared to the mid and proximal 
small intestine (Figure 2.4), the distal region is likely at higher risk of pathogenic bacterial 
challenge from the hind gut.  
 
Cytokine/ Chemokine Usual target 
IL-8, TNF (α/β), CXCL1, CXCL2, CXCL5 Neutrophils 
CCL28, CCL5 Eosinophils, Lymphocytes 
CCL11 Eosinophils 
GM-CSF, CX3CL1, CXCL9, CCL2 Monocytes 
IL-1 (α/β), IL-6, IL-7, IL-10, IL-12, IL-15, IL-18, TGF-
β, CXCL10, CCL22, CCL25, CCL7 
Lymphocytes 




Figure 2.4: comparison of small intestines of pigs three weeks post weaning (1a = 
duodenum, 1b = jejunum, 1c = ileum). Villi can be seen lining the gut lumen in all 
three sections and Peyer’s patches are visible as dark purple in the ileum sections.  
 
In intestinal section 1c (Figure 2.4) Peyer’s patches (stained purple) are easy to see as 
they are found as a continuous follicle in the ileum whereas, those located along the 
jejunum are found as discrete packages and have been missed in the 1b intestinal 
section. The distribution of both T cells and others such as macrophages and dendritic 
cells in these Peyer’s patches are organised, with CD2+/CD3+ receptors seen throughout 
the structures but sIg receptors only expressed in the follicles (Makala et al., 2001). Once 
transported to the GALT, antigens further stimulate an immune response by the 
interactions of professional immune cells and antigen presenting cells (Figure 2.5).  









The importance of interactions between the cells of both the GALT and those above the 
basal membrane to orchestrate an appropriate immune response is clearly seen in 
Figure 2.5 and relies on cell to cell communication. In fact, only capillary endothelial cells 
and those of the lamina propria express major histocompatibility complex (MHC) class 
two receptors in pig intestine, with those of the iIELs (CD2+) staining negative (Wilson et 
al., 1996). Despite the lack of MHC II on iIELs, Inman et al. (2010) hypothesise that 
endothelial cells in the mucosal layer of the neonatal pig are able to interact directly with 
T cells, as well as with dendritic cells located in the lamina propria, which in turn, are also 
capable of CD4+ Th cell proliferation and polarisation via MHC II. Furthermore, in the 
pig, most cells of the Peyer’s patches are antibody producing B type as opposed to T 
cells, unless the pigs are kept germ free (Pabst and Rothkӧtter, 1999). This indicates 
that the presence of bacterial microbiota play a key role in conditioning the GI immune 
system. It is possible that the increase of B cells relative to T cells may be due to 
colonisation of the gut with probiotic bacteria, since oral dosing of some lactic acid 
bacteria in mice has been shown to increase B cells but not CD4+ T cells (Perdigón et 
al., 1999).  
 
The mechanism for B and T cell activation is, at least in part, mediated by the production 
of IL-6, where in mice, non-pathogenic bacteria do not stimulate enough IL-6 to induce 
intestinal epithelial cells to produce IFN-γ or IL-12, unlike pathogenic strains which do 
(Vinderola et al., 2005). If IL-6 production is excessive and is in combination with TGF-β 
and IL-23, then naïve T cells may be triggered to express the Th17 phenotype (Vernal 
and Garcia-Sanz, 2008). At least in mice, these cells are largely controlled by the small 
intestines, with the highest populations found in the duodenum, and declining numbers 
the further along the tract they are measured (Esplugues et al., 2011). This makes them 
an important target in the understanding of GI immunology.          
 
Birth and weaning are both critical points in the development of the intestinal immune 
system as at these two points, the gut must ‘learn’ to distinguish between harmful 
antigens and safe nutrients. The neonatal pig soon develops a full complement of 
immune cells after birth in pre-formed Peyer’s patches (Pabst and Rothkӧtter, 1999; 
Makala et al., 2001), and is supported by an external supply of maternal immunoglobulins 
(IgG) and immune cells from colostrum for the first 24 hours post-parturition (Dividich et 
al., 2005; Bandrick et al., 2014). Their diffuse gut immune system normally develops in 
stages and is complete within six weeks of life (Lallès et al., 2007b).  At weaning, the 
composition and range of protein ingestion from food and gut microbiota change 
dramatically again from those at birth and the immune system must adapt again. 
Lymphocyte blastogenesis assays have previously suggested that weaning pigs below 
five weeks of age negatively affects pig cell-mediated immunity (Blecha et al., 1983). 
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Strong cell-mediated immunity would suggest an immune system that is able to rapidly 
respond to an immune challenge, thereby limiting potential damage from an invading 
pathogen and may explain some of the difference observed in growth performance. This 
is in line with commercial practice of weaning from week four.  
 
Evidence suggests that in the first two days post-weaning, there is a significant reduction 
in the ratio of CD4+/CD8+ in the jejunum but this seems to recover by the fourth day 
(Spreeuwenberg et al., 2001). Interestingly, Parra et al. (2013) measured the expression 
of pro-inflammatory cytokines: TNF-α, IL-8 and IL-18 in the intestines of newly weaned 
pigs and demonstrated a significant increase in the expression of all three by the fifth 
day post weaning and a subsequent decline thereafter. They propose that the elevation 
in these cytokines may contribute to post-weaning diarrhea. These changes in T cell 
populations may be partially the result of the neonatal microenvironment, since Inman et 
al. (2010) found that in contrast to adult pig intestines, neonatal endothelial cells played 
a role in presentation of antigens to T cells, in addition to the classical CD16+ dendritic 
cell/T cell presentation. Given the increased permeability of the intestines to antigens 
post-weaning (Spreeuwenberg et al., 2001), and the ability for professional and 
endothelial cells alike to present antigens, it is not surprising T cell phenotype ratios are 
dynamic. Post-weaning, small intestinal alkaline phosphatase (IAP) digestive capacity 
and maximal enzyme specific activity are both reduced (Lackeyram et al., 2010). The 
reason for this is unclear but Lackeyram et al. (2010) discuss a range of factors which 
together, seem likely to contribute to a down regulation of IAP transcription. The distal 
GI tract may then be more vulnerable to the effects of bacterial antigens stimulating TNF-
α via LPS mediated TLR4 activation, since IAP plays a role in dephosphorylating LPS, 
thus helping maintain intestinal barrier function (Lallès, 2010).   
 
These combined challenges at weaning often lead to a multi-factorial temporary growth 
check ( Lallès et al., 2007a), which is pronounced in abrupt weaning (Berkeveld et al., 
2007) but apparently mitigated in gradual weaning systems ( Bøe, 1991). The transition 
period is thus a critical time in the life of the pig that needs careful management. 
 
2.3. Nutrient requirements post-weaning 
Nutrient requirements must be met through the appropriate selection of dietary 
ingredients. The availability of these ingredients tend to be influenced by crop production 
in the various countries (Table 2.4), since those crops not grown locally must be 
imported.  




Table 2.4: 2010 crop production of likely pig feed ingredients in the UK and USA 
Crop United Kingdom 
2010 Production (millions of tonnes) 
United States of America 
2010 Production (millions of tonnes) 
Barley 5.3 3.9 
Maize N/A 316.2 
Soybeans N/A 90.6 
Wheat 14.9 60.1 
(Source: FAO, 2012) 
 
Wheat based diets for pigs are common in the UK, whereas maize-soybean diets are 
prevalent in the USA, reflecting the production patterns of Table 2.4. This factor must be 
considered when diets are formulated, since the standards are calculated using 
prediction models, validated through experiments. The diets fed in these experiments 
are likely to differ depending on which area of the world the research was conducted in, 
and thus which cereal base was used.  
 
Recommendations concerning the nutrient and energy requirements of the young pig 
were set out by the British Society of Animal Science (Whittemore et al., 2003) and the 
National Research Council of the National Academes (NRC, 2012). These concise 
documents are drawn up using a range of scientific publications and can thus be 
regarded as good compilations of our knowledge and understanding of pig nutrition. 
Even so, the former standard is now over a decade old, and while they are of high quality 
information, neither takes into account the health status of the herd or the breeding of 
the pigs.  
 
Aside from the key macro nutrients (fats, protein and carbohydrates) found in compound 
pig feeds, minerals are known to play many significant roles in body maintenance and 
growth. Unlike protein, carbohydrates and fats; minerals do not carry a potential physical 
energy (PPE) value, since they are independent of the digestible organic fraction of feed 
(Boisen, 2007). However, they are required to be present in significant quantities in the 
pig’s diet (Table 2.5) to prevent deficiencies that would otherwise result in clinical disease 











Table 2.5: Dietary mineral requirements of the weaner pig on a dry matter basis 
Nutrient BSAS recommendation 
(units/Kg [air dried] feed) 
NRC recommendation 
(units/Kg [DM] feed) 
 10 – 30 kg BW 11 – 25 kg BW 
Calcium (Ca) 8.0 g/kg 7.8 g/kg 
*Phosphorus (P) 3.8 g/kg 3.2 g/kg 
Sodium (Na) 2.0 g/kg 3.1 g/kg 
Potassium (K) 2.5 g/kg 2.9 g/kg 
Magnesium (Mg) 0.4 g/kg 0.4 g/kg 
Chloride (Cl) 2.0 g/kg 3.6 g/kg 
Zinc (Zn) 100 mg/kg 88.9 mg/kg 
Manganese (Mn) 30 mg/kg 3.3 mg/kg 
Iron (Fe) 120 mg/kg 111.1 mg/kg 
Cobalt (Co) 0.2 mg/kg - 
Iodine (I) 0.2 mg/kg 0.2 mg/kg 
Selenium (Se) 0.2 mg/kg 0.3 mg/kg 
Copper (Cu) 6.0 mg/kg 5.6 mg/kg 
*Digestible phosphorus, (Source: adapted from Whittemore et al., 2003 and NRC, 2012)  
 
The chemical form each mineral is provided in and the presence of modulators such as 
enzymes and anti-nutritional factors (ANF) will affect how the gut can metabolise and 
ultimately use these elements.    
 
2.3.1. Phosphorus and Calcium   
Phosphorus (P) and calcium (Ca) are essential inorganic elements that play diverse roles 
within the body. Balance studies have shown that absorption of Ca is largely regulated 
in the pig small intestines, since urine contains little Ca when dietary Ca intake increases, 
but that P is only partly regulated in the pig intestines, with urinary P output positively 
correlated with P intake (Fernández, 1995). However, if P is deficient for bone formation, 
the kidneys play a much greater role in Ca regulation (González-Venga and Stein, 2014). 
Further investigation has shown linear uptake of P by a Na-P co-transport system across 
both pig small intestinal and renal tissues (Brandis et al., 1987). This mechanism is 
independent of calcium level and is stimulated to increase P absorption in response to 
low dietary P intake (Saddoris et al., 2010). During suckling and post-weaning, Schröder 
et al. (1998) found that the kinetics (Vmax) of the Na-P co-transporter are greatly reduced 
compared with new born pigs. However, P transport affinity remained constant at 0.45 – 
0.63 mmol/litre in normal pigs. In their study, vitamin D3 deficient pigs also showed 
normal Na-P transport when new born but this was significantly reduced in the suckling 
and weaning period. Once supplemented with D3 post-weaning, the levels were not 
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significantly different from new born levels, suggesting active intestinal P transport is only 
vitamin D3 dependent post-weaning.     
 
Transcellular calcium absorption in the small intestine is the main route in low Ca 
concentrated diets via a three stage process mediated by CaT1 and vitamin D (calcitriol), 
followed by extrusion from the cell with CaATPase (Bronner, 2003). This is evident from 
the results of Schröder et al. (1998) who reported that the inclusion of dietary vitamin D3 
in pigs post-weaning was able to restore plasma Ca concentrations whereas, these 
values were 39 % lower in calcitriol deficient animals. In high Ca diets, paracellular 
transport over the whole length of the small intestines takes over as the main route of Ca 
absorption (Bronner, 2003).        
 
Extensive reviews of Ca and P requirements for pigs have been undertaken by working 
committees of the Agricultural Research Council (ARC, 1981), the British Society of 
Animal Science (Whittemore et al., 2003) and the National Research Council (NRC, 
2012) in a bid to suggest dietary guidelines. The most recent recommended standard 
(Whittemore et al., 2003) for UK weaned pigs (10 – 30 kg) suggests levels of 7.5 g/kg of 
total Ca and 3.4 g/kg (air dried matter basis) of digestible P. This standard is now over 
10 years old but is a good starting point to formulating practical diets, since they suggest 
nutrient levels to meet efficient production targets. They also state that they “are mindful 
of nutritional welfare and taking account of the needs for environmental protection in 
relation to emissions of nitrogen and phosphorus”. This suggests the recommended level 
may be a compromise between the needs of the pig and safeguarding the environment.  
 
2.3.2. Mineral Bioavailability   
Both the BSAS and NRC standards give similar recommendations for mineral 
requirements of newly weaned pigs, up to approximately four weeks post-weaning (Table 
2.5). While total P requirements are predicted to be around 7g/kg of feed, the digestibility 
of this mineral must also be considered. Modelling the fate of P and Ca in the 
stomach/small intestines has suggested that the dietary form P and Ca are supplied in 
is the biggest factor for absorption (Létourneau-Montminy et al., 2011). In animal 
products, P digestibility is typically 61 – 90 % (example given for bone precipitate and 
skimmed milk powder respectively). This is very similar to the digestibility values for pure 
inorganic P sources, which are also around 64 % for dicalcium phosphate and 90 % for 
monosodium phosphate. Lenis and Jongbloed (1999) compare these values with those 
from a variety of plant sources and found P digestibility to average only ~30 % in plant 
material for pig diets. It is therefore more appropriate to formulate diets using the 
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apparent or standardised total tract digestibility (ATTD or STTD) rather than total P, since 
undigested phosphorus is simply excreted and is therefore not available to the animal.  
 
Several approaches to describing P requirements for pigs have been referred to in the 
literature. Their use was recently re-visited by Peter Wilcock at the 1st International 
Phytase Summit in 2010. His conclusions indicate that digestible Ca and P are still the 
most appropriate expression to use when formulating pig diets but that they rely on a 
number of variables, making them hard to predict in practice. The main problem with 
using digestibility values is that they are only predictions based on experimental 
observation. They will naturally vary depending on factors such as the genotype of the 
pig (Alexander et al., 2010), their bio-availability and how they interact with other 
chemicals. Phytic acid (myo-inositol hexakisphosphate) for example, is a highly reactive 
molecule (Maenz et al., 1999) which has a high affinity to bind Ca into indigestible 
complexes (phytate) at neutral pH (Applegate et al., 2007). Even for inorganic P, it is 
predicted that increasing dietary Ca reduces P digestibility by 2 % due to the formation 
of insoluble Ca – P complexes (Létourneau-Montminy et al., 2011; 2012).     
 
The retention of P is also influenced by dietary Ca concentration in a quadratic 
relationship, rather than the linear reduction seen on digestible P (Létourneau-Montminy 
et al., 2012). This is consistent with the mineralisation of P into bone in a Ca dependent 
manner. In young pigs, (3.7 – 24.8 kg), a greater content of bone ash (in relation to total 
bone mineral content) is found in the trunk section, with lower but equally portioned 
content in the fore and hind legs (Mitchell et al., 2001). As the pig exceeds ~30 kg body 
weight, so the accumulation of bone ash in the trunk in relation to total bone ash starts 
to decrease, making way for linear increases in leg bone ash content (Mitchell et al., 
2001). 
 
Mineralisation of Ca in the bone is partly regulated by parathyroid hormone (PTH) which 
increases in response to a restriction in blood Ca supply (Hagemoser et al., 2000). 
Elevated PTH results in stimulation of vitamin D3 from the kidneys, thereby increasing 
intestinal Ca and P absorption as previously described. At the same time, increased PTH 
results in bone demineralisation, as Ca is mobilised to restore plasma levels. This is 
clearly demonstrated in pigs fed diets very deficient in Ca, where a time lag of 16 days 
from treatment to plasma Ca response is observed (Eklou-Kalonji et al., 1999). This 
resulted in a rapid increase in blood PTH to compensate, resulting in significantly 
reduced bone volume and reduced mineralisation (as indicated by significantly higher 




When Ca is in excess, the retention of Ca absorbed decreases in a linear fashion over 
the range 0.33% to 0.67% (linear, p=0.01), when a plateau becomes apparent 
(quadratic, p=0.01) above this level (Stein et al., 2011). This tends to be pronounced 
from the time of leg bone mineralisation noted by Mitchell et al. (2001), as the efficiency 
of retention is significantly higher in lower Ca diets around this time, having been 
significantly lower than Ca excess diets prior to this point (Aiyangar et al., 2010). This 
suggests there is a limit to how much Ca can be retained in the bones, with the efficiency 
of retention decreasing closer to this limit. Since hydroxyapatite (the main mineral 
structure in bone) is composed of Ca and P in a 2:1 ratio (Ca5(PO4)3), the retention 
efficiency of P should also slow as described by Létourneau-Montminy et al. (2012) as 
dietary Ca increases.      
        
In low P diets, young and growing pigs are more sensitive to a wide Ca:P, with Reinhart 
and Mahan (1986) reporting tendencies of lower growth performance when ratios 
exceeded 1.3 and 2.0 for low P and high P diets respectively. They also show linear 
decreases in bone ash content as the ratio widens from 1.3 – 4.0 in both starter and 
growing pigs. Dietary Ca and P for optimal growth performance differs from that ideal for 
bone mineralisation by at least 1 g/kg less (NRC, 2012). A brief survey of published 
scientific studies indicates a wide range of total Ca and P levels are fed as basal diets, 
which also differ in the Ca:P (Table 2.6).      
 
Table 2.6: Analysed total Ca and tP of selected experimental weaner pig basal diets 
Source Ca (g/kg) Total P (g/Kg) Ca:P 
(Woyengo et al., 2009) 9.4 5.0 1.9 
(Woyengo et al., 2010) 10.6 5.3 2.0 
(Simons et al., 1990) 5.2 3.3 1.6 
(Simons et al., 1990) 5.7 4.1 1.4 
(Mroz et al., 1994) 7.3 3.6 2.0 
(Lei et al., 1993) 4.4 3.2 1.4 
(Revy et al., 2006) 9.5 7.3 1.3 
(Augspurger et al., 2004) 7.0 3.2 2.2 
(Jones et al., 2010) 7.1 4.0 1.8 
 
While both the inclusion level and ratio of Ca and tP differ between authors (Table 2.6), 
they are broadly related to standard recommendations. Some of the variation may be 
down to the differing guidelines used (NRC vs BSAS), the age of the animals (weaning 
age and weight varies) and genotype/production targets the diets were designed for. The 
range of Ca:tP ratios described in Table 2.6 (1.3 – 2.2) were largely assessed by Qian 
et al. (1996) who used 1.2, 1.6 and 2.0 in their trial. They found that a ratio of 1.2 resulted 
in the best performance (in agreement with Reinhart and Mahan, 1986), P digestibility 
and phytase efficacy; which decreased linearly as the ratio was widened. A similar study 
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by Poulsen et al. (2010) concluded that Ca:tP ratios in the range of 0.9 – 1.8 did not 
significantly affect P digestibility which is in disagreement with Qian et al. (1996). In this 
latter study, all P was derived from plant phytate and revealed a Ca – phytase interaction 
on P utilisation, thus confirming the source of P and level of dietary phytase are both 
important factors to consider in addition to the total Ca:P.   
  
2.4. Dietary phytic acid  
Phosphorus derived from plant sources is predominately found as part of the organic 
molecule phytic acid (PA) (Table 2.8). Of the nine stereoisomers (Shears and Turner, 
2007), it is the fully phosphorylated form: myo-Inositol 1,2,3,4,5,6 hexakisphosphate 
(IP6), that is overwhelmingly found in nature, accumulating in both terrestrial and aquatic 
environments (Turner et al., 2002; Giles et al., 2011). Plants synthesise the various 
inositol phosphates for many diverse and multifunctional reasons (Loewus and Murthy, 
2000), resulting in a lock up of the majority of P in phytic acid salts (phytate). The highest 
concentrations of PA are typically found in the seeds (Table 2.7), where they act as a 
reserve store, mobilised through enzymatic activity during germination (Hall and Hodges, 
1966; Centeno et al., 2001).  
 
Table 2.7: Analysed total P and calculated PA content of selected raw materials 
Feedstuff Total P content 
(g/kg) 
Phytate P content 
(g/kg) 
Phytic acid content 
(g/kg) 
Source 
Maize 3.2 2.34 8.30 1  
3.24 1.86 6.60 2 
2.6 2.2 7.80 3 
Mean = 3.0±0.36 Mean = 2.1±0.25 Mean = 7.6±0.87 
 
Barley 4.23 2.67 9.47 1 
Wheat 3.17 2.02 7.16 1 
4.21 2.51 8.90 2 
Mean = 3.7±0.74 Mean = 2.3±0.35 Mean = 8.0±1.23 
 
Oats 3.7 2.2 7.80 1 
Wheat bran 11.4 8.7 30.85 1 
Wheat middlings 8.4 6 21.28 1 
13.05 7.99 28.33 2 
Mean = 10.7±3.29 Mean = 7.0±1.41 Mean = 24.8±4.99 
 
Soybean meal 6.99 4.675 16.58 1 
6.3 3.8 13.48 3 
8.36 3.95 14.01 2 
Mean = 7.2±1.05 Mean = 4.1±0.47 Mean = 14.7±1.66 
 
Rapeseed meal 12.4 7.3 25.89 1 







In wheat seeds, PA is predominately confined to the aleurone layer as opposed to the 
endosperm or germ (Williams, 1970; O’Dell et al., 1972), which explains why wheat bran 
and middlings have far greater concentrations than whole wheat (Table 2.7). Since these 
tend to be low value by-products, they have previously found application in pig diets, thus 
acting as a substantial source of dietary PA. Typical weaner pig diets in the UK contain 
~45% wheat/barley and ~15% soya, providing approximately 6 – 7 g PA/kg diet. The PA 
in corn is almost exclusively confined to the germ (O’Dell et al., 1972). However, progress 
has been made in terms of breeding low phytate crops (Raboy, 2002). These are 
particularly suited to the American corn/soybean based diets. In these low phytate plants, 
there does not appear to be any disadvantage in terms of germination, compared to 
conventional varieties, since the total P is not reduced; rather some PA is replaced with 
lower inositol phosphates or inorganic P (Raboy, 2007).   
 
2.4.1. Chemical structure of inositol phosphates 
IP6 consists of a six carbon ring, populated by six phosphate groups, giving the chemical 
formula C6H18O24P6. The calculated PA concentration in plant material (Table 2.7) is thus 
based on the assumption that one molecule contains 28.2% phosphorus, as derived from 
the molecular weight of its individual components (Table 2.8). 
   
Table 2.8: The chemical formulation of inositol 1,2,3,4,3,5,6 hexakisphosphate 
Symbol Element Atomic weight Number of atoms Mass % 
C Carbon 12.01078 6 10.9183  
H Hydrogen 1.007947 18 2.7488  
O Oxygen 15.99943 24 58.1765  
P Phosphorus 30.9737622 6 28.1564  
 
Recommendations for the numbering of carbon atoms in myo-inositol come from the 
Nomenclature Committee of the International Union of Biochemistry (NC-IUB), when in 
1988 they relaxed the lowest-locant rule (NC-IUB, 1989). The problem they faced is 
shown in Figure 2.6, where depending on the positional numbering (locants) of carbon 
atoms in the ring (clockwise or anticlockwise); there are two possible first carbons. This 
stems from the IUPAC CNOC and IUPAC-IUB CBN (1976) nomenclature of cyclitols 
recommendations I-4 and I-10. In the absolute configuration, rule I-10 specifies that when 
drawn in a vertical (Fischer-Tollens type) manor, C-1 is at the top, followed by C-2 and 
C-3 on the front edge. If then C-1 is projecting to the right, a clockwise numbering of the 
carbon atoms is used (D configuration) but if C-1 is projecting to the left, an anticlockwise 




Figure 2.6: Numbering of atoms in myo-inositol       (Source: NC-IUB, 1989) 
 
Figure 2.6 also reveals the solution to the problem. myo-Inositol (I) is shown in the L-
configuration where the numbering is anticlockwise (II), and also in the D-configuration 
where numbering is clockwise (III). The relaxation of the numbering rule (NC-IUB, 1989) 
means that either the L or D configuration can be used depending on convenience, thus 
so long as L or D is indicated, both are acceptable. The conformational structure was 
debated in the 1980’s (Maga, 1982) though Rabinowitz and Kraut (1964) correctly 
reported that there is only one hydroxyl group axial, conventionally now assigned to C-
2. Furthermore, they determined that in myo-Inositol crystals, each unit contains two 
asymmetric molecules. This property has recently been confirmed by Rebecca et al. 
(2012) who isolated crystals from the flesh of dragon fruit. Their approach to isolate and 
identify these crystals involved four different techniques (X-ray crystallography, HPLC, 
LC-MS/MS and NMR) which together, provide clear evidence that a considerable amount 
(4 g/kg) is also present in dragon fruit in addition to the traditional seeds. 
 
2.4.2. Anti-nutritional effects 
Due to the 12 ionisable protons, PA is a strong chelator of metal cations at neutral pH 
(Maenz et al., 1999) and forms stable complexes with these metals (Figure 2.7), 
inhibiting their digestion/absorption over a wide pH range (3.0 – 9.0) (Kim et al., 2010). 
An equilibrium study by Odani et al. (2011) further confirmed that the conformational 
behaviour of IP6 is pH dependent. At low pH they reported that there was a high liability 
of protons dissociating from the phosphate groups but that raising the pH increases the 
degree of polyamine protonation. Traditionally, PA has therefore been viewed as an anti-
nutritional factor (ANF) in pig diets, since phosphorus and complexed metal ions are 




Figure 2.7: Structure of phytic acid (A) and phytic acid chelate (B) 
         (Source: adapted from Schinckel, not dated) 
 
An in vitro experiment was conducted by Yu et al. (2012) which showed how these 
properties of PA may affect practical aspects of pig nutrition. They demonstrate that in a 
pH range of 2.5 to 3.8 (typical of conditions in the stomach of the pig), protein aggregates 
can form. However, below pH 2.0 this is not the case due to the dissociable proteins 
(they reported a clear solution). Additionally, they showed that as PA concentration 
increased in solution, so relative pepsin activity dropped sharply. Pepsin is an enzyme 
required to assist protein breakdown in the stomach, thus inhibition of pepsin activity may 
reduce protein digestion. 
 
A review by Selle et al. (2012) suggests that the anti-nutritional effects of phytic acid on 
protein digestion may not be limited to binary complexes, but may also extend to ternary 
complexes formed through cationic bridges above the protein isoelectric point. These 














2.4.3. Metabolic roles of inositol phosphates 
The inositol phosphates have been implicated in many metabolic pathways in both plants 
and animals (Holub, 1986; Loewus and Murthy, 2000; Raboy, 2003; Tsui and York, 2010; 
Valluru and Van den Ende, 2011). Indirect protein-protein reactions (as successive 
enzymes) are shown in the pathway map (Figure 2.8), based on information in the KEGG 
database (Kanehisa and Goto, 2000). The numbered boxes serve to identify individual 
EC enzymes and the reaction products are identified by hollow circles. It is clear from 
the array of reference metabolic pathways (Figure 2.8) that the inositol phosphates are 
implicated in many different reactions. This suggests that phosphate release is only the 
tip of the iceberg and that research should now focus on areas like cellular signalling 
pathways. 
 
In the pig, not all of these metabolism pathways are active. However, the pathways in 
green (Figure 2.8) reveal that there are still many lower inositol phosphate products 
produced. It is likely that the instability of these compounds allow them to play many 
diverse roles in the body. Conversely, the stability of IP6 makes it an effective precursor 
substrate. In fact, Barker et al. (2009) has described the molecule as a platform for which 
there are 63 theoretical stereochemical forms. Thus, not only can phosphate groups be 
removed, but extra P may be added, forming inositol pyrophosphates.  
 
It can be seen from Figure 2.8 that the phytase (EC 3.1.3.26 and EC 3.1.3.8) metabolism 
pathways are not active in the pig. This prevents the breakdown of IP6 to the lower esters. 
However, there are many other phosphate hydrolases and kinases working on the 
substrate. These metabolism pathways are important for cellular function with many 
reported roles of the active inositol phosphates (Miller et al., 2008; Tsui and York, 2010). 
In fact, there is increasing evidence that they have anticancer activity (Bozsik et al., 2007) 









2.5. Phytate degrading enzymes 
Phytases are a class of phosphatase enzymes, specific to phytate, classified by the 
Nomenclature Committee of the International Union of Biochemistry (NC-IUB) as 
phosphoric monoester hydrolases (EC 3.1.3.). They catalyse the dephosphorylation of IP6 
(Figure 2.9) and can be split into two main categories based on their pH optima: acid 
phytases and alkaline phytases. Of interest in monogastric nutrition are the histidine acid 
phytases (HAPhy) which demonstrate optimal activity at low pH (Oh et al., 2004) and are 
thus suited to working in the stomach, where phytate complexes are most vulnerable to 
degradation due to the low pH. There are two other classes of acid phytases: purple acid 
phosphatases (PAPhy) and protein tyrosine phytase (PTPhy) (Yao et al. 2011; Lei et al. 
2013).   
 
Figure 2.9: Hydrolysis of phytic acid by phytase enzymes        (Source: KEGG, 2012) 
 
Only one alkaline phytase has been characterised: β-propeller phytase (BPPhy). These 
have been isolated from Bacillus and Enterobacter bacteria and some plant seeds including 
Lilium longiforum, legume seeds, mung beans, spelt and Typa latifolia L (Liu et al., 1998; 
Oh et al., 2004). Their major drawback is their specificity for calcium phytate, of which the 
end product from alkaline phytases is IP3 and not a complete dephosphorization (Oh et al., 
2004; Kim et al., 2010; Zeng et al., 2011). This may limit their use as the sole phytase 
incorporated into mono-gastric animal feeds.    
     
Greiner and Bedford (2010) summarised the classification of phytases based on their 
catalytic mechanisms, pH optimum and mode of action. The latter refers to the official 
classifications of phytase into three classes by NC-IUBMB (2012). These sub-classes are 
known as 3-phytase (EC 3.1.3.8), 4-Phytase (EC 3.1.3.26) and 5-phytase (EC 3.1.3.72), 
depending on which carbon in the myo-inositol ring is hydrolysed first. Loewus and Murthy 
(2000) recognised that the nomenclature of inositols is a source of confusion. They point 
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out that that the positions of C2 and C5 are fixed but the two remaining pairs of carbon 
atoms (C1/C3 and C4/C6) can be numbered clockwise (L-configuration) or counter 
clockwise (D-configuration). Depending on which is used, 4-phytase may then be regarded 
as 6-phytase and 3-phytases can be called 1-phytase.  While it is generally regarded that 
microbes produce 3-phytase and seeds of higher plants produce 6-phytase,  there are some 
exceptions as noted by Konietzny and Greiner (2002). They propose that the D-
configuration should be used so that a distinction can be made between micro-organisms 
producing EC 3.1.3.8 (3-phytase), higher plant seeds producing EC 3.1.3.26 (4-phytase) 
and a few micro-organisms not following the rule that produce EC 3.1.3.26 (referred to as 
6-phytase to distinguish between that produced by seeds). It should be noted that 5-phytase 
(EC 3.1.3.72) also exists and is produced by a range of organisms including lily pollen 
(Barrientos et al., 1994), Bifidobacterium pseudocatenulatum (Haros et al., 2009) and 
Selenomonas ruminantium subsp. lactilytica (Puhl et al., 2008).     
 
Interestingly, while Zeng et al. (2011) have identified alkaline phytase from Bacillus as a 4-
phytase, alkaline phytase from lily pollen (Lilium longiforum) is a 5-phytase (Barrientos et 
al., 1994). There are very few documented cases of alkaline phytase in the literature being 
used for animal nutrition, the exception is fish (Liu et al., 2013), but both 3- and 6- histidine 
acid phytases have been successfully produced and marketed as feed enzymes for the last 
few decades. Even so, they are usually only able to dephosphorylate down to lower esters 
(Konietzny and Greiner, 2002). For complete destruction of myo-inositol phosphate to myo-
inositol and a free phosphate, inositol-phosphate phosphatase (EC 3.1.3.25) can be used 
(NC-IUBMB, 2012), or one of the enhanced phytases (which have better substrate affinity 
for lower IPs).  
 
At least three phytase classes (HAPhy, PAPhy and BPPhy) are known to hydrolyse phytate 
salts of Ca2+ and Mg2+ but have been shown not to dephosphorylate Al3+, Cu2+, Fe2+, Fe3+ 
or Zn2+ phytate (Tang et al., 2006). The fourth class (PTPhy) was unknown at the time of 
the study. This reflects the order of binding strength each mineral has to PA (Maenz et al., 
1999). Since phytate has multiple Ca binding sites, BPPhy is particularly good at degrading 
insoluble calcium phytate and can prevent it forming salts with other metal ions (Kim et al., 
2010). These phytases may therefore be particularly suited for use in the neutral pH 
conditions of the upper digestive tract, where insoluble phytate may re-form. In the acidic 
conditions of the stomach, PA is no longer complexed and can easily be degraded by the 
acid phytases. Given that each sub-class of phytase leads to a particular species of lower 
inositol phosphate, it is important that the end product is considered, since they play many 
roles in cellular signalling pathways and other metabolic processes (Liu et al., 1998; 





2.5.2. Phytase in animal nutrition 
The first widely used commercial cloning and expression technology for exogenous phytase 
enzymes in animal feed was patented by van Gorcom et al. in 1991. Their system relied on 
the purification of a fungal phytase (Aspergillus), however, they also suggested their patent 
could be used as a template for modified wild type phytases (second generation phytases). 
Alternatively, Vaara et al. (1992) patented the concept of steeping grains in phytase 
enzymes for 48 hours prior to milling for animal feed. Although, in practice, steeping in 
phytase prior to feeding has been found to confer little benefit over phytase added to dry 
feed (Columbus et al., 2010). By 1995 commercial enzyme preparations containing both 
phytase and acid phosphatase activity were patented that had enhanced efficacy through 
thermal treatment (Vanderbeke et al., 1995). More recently, methods combining at least two 
HAP phytases (preferably both a 3-phytase and a 6-phytase) have also been patented, in 
a bid to ensure complete dephosphorylation (Boze and Moulin, 2013).   
 
Taking a different approach to treating the feed, Golovan et al. (2001) genetically modified 
the pig in such a way as to express the E. coli appA phytase gene in the parotid gland. The 
resulting phytase released in the saliva proved to be quite effective at breaking down 
phytate, leading to a 75% reduction in faecal P output. Despite the technology being 
patented in 2006 (Forsberg et al., 2006) and proven stability over nine generations 
(Forsberg et al., 2013), Ontario Pork ceased funding for the project in 2012 (Ontario Pork, 
2014). Since the herd kept at the University of Guelph was euthanized and are not in 
commercial production, next generation exogenous phytase preparations are now in strong 
demand for treating feeds.   
 
These third generation phytases have enhanced intrinsic thermostability and substrate 
affinity, making them far better and more effective than their predecessors. Within the 
European Union, there are currently nine preparations (except Finase EC which is second 




















Date of EU 
authorisation 
Finase (EC) 6 Trichoderma reesei ROAL Oy 
21.04.2010 / 
26.09.2011 
Quantum  6 Pichia pastoris Syngenta Ltd 08.07.2008 
Quantum Blue 6 Trichoderma reesei ROAL Oy 11.04.2014 
Natuphos 3 Aspergillus niger BASF SE 
01.12.2009 /  
27.06.2008 






















(Source: adapted from EU, 2015)  
 
The majority of those authorised are 6-phytases, with the two 3-phytases among the first to 
be registered (Table 2.9). In addition to the five expression systems used in the protein 
production, it is important to note where the original gene sequence is from. In the case of 
Finase EC, Optiphos, Phyzyme, Quantum and Quantum Blue, the phytase gene originates 
from E. coli. In Natuphos the original sequence was isolated from A. niger NRRL 3135 and 
the gene from P. funiculosum is used in Rovabio PHY AP. The phytase gene in Ronozyme 
originates from Peniophora lycii. Phytases from each of these sources will differ in pH 
optimum, temperature optimum and end product produced (Table 2.10).  
 
Table 2.10: Selected characteristics of phytase found in commercial feed products  
Original organism Group pH optimum Temperature optimum (°C) 
A. niger HAP Phy A 2.5 – 5.0 55 – 60 
P. funiculosum -  4.0 – 5.0  50 
E. coli HAP Phy C 5.0 – 6.0  40 – 60  
- Unknown  (Source: adapted from Oh et al., 2004; Pierrard et al., 2008)  
 
Phytase activity is measured as the concentration of inorganic phosphate released from a 
specific phytate substrate per minute, under specific reaction conditions. The original 
method called for phytase to be incubated with sodium phytate at 37±0.1°C and pH 5.5 and 
defined one phytase unit (FTU) as the quantity of enzyme that liberates 1 mol of inorganic 
P per minute, under the conditions of the assay (Engelen et al., 2001).  While this method 
is useful for the pure phytase product, Kim and Lei (2005) suggested an improved version 
using spin columns, under the same conditions, specifically for determination of phytase in 
animal feed, due to the higher levels of background P. The official definition of phytase 
activity was updated by Gizzi et al. (2008) and subsequently published as ISO 30024 in 
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2009. One FTU is currently defined as “the amount of enzyme that releases 1 µmol of 
inorganic phosphate from 5 mM phytate/min at pH 5.5 and 37°C”.  
 
Given that both the pH and temperature optimums for commercial phytases are different to 
those specified by the in vitro test (Table 2.10), a number of phytase manufacturers have 
designed their own in house tests specific for their products. For the product Quantum™, a 
new assay was proposed for the determination of activity in feedstuffs. The new method 
proposed modified conditions for testing at pH 4.5 and 60°C in replace of pH 5.5 and 37°C 
in the official method (CRL-FA, 2007). Under these conditions, phytase activity is expressed 
in Quantum™ phytase units (QPU/kg). Similarly, Optiphos® activity was submitted to the 
European Food Safety Authority (EFSA) in units of OTU/kg and not FTU/kg. The definition 
of one OTU is given as: “the amount of enzyme that catalyzes the release of 1.0 micromole 
of inorganic phosphate per minute from 5.1 mM sodium phytate in pH 5.5 citrate buffer at 
37 °C, measured as the blue P-molybdate complex colour at 820nm” (EFSA, 2011). In this 
case, the buffer has been changed from acetate to citrate; the latter has been shown to be 
effective at solubilising some phytates (Maenz et al., 1999; Tang et al., 2006). The definition 
of phytase activity in authorised EU products are detailed in Table 2.11.  
 
Table 2.11: Definition of phytase activity units authorised for animal feed in the EU 
Product Unit Definition of phytase activity 
Finase (EC) PPU 1 PPU/g is the amount of enzyme which liberates one 
μmol of inorganic phosphate from sodium phytate per 
minute at pH 5 and 37 °C 
Quantum; 
Quantum Blue;  
Phyzyme XP 
FTU 1 FTU is the amount of enzyme which liberates 1 
micromole of inorganic phosphate from sodium phytate at 
pH 5.5 and 37 °C in one minute. 
Quantum 
(alternative units) 
QTU 1 QTU is the amount of enzyme that releases 1 µmol of 
inorganic phosphate from 5 mM phytate/min at pH 5.5 and 
37°C 
Natuphos FTU 1 FTU-unit is the amount of 3-phytase which liberates 1 
μmol of inorganic phosphate per minute from sodium 
phytate at pH = 5.5 and 37 °C. 
Optiphos OTU 1 OTU is the amount of enzyme that catalyzes the release 
of 1.0 micromole of inorganic phosphate per minute from 
5.1 mM sodium phytate in pH 5.5 citrate buffer at 37 °C, 
measured as the blue P-molybdate complex colour at 
820nm  
Rovabio PHY AP RPU 1 RPU is the amount of enzyme that releases 1 μM 
inorganic ortho-phosphate per minute from sodium 
phytate as substrate at pH 5.5 and 37°C. 
Ronozyme NP FYT 1 FYT unit is the quantity of enzyme which liberates 1 
micromole of inorganic phosphate per minute from sodium 
phytate at pH = 5.5 and 37°C 
Ronozyme 
HiPhos 
FTU 1 FYT unit is defined as the amount of enzyme that 
releases 1 μmol of inorganic phosphate from phytate per 
minute under reaction conditions with a phytate 
concentration of 5.0 mM at pH 5.5 and 37 °C. 
(Source: adapted from CRL-FA, 2007; 2009; EFSA, 2007; 2008a; 2008b; 2009a; 2009b; 
2011; 2012; 2013) 
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Although the unit of phytase activity acronym differs between products (Table 2.11), the 
definitions remain largely unchanged from the official ISO 30024 method. The normal dose 
of phytase enzymes recommended in the EU for pigs varies depending on age of the animal 
and the product registered are detailed in Table 2.12.   
 














6 250 – 1000 250 – 1000 250 – 1000 PPU 
Quantum 6 100 – 2500 - - FTU 
Quantum 
Blue 
6 500 – 1750 250 – 1750 250 – 1750 FTU 
Natuphos 3 500 100 500 FTU 
Optiphos 6 250 – 500 250 – 500 125 – 500 OTU 
Rovabio 
PHY AP 
3 250 – 500 350 – 500 - RPU 
Ronozyme 
NP 
6 500 500 750 FYT 
Ronozyme 
HiPhos 
6 500 – 4000 500 – 4000 1000 – 4000 FTU 
Phyzyme 
XP 
6 500 – 1000 500 – 1000 500 FTU 
(Source: adapted from Commission Regulation (EU) No. 277/2010; 886/2011; 554/2008; 
292/2014; 1269/2009; 243/2007; 505/2008; 98/2012; 1141/2007; 171/2011; 837/2012; 
379/2009) 
 
The recommended doses of phytase for pig diets range from 100 – 4000 units/kg (Table 
2.12) and is derived from data submitted by the applicant to the EFSA on the safety and 
efficacy of the product to improve the digestibility of dietary P. Due to the variable nature of 
the mono-gastric digestive tract environment, in vivo, phytase activity may not reflect that 
measured in vitro. Studies of how phytase actually performs in live animals are therefore 
needed to attain this information.     
 
2.5.3. Phytase efficacy in vivo   
The efficacy of phytase to degrade phytate in the pig may be better expressed as the 
improvement in digestible P derived from the dephosphorylation of dietary phytate. Several 
approaches to expressing P digestibility have been previously described whereby, 
digestibility is measured at the terminal ileum or as ATTD. An updated description of the 
latter accounts for the secretion of endogenous P and is referred to as standardised total 
tract digestibility (STTD). There have been many studies over the years to improve P 
utilisation in pig diets, starting with unsuccessful live yeast cultures (Chapple et al., 1979) 
but progressing to purified commercially available phytase products (Adeola et al., 2006; 
Jones et al., 2010). Microbial phytase first showed efficacy to improve P digestibility in pigs 
from 34 % to 56 % and reduced P excretion by 33 %, 26 years ago, when fed at a 1000 
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FTU/kg (Simons et al., 1990). This was based on a purified culture of Aspergillus ficuum fed 
to only six cannulated fattening pigs. More recent and larger studies have also confirmed 
linear increases in P digestibility for E. coli, P. lycii,   and A. niger derived phytases fed at 
similar levels (Adeola et al., 2006; Kies et al., 2006a).  
 
An alternative approach to defining phytase efficacy in vivo calculates the additional release 
of P by phytase, based on the increase P mineralisation of bone relative to that from dietary 
inorganic P. This method expresses additional available P in relation to a response criteria 
but does not account for that excreted (Adeola and Applegate, 2010). Available P release 
curves based on this method have been constructed for a number of phytase products and 
have generally shown them to be effective at releasing P up to a plateau of 1000 FTU/kg 
(Figure 2.10).    
 
 
Figure 2.10: Available phosphorous release curve for E coli derived phytase in P 
deficient diets fed to weaned pigs.       (Source: adapted from Jones et al., 2010).  
 
 
The reconstructed curve in Figure 2.10 based on the equation published by Jones et al. 
(2010) shows that the 500 FTU/kg of 6-phytase is able to release the equivalent of 0.1 % 
aP, increasing to 0.12 % by 750 FTU/kg. Although effective up to 1000 FTU/kg, little extra 
benefit is gained from going beyond 750 FTU/kg. This fits well with the EU recommended 
doses (Table 2.12), suggesting a normal dose of phytase for pigs should be 500 – 750 

































2.5.4. Physiological effects 
As previously described, bone mineralisation due to the increased P and Ca released from 
phytate by phytase is routinely used to calculate available P release. The increase in bone 
mineralisation is also positively correlated with bone breaking strength, which has been 
reported to increase linearly with phytase dose (Veum et al., 2006; James et al., 2008; Zeng 
et al., 2014). Despite the increase in available P from PA at normal phytase doses, there is 
little evidence of improved growth rates in the first month post-weaning when compared 
with P adequate diets (Stahl et al., 2004; Veum et al., 2006; Zeng et al., 2014). However, 
Veum et al. (2006) did report that weaned pigs supplemented with 500 FTU/kg of E. coli or 
P. lycii phytase grew 73 g/day more than those without phytase, fed a P adequate diet, from 
day 28 – 42 post-weaning. In this experiment, those on the P adequate diet grew 100 g/day 
more in the same post-weaning period as those fed the non-phytase supplemented basal 
diet. Even though the phytase supplemented basal diet was formulated below the P 
requirement of the pig, assuming 500 FTU/kg released 0.1 % available P (based on Figure 
2.10) meeting the pig’s requirements, then the additional growth is likely due to the phytase 
and not the released P.  
 
In poultry, the addition of both fungal and bacterial derived phytase have been shown to 
improve immune function. Liu et al. (2008) investigated the addition of up to 1000 FTU/kg 
of E. coli phytase on antibody production to Newcastle disease virus (NDV) vaccine. At 
seven days post-vaccination it is unclear if phytase had a significant effect, as the authors 
have reported non-significance but have also suggested that birds supplemented with 1000 
FTU/kg phytase had significantly higher NDV antibodies than those not supplemented with 
phytase on a 0.44 % phytate diet. By day 21 post-vaccination, both 500 and 1000 FTU/kg 
phytase had increased NDV antibodies over the 0.44 % phytate control. In a second similar 
study by Ghahri et al. (2012) the addition of up to 1000 FTU/kg A. niger phytase also 
increased antibody levels to NDV vaccination by 19 days post-vaccination. In addition to B 
cell stimulation, Liu et al. (2008) also reported that the addition of dietary phytase 
significantly increased the number of both CD4+ and CD8+ lymphocytes but did not affect 
their ratios. They further reported that secretory IgA levels were higher in the phytase 
supplemented diets. Taken together, the evidence suggests that dietary phytase 
supplemented up to 1000 FTU/kg may enhance immune status. However, in pigs very little 
has been done to investigate the effects of phytase on immunity. Almeida et al. (2007) 
investigated doses of 500 FTU/kg on white blood cell differentiation and secretory 
immunoglobulins of finishing pigs (100 kg) and concluded there were no effects from this 
dose. It is known however, that T lymphocyte mediated response (to phytohemagglutinin) 
is linearly increased in weaned pigs as dietary available P increases from deficient to 
adequate (Kegley et al., 2001). This raises the possibility that doses >500 FTU/kg may 
influence immunity in young pigs, similar to that found in chickens.  
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2.6. Super dosing  
It is clear that normal doses of phytase (500 – 1000 FTU/kg) are able to restore growth 
performance in the first few weeks post weaning in negative P diets, back to the level of 
those fed the recommended dose of P (Zeng et al., 2014; Vigors et al., 2014). However, 
although Veum et al. (2006) showed that pigs supplemented with phytase up to 500 FTU/kg 
did not grow significantly different to, or tended (p<0.10) to perform slightly less than an 
adequate P control diet, when increased to above 2500 FTU/kg, pigs grew 64 g/day more 
than a P adequate diet (p=0.03). This also reflects the findings of Kies et al. (2006a) who 
found that it was not until >750 FTU/kg that growth rates matched a 1.5 g/kg inorganic P 
supplemented positive control (PC) diet and tended (p<0.08) to exceed them past 1500 
FTU/kg (Figure 2.11).   
 
 
Figure 2.11: The effect of phytase on the growth rate of weaned pigs. The threshold 
line represents growth from a positive control diet containing adequate digestible P.    
(Source: adapted from Kies et al., 2006a).    
 
The findings of Kies et al. (2006a) highlight the importance of meeting the digestible P 
requirement of the pig because even in their PC diet and at their highest phytase dose, they 
still have not met the BSAS recommendations of 3.4 g/kg (Whittemore et al., 2003), 
explaining why the pigs have not met their full growth potential by 15,000 FTU/kg. Given 
that Zeng et al. (2014) found no difference in the growth performance of weaned pigs fed 
20,000 FTU/kg over those fed a P adequate diet (4.2 g/kg), the evidence for ‘extra 
phosphoric’ effects on growth rates due to phytase super-dosing in pigs unclear. Phytase 
super dosing in poultry however, has recently been reviewed (Cowieson et al., 2011), 
showing clear benefits in growth performance. Although a number of mechanism have been 
proposed, particularly the release of amino acids (Selle and Ravindran, 2008), further work 
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2.6.1. Binary phytate – protein complexes    
It is possible that these ‘extra phosphoric’ benefits may be related to the release of chelated 
minerals and nutrients as phytate complexes are destroyed (Kies et al., 2006a), or from 
physical changes in the gut, such as prevention of crypt shrinkage and expression of gut 
transporters (Woyengo et al., 2011; Vigors et al., 2014) and other gut hormones (Liu et al., 
2009). Cooper and Growing (1983) found endogenous phytase in the brush border 
membrane of rat intestines and hypothesised that because of its location, it may play a role 
in facilitating metal absorption from dietary phytate. Very low levels of phytase have also 
been found in the gut of humans (Iqbal et al., 1994). Similar observations were made by 
Maenz and Classen (1998) in chickens, who found brush border endogenous phytase 
activity mostly occurs only in the pH range 5.5 to 6.5. Interestingly in all studies, the authors 
reported the highest intestinal phytase activity taking place in the upper sections of the small 
intestines, though levels they observed were very low, given that extra phosphoric effects 
have mostly been associated with super dosing phytase (>1500 FTU/kg).  
 
Kemme et al. (2006) investigated phytate degradation in the upper gastrointestinal tract of 
the pig using up to 900 FTU/kg of a 3-phytase derived from Aspergillus niger. Their 
evidence, based on using cannulated weaned pigs fed a maize/soybean diet, indicated a 
difference in the quantitative pattern of lower inositol phosphate products. They noted high 
formation of IP5 and IP4 in the duodenum at low phytase levels (186 FTU/kg) which shifted 
to destruction of higher inositol phosphate products (IP6-4) but high formation of IP2 at a 
phytase dose of 1000 FTU/kg. It has been demonstrated that lower IPs do not have the 
same, if any, protein binding capacity at low pH (Yu et al., 2012) and are thus less likely to 
reduce protein digestibility through binary phytate-protein complexes formed at low pH (Kies 
et al., 2006b).  
 
Evidence shows that in vitro, phytase significantly reduces phytate-protein complexes (Yu 
et al., 2012; Kies et al., 2006b) and conversely in vivo, high dietary phytic acid reduces 
protein digestibility to a greater (Liao et al., 2005a; Lehnen et al., 2011) or lesser extent 
(Woyengo et al., 2009). Despite this, in vivo experiments indicate that supplemental phytase 
of ~500 FTU/kg marginally increase crude protein (CP) digestibility by ~2 % (Mroz et al., 
1994; Liao et al., 2005b)  but super dosing phytase provides no additional benefits for pigs 
(Traylor et al., 2001; Liao et al., 2005a) or chickens (Augspurger and Baker, 2004). This 
may be due to the presence of high dietary mineral concentrations, since a meta-analysis 
by Lehnen et al. (2011) indicates that high Ca and P can reduce phytase activity. 
Alternatively, the diet matrix may also play a role as Liao et al. (2005b) only found a phytase 
effect on CP in wheat-soybean meal/canola meal diet and not in corn-soybean, wheat-




2.6.2. Ternary phytate – mineral – protein complexes    
In vitro experimentation by Yu et al. (2012) has  indicated that doses of microbial phytase 
of between 1000 - 2000 FTU/Kg degrade phytate in just 10 - 20 minutes but lower doses of 
250 - 800 FTU/Kg require considerably more time to work (3 - 7+ hours). A rapid breakdown 
of phytate complexes in the stomach by using high doses of phytase (1000+ FTU/Kg) may 
thus still be of great use in practical pig diets. In particular, the smaller dimensions of the 
weaner stomach in relation to adult animals lends itself well to a rapid breakdown of phytate 
complexes by using higher doses of better performing (second/third generation) phytases. 
This may allow for the vast majority of IP6 to be reduced to lower esters before they enter 
the small intestines, therefore maximising the opportunity for nutrient absorption by 
minimising the probability of ternary phytate-mineral-protein complexes described by 
Champagne (1988) formed at intermediate pH. Estimates of additional digestible mineral 
generation from exogenous phytase based on a meta-analysis of the literature are 
presented in Table 2.13. 
 


















0 0.00 0.00 0.00 0.00 0.00 0.0 0.0 
100 0.46 0.04 0.49 0.04 0.25 1.3 2.2 
250 0.62 0.05 0.67 0.06 0.33 1.8 3.0 
400 0.71 0.06 0.76 0.06 0.38 2.0 3.4 
500 0.75 0.07 0.80 0.07 0.40 2.1 3.6 
750 0.83 0.07 0.88 0.07 0.44 2.4 4.0 
1000 0.88 0.08 0.94 0.08 0.47 2.5 4.3 
1250 0.92 0.08 0.99 0.08 0.49 2.6 4.5 
1500 0.96 0.08 1.02 0.08 0.51 2.7 4.6 
2000 1.01 0.09 1.08 0.09 0.54 2.9 4.9 
5000 1.18 0.10 1.27 0.11 0.64 3.4 5.8 
(Source: adapted from Jongbloed and Bikker, 2010)   
 
The relationships between added phytase level and generated digestible mineral is 
quadratic and positive for all minerals analysed (Table 2.13). Phytase super dosing may 
thus require a re-appraisal of dietary formulations, given that a release of minerals and 
some proteins from phytate complexes can be expected. Many of these liberated mineral 
ions have also been shown to play essential roles in biochemical pathways and immune 
function. Taken together, it can be speculated that super dosing effects may be particularly 
useful in mitigating some of the symptoms associated with the post-weaning growth check, 
however, there is no clear consensus regarding the underpinning mechanisms. Currently, 
there is no data on the maximum dose of phytase that is effective at producing increased 
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growth performance in pigs, since Veum et al. (2006) did not reach a growth plateau at 
12,500 FTU/kg. 
 
2.7. Zinc interactions 
Zn supplied in various forms is well known to help reduce post-weaning challenge due to 
its roles in gut integrity (Hu et al, 2013; Han et al, 2014), and immune function (Kidd et al., 
1996). Depending on the form it is fed, absorption varies from up to 100 % from zinc 
sulphate (ZnSO4) and 50 – 80 % in zinc oxide (ZnO) (NRC, 2012), although a lower estimate 
for ZnO of only 20 % has been reported (Poulsen and Larson, 1995). Recommendations 
for inclusion in weaner pig diets vary depending on dietary ingredients but 75 – 100 mg/kg 
is generally considered to be sufficient (Whittemore et al., 2003; NRC, 2012; Hill et al., 
2014). In cases of post-weaning diarrhoea, pharmaceutical supplementation of zinc (1000 
– 5000 mg/kg) is commonly prescribed. In general, ZnO supplementation post-weaning 
improves growth rates, feed intake and feed conversion ratios (Sales, 2013), although these 
have not been seen in all cases (Walk et al., 2013; Chai et al., 2014). This may be explained 
by zinc’s antimicrobial action against some pathogens (Bratz et al., 2013) but not against 
others (Li et al., 2001; Šperling et al., 2014; Chai et al., 2014). This mixed response to the 
effectiveness of high zinc supplementation for newly weaned pigs needs further research 
given that excess Zn is excreted via faecal matter in high levels and is well known to pollute 
land and watercourses.  
 
Phytate is a strong chelator of Zn which forms phytase resistant complexes (Maenz et al., 
1999) with endogenous zinc secreted in the upper GI tract (Harland and Oberleas, 2010). 
Exogenous phytase activity thus needs to primarily occur in the stomach due to the solubility 
of phytate at low pH (Schlemmer et al., 2001). Zn dependent phytase has been reported to 
be localised to the brush boarder membrane of the duodenum of the rat (Davies and Flett, 
1978), suggesting this is an important site for phytase and Zn interactions. At normal doses 
of phytase, zinc bound to phytate complexes is released, allowing for the recommended 
inclusion levels in the diet to be substantially lowered from ~100 mg/kg to 35 mg/kg (Revy 
et al., 2006). However, at pharmaceutical levels Zn supplementation has been shown to 
reduce the efficacy of phytase for releasing dietary P for pigs (Augspurger et al., 2004).  
Recent research has, however, suggested that super doses of phytase enzymes may be 
an alternative strategy to high levels of zinc supplementation post-weaning to boost growth 
rates (Walk et al., 2013). Research should therefore focus on comparing super dosing of 
phytase to a ZnO positive control in seemingly healthy pigs, to establish if they have similar 
growth promoting effects. Of equal interest is the possibility that pharmaceutical ZnO may 
reduce the effects of phytase super dosing due to suppression of phytase activity by high 
zinc concentrations.   
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2.8. Conclusions and research gap 
Numerous studies have assessed the impact of nutrition around weaning on the lifetime 
performance of pigs. Abrupt weaning is clearly a critical control point in the life of the pig 
when changes in environment and diet lead to altered intestinal architecture, gut microbiota 
and gut immunity. The removal of dietary anti-nutritional factors, in particular phytate, at this 
time, may help the pig to mitigate some of the factors culminating in the commonly observed 
post-weaning growth check. There is some evidence to suggest that super doses of phytase 
enzymes can be used post-weaning to almost completely breakdown dietary phytate and 
to enhance mineral digestibility, especially zinc. It is also known that pharmaceutical doses 
of zinc oxide help reduce pathogenic microbial loading in the gut but only for some microbes. 
High levels of ZnO, such as those currently stated on the POM-V label (3100 mg/kg), may 
however suppress phytase activity, meaning that further information is needed on the 
optimal inclusion rates of phytase post-weaning and its effect in combination with zinc oxide. 
This needs to be focused on wheat based diets for the UK market, to help inform guidance 




CHAPTER THREE  
General materials and methods 
3.0. Introduction 
Common materials and methods used throughout this thesis are reported in this chapter. In 
addition, developmental works are also included, on the selection of vacutainers for trace 
element analysis (section 3.4.2) and the selection of suitable reference genes for gene 
expression analysis (section 3.6.1). Specific information regarding the choice of techniques 
are detailed in the relevant experimental chapters. 
 
3.1. Animals 
All experimental procedures were approved by Harper Adams University Ethics Committee 
and regulated procedures were conducted in compliance with UK regulations (Animals 
[Scientific Procedures] Act 1986). Protocols were designed in accordance with the ARRIVE 
(Kilkenny et al., 2010) and MIQE (Bustin et al., 2009) guidelines. Pigs were sourced from 
the Harper Adams University Pig Unit, which maintains a high health status and conforms 
to the Red Tractor Assurance for Farms - Pigs Scheme (AFS, 2013).  
 
3.1.1. Reduction 
Three components were assessed in order to reduce the number of pigs required for each 
experiment: 
 
1. Control of inter-subject variation 
2. Sample size determination 
3. Integration of experiments  
 
Healthy animals were used at all times to reflect baseline parameters found in commercial 
pig production and to reduce variation in the measured parameters, thus helping to control 
inter-subject variation.    
 
The sample size required to give adequate statistical power for each experiment was based 
on data obtained under similar conditions from previous experiments, using the procedure 
of Berndtson (1991), to detect an n % difference, with 80 % power, at the 95 % level of 
probability. Justification for the level of type one and type two error come from the 
requirements of FEEDAP (2011) for designing studies to assess tolerance and efficacy of 
zootechnical feed additives. Pigs are social animals and prefer to live in herds rather than 
in isolation, potentially becoming more easily stressed if individually housed, in part due to 
a lower maximum corticosteroid binding capacity (Barnett et al., 1981). Grouping animals 
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into pens rather than separating individuals allows the animals to express normal social 
behaviour. Pen studies also provide better quality information, since each replicate is an 
average measure of several pigs, thus reducing variation associated with individuals. Given 
the nature of the trials, the diets or housing conditions were not expected to produce any 
adverse effects. Balancing this with the stress that individual housing may cause, pens of 
animals were thus the most appropriate method to meet objectives in these studies.  
 
3.1.2. Refinement 
Environmental conditions in all experiments were close to those found in commercial 
practice and were designed to maximise performance by reducing stress and maintaining 
healthy stock. In addition, trained and highly experienced technicians were in attendance to 
ensure adequate care was provided. Protocols were refined following review by a qualified 
veterinary surgeon.   
 
3.1.3. Replacement 
The use of pigs in this thesis was unavoidable, as other animals would not adequately 
represent the conditions of the pig GI tract. Furthermore, other species require different 
dietary levels of nutrients that would not be appropriate for pig production. Consideration 
was given to non-animal models and in vitro studies where appropriate.   
 
3.1.4. Genotypes 
Pigs used in this thesis were from two dam lines (JSR Genpacker 90 [LWxLR] and PIC 
Camborough [[LWxLR] x White Duroc]) mated to various terminal sire lines, specified in 
each chapter. Both genotypes are representative of the UK national herd and were 
balanced across all treatments. One day prior to weaning, all progeny in the farrowing batch 
(n=~32 sows) were weighed, tagged in the ear with a unique number and the sex and 
genotype were recorded for selection purposes.  
 
3.1.5. Housing 
Fully slatted weaner accommodation with environmental controls were used in all 
experiments. Housing type A (Figure 3.1 a) consisted of twelve pens per building and was 
used in experiments SM1, SM3 and SM5, whereas housing type B (Figure 3.1 b) consisted 




Figure 3.1: Housing type A (a) used in experiments SM1, SM3, SM5 and housing type 
B (b) used in experiment SM2  
 
Single sex and genotype pens were established for trials SM1, SM3 and SM5, with mixed 
pens used in trial SM2 due to building limitations. Building temperature was set at 28 0C 
during week one and stepped down by 1 0C every two days until a final temperature of 24 
0C was achieved by the end of week three post-weaning.  
 
3.2. Feed analysis  
Approximately 1 kg of feed was collected into plastic sample bags from unused 25 kg bags 
at the start of each batch. These were immediately frozen and stored at -20 0C until analysis.  
   
3.2.1. Premix formulation 
All experimental diets contained a premix sourced and mixed by Primary Diets Ltd (Rippon, 
UK) providing (per kg of complete diet as fed): 11,500 IU of vitamin A, 2,000 IU of vitamin 
D3, 100 IU of vitamin E, 4 mg of vitamin K, 27.5 μg of vitamin B12, 15 mg of pantothenic 
acid, 25 mg of nicotinic acid, 150 μg of biotin, 1.0 mg of folic acid, 160 mg of CU (CuSO4), 
1.0 mg of Iodine (KI, Ca(IO3)2), 150 mg of Fe (FeSO4), 40 mg of Mn (MnO), 0.25 mg of Se 
(BMPTM-Se), 110 mg Zn (ZnSO4).  
 
3.2.2. Minerals 
Inorganic elements were quantified in feed using inductively coupled plasma mass 
spectrometry (ICP – MS) based on the method of Cope et al. (2009). 0.5 g of freeze dried, 
milled sample was weighed into plastic DigiTubes and digested in 1 ml concentrated 
analytical grade HCL (Fisher Scientific) + 6 ml concentrated analytical grade HNO3 (Fisher 





Table 3.1: DigiPREP heating program for acid digestion of compound pig feed 
destined for mineral analysis by ICP-MS 

















In addition to the samples, a tube containing only the acid mix was also heated in each 
batch as a reagent blank. Following digestion, all samples including the reagent blanks were 
made up to 50 ml volume with Purite water and stored at ~8 0C until analysis. Duplicate 250 
µl of digested sample was vortexed with 4.75 ml of Ga (Romil) spiked diluting acid (1000 
ppb Ga + 20 ml concentrated HNO3 + 10 ml methanol + 1 ml Triton X + Purite water to 
volume) into 5 ml plastic sample tubes.  
 
The 1:20 diluted samples were run on an X Series 2 ICP-MS (Thermo Fisher Scientific Inc) 
in standard operating mode. Before analysis, mass calibration was run to ensure the 
machine was operating within normal parameters using 5 ppb Tune A (Thermo Electron 
Corporation, Bremen, Germany) with ten reference elements (Figure 3.2).    
  
 
Figure 3.2: Typical mass calibration peaks of 5 ppb Tune A using X Series 2 ICP – MS  
 
Accepted peak width (measured at 10 % of peak maximum) range was 0.65 – 0.85 and 
maximum peak error was below 0.1 %. The ratio of 156CeO to 140Ce was not allowed to 
exceed 0.02. A cross calibration and voltage detector setup was run post the successful 
pass of the mass calibration, using 50 ppb Tune F solution (Thermo Electron Corporation, 
Bremen, Germany).   
 
Standard calibration curves were established for each element using a five point serial 
dilution (see relevant chapter for the range of elements analysed) and mathematically 
forced through the blank acid. The paired technical duplicate aliquots were loaded into an 
auto-sample rack for analysis with a Ga acid blank and calibration standard run after every 
ten samples. A mean value for each sample was calculated from three readings of each of 
the technical sample aliquots. These were normalised in relation to the Ga internal standard 
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and the reagent blank was subtracted. Final values were calculated by adjusting for the 
original sample weight. Each run of analysis was validated against two European 
Commission certified reference materials (Hay powder - BSR® 129 and Dairy feed - BSR® 
708) for feed and faecal samples. Liver samples were validated against one European 
Commission certified reference material (Bovine liver - BSR® 185R).      
 
3.2.3. Inositol 
Inositol was measured by pulsed amperometry at the School of Biological Sciences, 
University of East Anglia. Filtered samples were diluted 50-fold in 18.2 MOhm.cm water. 
Aliquots (20 µL) were injected onto a 4 mm x 250 mM CarboPac MA1 column (Dionex) fitted 
with a 4 mm x 50 mm guard column of the same material. The column was eluted 
isocratically with 150 mM NaOH delivered at a flow rate of 0.4 mL/minute from a Dionex 
GP50 HPLC pump. Inositol was detected on a gold electrode with a Dionex ED40 
electrochemical detector. The column and electrode were maintained at 35 °C in a Dionex 
LC25 oven. The following pulse protocol was applied to the electrode (Table 3.2.): 
 
Table 3.2: Pulse amperometry protocol for HPLC quantification of inositol 
Time (min) 0:0 0:20 0:40 0:41 0:42 0:43 0:44 0:50 
Voltage (V) 0.1 0.1 0.1 -2.00 -2.00 0.60 -0.10 -0.10 
 
Signal was integrated in the 0.2 – 0.4 minute interval and sampled at a frequency of 0.5 Hz. 
Calibration curves for inositol measurement were afforded by injection of 20 µL aliquots 
containing 0.25 –  4 nmol of inositol (Sigma-Aldrich Co LLC).  
 
3.2.4. Inositol phosphates 
Inositol phosphates were extracted from freeze-dried, milled feed material or digesta (0.1 
g) at the School of Biological Sciences, University of East Anglia, with 5 mL of 200 mM 
disodium EDTA, 100 mM NaF, adjusted to pH 10.0 with NaOH in 15 mL polypropylene 
centrifuge tubes (Corning CentriStar, part no. 430791).  Samples were incubated on a 
rotating platform (250 rpm) for 30 minutes at room temperature and then transferred to a 
bath sonicator and extracted for a further 30 minutes at 4 °C.  The resulting samples were 
centrifuged at 9,000 x g for 15 minutes. 2 mL of the supernatant was filtered by hand through 
a 13 mm, 0.45 µm PTFE syringe filter (Kinesis, part no. ESF-PT-13-045) into 2 mL 
borosilicate glass auto-sampler vials. Aliquots of the filtrate (typically, 20 – 40 µL) were 






Inositol phosphates were then separated on a 3 mm x 250 mm CarboPac PA200 column 
(Dionex) and 3 mm x 50 mm guard column of the same material. The column was eluted 
with a gradient of methanesulfonic acid delivered from solvent reservoirs A and B containing 
60 mM and 600 mM methane sulfonic acid, respectively. The gradient was delivered at a 
flow rate of 0.4 mL/minute according to the following programme (Table 3.3):  
 
Table 3.3: Methanesulfonic acid delivery protocol for HPLC quantification of inositol 
phosphates 
Time (minutes) 0 22 25 38 
% B 10 60 100 100 
 
Solvents were delivered using a Jasco PU-2089i Plus inert quaternary pump and samples 
were injected at 49 minute intervals using a Jasco AS-2055i Plus inert auto-sampler. The 
solvent stream eluting from the column was mixed, using a mixing T, with a solution of 2% 
perchloric acid containing 0.1% w/v ferric nitrate delivered at a flow rate of 0.2 mL/minute 
using a Jasco PU-1585 pump, before passage through a knitted reaction coil (200 uL) and 
detection of peaks at 290 nm in a Jasco UV-2077 Plus UV detector.  
 
3.2.5. Total phytic acid 
Samples from trial SM2 were analysed by Enzyme Services & Consultancy (ESC), UK using 
a modified Megazyme method K-PHYT 08/14 (Megazyme International Ireland) designated 
SAM074. Samples were extracted in 0.66 M HCL (> four hours/overnight with a ratio of 
liquid to sample of 20:1) for inositol phosphates followed by treatment with a phytase that 
is specific for phytic acid (IP6) and the lower inositol phosphate forms. Subsequent treatment 
with alkaline phosphatase ensured the release of the final phosphate from myo-inositol 
phosphate (IP1) which is relatively resistant to the action of phytase. The total phosphate 
released was measured using a modified colorimetric method. This was converted to phytic 
acid by dividing the values by 0.282 (it is assumed that phytic acid contains 28.2 % P). 
Samples from trial SM2 and SM3 were analysed by ESC using a Near Infrared (NIR) 
spectrometer (FOSS, Cheshire, UK), with the Phytate-P levels predicated using AUNIR 
calibration standards (designated by ESC as method: SAM120). The correlation coefficient 
between the same samples from experiment SM2 analysed by the Megazyme method and 
NIR was 0.988 (p<0.001), suggesting that either method was appropriate.  
     
3.2.6. Phytase activity 
Feeds were analysed for phytase activity by Enzyme Services & Consultancy (ESC), UK 
using an ELISA method with Quantiplate Kits for Quantum Blue® (Envirologix, USA) based 




1. Sample extraction was carried out by automated stirring, as opposed to the technique 
of shaking by hand as described in the Envirologix method and in the ratio of ~1:10 
sample:buffer, as described in the wet chemistry method, rather than ~1:4 as described 
in the Envirologix method.  
 
2. Results were standardised against a standard curve prepared in-house at ESC, from a 
sample of Quantum Blue® enzyme with a known activity in FTU/g, as determined by 
the Quantum product method, rather than using the standards supplied with the ELISA 
kits. Dilutions of the Quantum Blue® enzyme product and of the sample extracts were 
carried out in acetate buffer (pH 5.5) as described in the Quantum product method, as 
opposed to the Quantum Assay Diluent supplied in the kits. 
 
3. Samples were also analysed in duplicate (duplicate extractions), with each extraction 
also tested in duplicate wells, whereas the kit method normally applies a single 
extraction and with a single well test. 
 
In addition to the ELISA test, mega doses of phytase were double checked using a wet 
chemistry method, based on phytase activity using phytic acid (Sigma-Aldrich Co LLC, 
Product code: P8810) from rice as a substrate, according to the Quantum feed assay 
(extraction for 30 minutes in 25 mM Borate, pH 10.0, analysis at pH 4.5 and 60 0C). The 
method is based on the end-point determination of phosphate using a molybdate-vanadate 
colour system. Units were measured in QPU and then converted to FTU by dividing the 
QPU by a conversion factor of 5.67.   
   
3.3. Nutrient digestibility 
Nutrient digestibility was estimated using live pigs by the index method (Adeola, 2001). The 
feed marker of choice was Ti02 (Titanium (IV) oxide anatase [Sigma-Aldrich Co LLC, 
Product code: 248576]), added to all experimental diets at a rate of 3 g/kg (as fed). Digesta 
was collected from individual pigs immediately post-mortem and fresh faecal samples were 
collected immediately post defecation off a slatted floor from at least three animals per pen 
of five, into 100 ml plastic pots. In either case, these were frozen at -20 0C until freeze drying 
at -45 0C for ~10 days (until a constant weight). Samples were then manually ground using 
a pestle to avoid milling contamination. Following acid digestion (as described in section 
3.2.2), the titanium was quantified using ICP-MS in standard operating mode, as an 
additional element per run, in parallel to the mineral analysis. Isotope 49Ti was measured 
instead of the common 47Ti isotope due to possible interference with the argon carrier gas.  





Dry matter digestibility:  
Indicator in faeces or digesta (g/kg) - Indicator in food (g/kg)
Indicator in faeces or digesta (g/kg)
 = Dry matter digestibility  
 
Nutrient digestibility coefficients: 
 
1 − [
𝑀𝑎𝑟𝑘𝑒𝑟 𝑖𝑛 𝑓𝑜𝑜𝑑 (𝑚𝑔 𝑝𝑒𝑟 𝑔 𝐷𝑀) ∗ 𝑁𝑢𝑡𝑟𝑖𝑒𝑛𝑡 𝑖𝑛 𝑤𝑎𝑠𝑡𝑒 (𝑚𝑔 𝑝𝑒𝑟 𝑔 𝐷𝑀)
𝑀𝑎𝑟𝑘𝑒𝑟 𝑖𝑛 𝑤𝑎𝑠𝑡𝑒 (𝑚𝑔 𝑝𝑒𝑟 𝑔 𝐷𝑀) ∗ 𝑁𝑢𝑡𝑟𝑖𝑒𝑛𝑡 𝑖𝑛 𝑓𝑜𝑜𝑑 (𝑚𝑔 𝑝𝑒𝑟 𝑔 𝐷𝑀)
] = 𝑁𝑢𝑡𝑟𝑖𝑒𝑛𝑡 𝑑𝑖𝑔𝑒𝑠𝑡𝑖𝑏𝑖𝑙𝑖𝑡𝑦 
*Waste denotes faeces or digesta   
 
3.4. Haematology 
Blood samples were collected by jugular venepuncture, into suitable vacutainers, using 25 
mm (20 gauge) needles for pigs sampled during the first or second week post-weaning and 
25 mm (18 gauge) needles for those sampled in the third week post-weaning. Pigs were 
restrained using a V-shaped board of an appropriate size throughout the procedure. 
  
3.4.1. Cell differentiation 
Blood was collected by jugular venepuncture into a 4.0 ml BD Vacutainer® containing 7.2 
mg K2EDTA (as described in 3.4.). Blood was refrigerated overnight and analysed in 
technical duplicates using an MS45 impedance counter (Melet Schloesing Laboratories, 
Osny, France), following the manufacture’s protocol and validated with a normal level 
control sample (Woodley Equipment Company Ltd, Lancashire, UK). This provides a five 
cell differentiation for the white blood cells (basophils, eosinophils, neutrophils, monocytes 
and lymphocytes) and also reports red blood cell count (RBC), MCV, Hct, MCH, MCHC, 
RDW, Hb, THR, MPV, Pct and PDW. 
 
3.4.2. Plasma and serum minerals 
The use of mineral concentration as an indicator of health is a tool widely used by 
veterinarians and animal scientists. The optimal choice of sample type and collection 
protocol is dependent on the mineral under investigation (Herdt and Hoff, 2011). If blood is 
to be used, it can either be allowed to clot (for serum) or prevented from clotting (for plasma) 
prior to analysis. BD Vacutainer® tubes contain a range of anticoagulants and have a 
product line specifically for trace element analysis. A pilot study (SM4) was conducted to 
assess differences in determined blood mineral concentration dependent on the choice of 




Blood was collected by jugular venipuncture from four weaned pigs (see section 3.4.), fed 
on a wheat based commercial diet, in three different BD Vacutainer® tubes (Becton, 
Dickinson and Company: Oxford, UK). These were one serum trace element tube (CAT), 
one trace element tube spray coated with K2EDTA and one standard tube spray coated with 
lithium heparin (LH). Tubes were allowed to stand at room temperature for two hours before 
centrifugation at 1000 x g for ten minutes at 4 °C. Plasma and serum were pipetted into 2.0 
ml microtubes and stored at 4 °C overnight prior to storage at -20 °C. Defrosted plasma and 
serum was vortexed and diluted 1:20 with 1 % HNO3 prior to elemental analysis using an X 
series 2 ICP-MS in standard mode, running Plasma Lab software (Thermo Scientific Inc, 
USA). Calculations were performed in Excel 2010 (Microsoft Corporation) and analysed in 
GenStat sixteenth edition (VSN International Ltd) using ANOVA blocked by pig and followed 
by Tukey test (Tukey, 1949) where significance was indicated. 
 
There were no differences in blood mineral P, Ca, Mn, Fe, Cu, Se or Mo concentrations 
when obtained from serum or plasma. Zinc concentrations were lower in serum than in 
either of the plasma samples (p=0.01). Magnesium concentrations were lower in the LH 
tubes over the two trace element tubes (p=0.002). K concentration was elevated in the 
K2EDTA coated tubes (p=0.001) as expected due to the K present in the preservative but 
was also different between serum and LH plasma (p<0.05). The concentration of Na was 
higher in the K2EDTA coated tube compared with the serum tube (p=0.04) but neither were 
different to LH plasma. Concentrations of Co obtained from the serum samples were lower 
(p=0.03) than those found in LH plasma but not from K2EDTA plasma. Variation between 
pigs was generally low (<20%) with the exception of Fe (41.8%) and Co (31.8%). The 
biological ranges measured were within the reported ranges from the literature (Table 3.4), 
with the exception of Fe, Zn and Cu.  
 
Table 3.4: Deviation in blood minerals between BD Vacutainer® collection tubes and 
normal reference ranges for pigs 
Element Unit Normal range1 




Na mmol/l 14 2.16 4.61 
Mg mmol/l 0.82 0.22 0.55 
P mmol/l 2.25 0.36 0.89 
K mmol/l 2.7 1.25 1.90 
Ca mmol/l 1.12 0.04 0.38 
Mn µmol/l - 0.09 0.17 
Fe µmol/l 12 14.9 46.67 
Co µmol/l - 0.00 0.01 
Cu µmol/l 1.3 1.26 13.71 
Zn µmol/l 1.2 2.88 7.47 
Se µmol/l - 0.08 0.38 
Mo µmol/l - 0.09 0.33 
1Min – max of literature quoted normal values; 2The difference between the highest and 
lowest vacutainer means; 3Range calculated for all replicate tubes (not just mean values).  
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Despite the statistical differences, when the variation between vacutainer means are 
compared (Table 3.4), there is little practical difference for most minerals. The exceptions 
are Fe, Zn and Cu which have larger biological ranges than expected.  
 
As a result of SM4, plasma samples for experiments SM2, SM3 and SM5 were collected 
into lithium heparin vacutainers. These were centrifuged at 1000 x g for 10 minutes at 4 °C, 
prior to plasma storage at -20 °C until analysis. Defrosted plasma was vortexed and diluted 
1:20 with 1 % HNO3 prior to elemental analysis using an X series 2 ICP-MS in standard 
mode, running Plasma Lab software (Thermo Scientific Inc, USA). The results in ppm or 
ppb were then divided by their molecular weight for conversion to mmol/L or µmol/L.   
 
3.5. Gut histology 
Gut histomorphology was based on the method of Pluske et al., (1996). Over days 22/23 
post-weaning, one mean average weight pig from each pen was euthanized by captive bolt 
followed by destruction of the brain stem. Carcases were briefly washed in hot water and a 
vertical incision made along the belly from sternum to the pubis (Figure 3.3 a). The small 
intestines were clamped at the junction of the stomach/duodenum and the terminal 
ileum/colon, before being removed and carefully spread out on a clean surface. Plastic 
cable ties were used to divide the intestines into three equal sections representing the 
duodenum, jejunum and ileum (Figure 3.3 b).  
  
Figure 3.3: Dissection of small intestines out of pig abdomen (a) and sectioning of 
pig small intestines into duodenum, jejunum and ileum, using cable ties (b) 
 
A three centimetre sample of each section was excised and immediately washed and stored 
in 10 % neutral buffered formalin. To represent the duodenum, this was taken ~15 CM 
posterior to the stomach/duodenum junction, from the centre of the small intestines to 
represent the jejunum and at ~15 CM anterior to the ileum/colon junction for the ileal section. 
On arrival at Finn Pathologists (Norfolk, UK), the sections were cut through the middle and 







Table 3.5: Tissue processing procedure for embedding intestinal samples into wax 
Reagent Time (minutes) Temperature (0C) 
70 % Industrial Mentholated Spirit 90 Ambient 
95 % Industrial Mentholated Spirit 30 Ambient 
95 % Industrial Mentholated Spirit 45 Ambient 
100 % Industrial Mentholated Spirit 30 Ambient 
100 % Industrial Mentholated Spirit 60 Ambient 
100 % Industrial Mentholated Spirit 120 Ambient 
Xylene 30 Ambient 
Xylene 60 Ambient 
Xylene 90 Ambient 
Wax 30 61 
Wax 60 61 
Wax 60 61 
 
The blocks were sectioned to 5 µm thick, baked for 30 minutes and then stained with 
Heamatoxylin and Eosin using an automated Leica ST4040, before being mounted on 
slides. Slides were examined by optical microscopy (Olympus CX31, equipped with an 
Olympus V-CMAD3 digital camera), calibrated with a graduated scale bar (C. Baker, 
London) and running Infinity Analyse version 6.2 (Lumenera Corporation, 2012) software to 
measure villus height, crypt depth and length of an average mucosal gland.  
 
3.6. Gene expression 
Absolute quantification (copies per reaction) of gene expression was used for trial SM2, 
whereas relative quantification was considered sufficient for experiment SM5. Intestinal 
sections (duodenum, jejunum and ileum) were macroscopically dissected (approx. 500 mg) 
from pigs post-mortem (see section 3.5) and immediately stabilised in RNAlater® (Sigma-
Aldrich, St. Louis, Missouri, USA) for 24 hours, prior to removal of excess RNAlater®  and 
long term storage at -80°C.  
 
3.6.1. Selection of reference genes 
Reference genes for normalisation of data were selected using the geNorm™ method 
(Hellemans et al., 2007) with six reference genes (Primer Design Ltd, Southampton, UK), 
from experiment SM5. Samples equally represented the treatment control group (pigs fed 
a 5.8 g/kg dgP basal diet), dietary ZnO group, dietary phytase group and those fed a ZnO 





3.6.2. geNorm analysis  
RNA was extracted and purified using the SV total RNA isolation system (Promega 
Corporation, Madison, Wisconsin, USA) from ~20 mg of macro-dissected duodenum tissue 
(Table 3.6). This was previously stabilised in RNAlater® (Sigma-Aldrich, St. Louis, Missouri, 
USA), prior to storage at -80°C for five months. Genomic DNA was removed in a 15 minute 
digestion with DNase 1 (Promega Corporation, Madison, Wisconsin, USA).  
 








Standard Deviation 260/280 260/230 
1 - - 272 185.7 2.1 2.1 
2 - 2500 408 56.8 2.1 2.0 
3 2500 - 209 67.2 2.1 1.9 
4 2500 2500 421 111.1 2.1 2.1 
 
Reverse transcription (RT) from RNA to cDNA was completed using Precision NanoScript™ 
2 (Primer Design Ltd, Southampton, UK), with a random nonamer primer, since RNA 
integrity could not be checked. No more than 2 µg of total RNA was used in each 20 µl 
reaction. RT conditions involved a five minute annealing step at 65°C, followed by five 
minutes incubation at room temperature and then a 20 minute extension at 42 °C. Finally, 
the reaction was stopped by heating to 75 °C for 10 minutes. cDNA was diluted to a final 
concentration of 2.5 ng/µl and kept on ice for two hours until qPCR.  
 
Three biological replicates per treatment group were analysed in duplicate technical 
replicates at the qPCR stage. Each 96 well white plastic plate (Bio-Rad, Hemel Hempstead, 
UK) contained all of the samples for that gene; with a total of three genes plus controls in 
each run, which negates the need for inter-run calibration (Hellemans et al., 2007). qPCR 
was performed using a 20 µl reaction, loaded with 12.5 ng of cDNA, nuclease free water, 
primer (300 nM) and PrecisionPLUS™ 2x qPCR Mastermix containing SYBR green 1 
(Primer Design Ltd, Southampton, UK). Plates were run in immediate succession on a Bio-
Rad CFX96 PCR system (Bio-Rad, Hemel Hempstead, UK), under the following reaction 
conditions (Table 3.7): 
 
Table 3.7: qPCR reaction conditions for geNorm analysis for use with Bio-Rad CFX96  
 Step Time (minutes) Temperature (°C) 
 Enzyme activation (hot start) 2:00 95 
Cycling (x50) 
Denaturation 0:15 95 
Data collection 1:00 60 




While the primer sequence for the assays are not available, Table 3.8 gives details of the 
anchor nucleotide and the context sequence length, which are acceptable replacements 
(Bustin et al., 2011).  
 
Table 3.8: geNorm™ Reference gene Selection Kit (pig) assay details  
Gene name Accession number Anchor nucleotide Context sequence length 
ACTB DQ452569 189 182 
GAPDH AF017079 918 188 
GSR AY368271 100 99 
GPI NM_214330 685 105 
GPX1 NM_214201 265 158 
PPIA NM_214353 137 152 
(Source: PrimerDesign Ltd, 2014) 
 
Specificity of the target was confirmed by a unified peak in the melt curve at the expected 
amplicon temperature (Figure 3.4). The presence of gDNA was excluded by no template 
controls (NTC), which tended to form primer dimers after ~38 cycles, with a characteristic 
melting temperature of ~75 °C (Figure 3.4).  
 
Figure 3.4: Melt curve analysis of geNorm reference genes. a) GSR, b) GAPDH, c) 
ACTB, d) PPIA, e) GPX1 and f) GPI. NTC are characterised by a melting temperature 
of ~75 °C, while target amplicons exhibit a melt peak ≥ 80 °C.   
 
Raw fluorescence data without baseline correction was exported from CFX manager (Bio-
Rad, Hemel Hempstead, UK) into LinRegPCR version 2014.2, where Cq values were set 
by amplicon group and PCR efficiencies were calculated using a four point window-of-
linearity (Ramakers et al., 2003; Ruijter et al., 2009). Calculated Cq values were analysed 
using qbase+ software (Biogazelle, Zwijnaarde, Belgium) in the method of Hellemans et al., 
(2007), adjusting for PCR amplicon efficiency (Table 3.9). Outliers were excluded from data 
analysis if they were in excess of 0.5 cycles apart from their technical replicate, resulting in 
an 86.1 % pass rate.  
 
a) b) c) 
d) e) f) 
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Table 3.9: PCR amplification efficiencies and amplicon melting temperature  
Amplicon PCR Efficiency (%) Melting temperature (°C) 
ACTB 93.8 81.0 
GAPDH 80.7 86.0 
GPI 92.9 82..0 
GPX1 90.9 83.5 
GSR 92.1 80.5 
PPIA 91.6 80.0 
 
The stability of the candidate reference genes were calculated and showed high reference 
target stability (average geNorm M ≤ 0.5), usually associated with homogenous samples 
(Figure 3.5).  
 
 
Figure 3.5: Expression stability score (geNorm M) of six candidate reference genes 
ranked from lowest (left) to highest (right),  tested on 12 samples of duodenum tissue 
from weaned pigs. Horizontal line indicate gene stability threshold.  
 
Finally, the best combination of reference genes was calculated by taking the two most 












































Figure 3.6: Pairwise comparisons (geNorm V) of six candidate reference genes tested 
on 12 samples of duodenum tissue from weaned pigs. Horizontal line indicate gene 
stability threshold.   
 
A score of < 0.15 (geNorm V) was considered to be stable (Figure 3.6). Based on this, the 
optimal normalization factor could be calculated as the geometric mean of reference targets 
GPI and GSR. These were therefore used in experiments SM2 and SM5 to normalise the 
gene expression values.  
 
3.6.3. Gene expression analysis 
For experiment SM2: RNA was extracted and purified from intestinal tissue samples (see 
section 3.6) using an RNeasy kit (Qiagen Ltd, Manchester, UK). Purified RNA was then 
checked for integrity using a bioanalyzer (Agilent Technologies, Inc.) and yield/purity with a 
Nanodrop 2000 (Thermo Fisher Scientific Inc.), prior to RT.  800 ng of RNA were reverse 
transcribed using the Qiagen Quantitect reverse transcription kit (Qiagen Ltd, Manchester, 
UK), in a 10 uL reaction, according to the manufacturer's instructions. This RT kit includes 
a mandatory gDNA wipe-out step, which was extended to 4 minutes at 42 °C for these 
samples. RT duplicate reactions were performed for four samples. The completed reaction 
was diluted 10-fold with 5 ug/mL tRNA in water. Two microliters of cDNA were amplified in 
a 10 uL reaction using Agilent Brilliant III SYBR Green mix with each primer at a final 
concentration of 500 nmol/L. The no-template control reaction contained 2 uL of tRNA 
(diluted to 5 ug/mL). DNA standards (107-101 copies/reaction) for each gene were included 
in each run. Reactions were pipetted robotically using a Qiagility. The PCR amplifications 
were performed using a Rotor-Gene 6000 (Qiagen Ltd, Manchester, UK) under the following 




















Table 3.10: qPCR reaction conditions for gene expression analysis for use with Roto-
Gene 6000 
 Step Time (minutes) Temperature (°C) 
 Enzyme activation 3:00 95 
Cycling (x40) 
Denaturation 0:10 95 
Data collection 0:20 60 
 
Melt curves were checked for product specificity (single peak) and the presence of primer 
dimers. All primers were designed by qStandard (Middlesex, UK) to be intron-spanning and 
therefore unable to amplify gDNA. Assay specify was checked by agarose gel 
electrophoresis of PCR products and these were used to produce standards of known copy 
numbers. Linearity, sensitivity and efficiency of the standards were assessed by running a 
7 log standard curve. Copy numbers/reaction were derived from the standard curves using 
the Rotor-Gene software and normalised to GPI and GSR (as identified in section 3.6.2). 
The primers for GPI and GSR for experiment SM2 were designed by qStandard and 
summarised in Table 3.11.   
 
Table 3.11: Assay details for qPCR primers designed to detect SGLT1, ALPI and ZIP4 









GPI GPI NM_214330 
S – TAGGACAGCCAGTGAGGAGT 
A – TTCTCCTCTGCCACAGATGTC 
99 
GSR GSR XM_003483635 
S – CCAGCCTAGGAATTACCAGTG 
A – GGATTCCAGCTATCTCCACAG 
105 
 (Source: qStandard, 2015)  
 
For experiment SM5: RNA was extracted and purified from intestinal tissue samples (see 
section 3.6) prepared from section 3.6.1, using the SV total RNA isolation system (Promega 
Corporation, Madison, Wisconsin, USA). Genomic DNA was removed in a 15 minute 
digestion with DNase 1 (Promega Corporation, Madison, Wisconsin, USA). Purified RNA 
was then checked for integrity using an E-gel (Thermo Fisher Scientific Inc.) and yield/purity 
assessed using a Nanodrop 2000 (Thermo Fisher Scientific Inc.), prior to RT. Reverse 
transcription from RNA to cDNA was completed using Precision NanoScript™ 2 Reverse 
Transcription kit (Primer Design Ltd, Southampton, UK) with random nonamer primers in a 
20 µL reaction. No more than 2 µg of total RNA was used in each 20 µl reaction. cDNA was 
diluted to 5 µL/ml and genes of interest were amplified in 20 µL reactions, using custom 
SYBRgreen gene specific primers with a Bio-Rad CFX96 PCR system (Bio-Rad, Hemel 






Table 3.12: qPCR reaction conditions for cytokine gene expression analysis for use 
with Bio-Rad CFX96 
 Step Time (minutes) Temperature (°C) 
 Enzyme activation (hot start) 2:00 95 
Cycling (x50) 
Denaturation 0:15 95 
Data collection 1:00 60 
 Melt curve 70 60 – 95 
 
Melt curves were checked for product specificity (single peak) and the presence of primer 
dimers. Cq values were set by amplicon group and PCR efficiencies were calculated using 
a four point window-of-linearity (Ramakers et al., 2003; Ruijter et al., 2009). Normalisation 
of data was carried out using the geNorm™ method with six reference genes (Primer Design 
Ltd, Southampton, UK) and analysed using qbase+ software (Biogazelle, Zwijnaarde, 
Belgium). 
 
3.7. Bone analysis 
Following being euthanized by captive bolt and destruction of the brain stem (as described 
in 3.5), the pig’s front right side leg was removed and frozen at -20 °C. Legs were defrosted 




Figure 3.7: Dissection of the third and fourth metacarpals from the right side leg of 







All bones were re-frozen at -20 °C in clear plastic bags for further testing. All the 4th 
metacarpals were freeze dried before the strength test and the 3rd metacarpals tested fresh, 
after being defrosted in a fridge overnight. 
 
3.7.1. Bone strength  
The lengths of all bones were measured at the longest point and the midpoint using a digital 
calliper (Mitutoyo), which was then marked with a marker pen to identify the centre of the 
bone. Shear strength measurements were obtained using a Sans SHT4035 300 kN testing 
machine at room temperature, in a modified method based on Combs et al. (1991), where 
the area of the bone was estimated by tracing the mid-point of the bone on 1 mm2 graph 
paper. The instrument was calibrated and verified for compression for increasing forces to 
BS EN ISO 7500-1:2004, using verification equipment calibrated to BS EN ISO 376: 2004. 




Figure 3.8: Shear strength testing of 3rd pig metacarpal bone using a SANS SHT4035 
testing rig. A constant force of 10 mm/minute was applied to the bone (left image) 
until shearing was complete (right image).  
  
The shear failure point was determined from a load graph to define the maximum load 
required for bone failure. Shear stress was calculated as:   
 





All bones were replaced into the labelled bags/pots and the 3rd metacarpals were frozen 
and freeze dried prior to ashing (see section 3.7.2.). Femurs and tibia bones were dried for 
four hours at 70 °C and assessed for compressive strength as detailed by Morris (2016). 
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3.7.2. Bone ash analysis 
Porcelain crucibles were prepared by washing in Aqua regia (1 part HNO3 and 3 parts HCl), 
neutralised in sodium bicarbonate and then washed in distilled water prior to bone ashing. 
Freeze dried whole bones recovered from shear testing were ashed in a muffle furnace at 
800 °C for 18 hours (CEM, 2011), at a ramp rate of 3 °C per minute.  
 
Ash percentage was defined as: 
 
𝐴𝑠ℎ [%] =
(𝐴𝑠ℎ [𝑔] − 𝑐𝑟𝑢𝑐𝑖𝑏𝑙𝑒 𝑤𝑒𝑖𝑔ℎ𝑡 [𝑔])
(𝑑𝑟𝑖𝑒𝑑 𝑏𝑜𝑛𝑒 𝑤𝑒𝑖𝑔ℎ𝑡 [𝑔])
∗ 100 
 
Ash samples (0.25 g) were then digested for mineral analysis by ICP-MS in the procedure 
described in section 3.2.2.  
   
3.8. Liver mineral analysis 
Over days 22/23 post-weaning, one mean average weight pig from each pen was 
euthanized by captive bolt followed by destruction of the brain stem. Carcases were briefly 
washed in hot water and a vertical incision made along the belly from sternum to pubis 
(Figure 3.3 a). Liver samples were taken from the bottom of the liver lobe and frozen (-25 
°C) prior to 0.25 g of being dried in a forced air oven (Phillip Harris LTD, Shenstone, UK) at 
60 °C overnight without a lid. The tubes were cooled and re-weighed to calculate dry matter 
prior to digestion of the liver in 6 ml of nitric acid (HNO3) at 60 °C overnight. Samples were 
diluted to 50 ml with Purite water and thoroughly mixed before being stored (4 – 6 °C) until 
analysis by ICP – MS. Mineral analysis was carried out according to section 3.4.2.  
 
3.9. Sialic acid determination 
Sialic acid standard (N-Acetylneuraminic acid {N-AM}) prepared from Escherichia coli was 
purchased (Sigma-Aldrich, UK, CAT No. A-2388).  A fresh 1 mM stock solution was 
prepared by accurately weighing out 0.0309 g and dissolving this in 100 ml distilled water, 
before storing at a temperature of -20 ºC until required. A total of seven N-AM standards 
were prepared, covering a range of concentrations between 0 and 0.3 μmol.  The standards 
were prepared in 10 ml screw-capped glass tubes, where 0, 0.05, 0.1, 0.15, 0.2, 0.25 and 
0.3 ml stock solution of N-AM were added to each tube in sequence.  The tubes were then 
made up to a final volume of 0.5 ml, with the addition of 0.5, 0.45, 0.4, 0.35, 0.3, 0.25 and 




Samples of freeze dried ileal digesta were analysed for their content of sialic acid (N-
acetylneuraminic acid) according to a modified version of the method of Jourdian et al., 
(1971).  A mass of 0.02 g of samples were weighed accurately into 10 ml screw-capped 
tubes (VWR Ltd., UK) and 0.5 ml distilled water was added to each, to make the tube 
volumes equivalent to that of the standards.  The tubes for both samples and standards 
were treated equally for the remainder of the assay. A volume of 0.1 ml periodic acid (0.4559 
g periodic acid (VWR Ltd, UK, CAT No. 20593.151) was weighed accurately, transferred to 
a 50 ml volumetric flask and made up to volume with distilled water to prepare a 0.04 M 
solution. This was added and the tubes mixed well, before the tubes were immediately 
placed in an ice bath for a period of 20 min, to allow the production of chromogens by 
oxidation of N-AN.   
 
With the tubes still standing in ice to slow the reaction, a volume of 1.25 ml resorcinol 
solution (7 mg of CuSO4.5H20 [VWR Ltd., UK] was weighed accurately and placed into a 
beaker along with 0.6g resorcinol granules [Sigma-Aldrich, UK, CAT No. R-5645]. Using a 
measuring cylinder, 40 ml distilled water and 60 ml of 25 % HCl were each dispensed, and 
these were also added to the beaker and mixed thoroughly) was added and the tube 
contents mixed well. The tubes remained in the ice bath for a further 5 min.  After this time, 
the outer tube surfaces were dried using tissue and tubes were placed in a forced air oven 
at 105 ºC for a period of 30 min.  On removal, the tubes were instantly cooled in tap water 
and a volume of 1.25 ml tert-butyl alcohol pipetted into the tubes, vortexed thoroughly to 
achieve a single-phase solution.  The tubes were then set into a water bath at 37 ºC for a 
period of 3 min, to stabilise the colour achieved in the reaction before cooling to room 
temperature.  The sample tubes were centrifuged for 5 min at 1500 x g to remove solid 
particles from suspension.  The supernatant from each tube was pipetted into plastic 1 ml 
macro-cuvettes and absorbances in the sample cuvettes were read at 630 nm in a 
spectrophotometer. A standard curve prepared from the standard tubes (Figure 3.9) was 





Figure 3.9: Standard curve for the determination of sialic acid concentration in 

































Phosphorus requirements of the weaner pig 
 
4.0. Introduction 
Phosphorus (P) requirements of pigs are revised regularly on the basis of improved 
scientific data (ARC, 1981; NRC, 1998; Whittemore et al., 2003; NRC, 2012). This has led 
to a gradual change in the way requirements are expressed, in addition to the levels 
recommended. Available P is typically measured as changes in bone ash P content in 
relation to that fed, representing the amount of P digested and metabolised (i.e. available 
for the animal to use). Refinements to this procedure may involve radioisotopic 
determination of 32P in the femur to exclude P from endogenous sources (Whittemore and 
Thompson, 1969). In the UK however, digestible phosphorus (dgP) is the expression unit 
of choice, reflecting the extent to which the total P contained within plant, animal and mineral 
dietary constituents are apparently digested and absorbed across the GI tract. This can be 
expressed in two ways.  
 
Firstly, a sample of digesta can be taken directly from the ileum, thus excluding any P 
modifications associated with the hindgut, resulting in a measure of apparent ileal 
digestibility (AID). This is hard to achieve in practice, as it either requires the animals to be 
sacrificed or the ileum to be canulated. Furthermore, there may be high amounts of P from 
endogenous sources present in the ileum compared to those in the faeces (Fan et al., 2001), 
possibly due to additional P absorption in the cecum (Liu et al., 2000). Alternatively, P 
digestion can be expressed as apparent total tract digestibility (ATTD), calculated as the 
difference between total P entering the digestive tract verses that contained in the faeces. 
However, no account of endogenous losses are considered using the ATTD method. 
Several methodologies have been developed to correct for this and estimate either true P 
digestibility or apply a standard correction factor. These are based on either linear 
regression (Fan et al., 2001) or P free diets (Petersen and Stein, 2006) respectively.   
 
Extensive statistical modelling suggests that the form dietary P is fed in, is an important 
factor governing the pig’s ability to digest and retain the element (Létourneau-Montminy et 
al., 2012). In the UK, wheat and soybeans form the basis of most commercial pig feeds, 
each containing approximately 60 % of dietary P in the form of phytate (Ravindran et al., 
1994). Hydrolysis of P from phytate is strongly influenced by stomach pH (Létourneau-
Montminy et al., 2011), where under very acidic conditions (pH 2.0), phytate disassociates 
from cleated minerals and proteins (Yu et al., 2012). Feed tends to increase stomach pH 
due to a buffering effect, reducing stomach acidity (pH 2.5 – 3.5), whereby binary phytate-
protein aggregates can form (Yu et al., 2012). This reduces the ability of phytases to release 
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orthophosphate in the stomach. Once in the duodenum, the addition of bile salts increase 
the pH to near neutral conditions (pH 6.5), allowing phytate to precipitate out of solution and 
form ternary complexes through cationic bridges with minerals (Selle et al., 2012). This 
makes P from plant phytates largely unavailable to pigs.  
 
In the absence of exogenous phytases, inorganic P has been used to provide all the dietary 
P required by the animal. The optimal amount of digestible P needed is strongly negatively 
correlated to the bodyweight of the animal (NRC, 2012) and is regulated through several 
mechanisms. Around 60 – 80 % of P is directly stored in skeletal tissue, bound with Ca, 
2.2:1 (Ca:P) as hydroxyapatite (Ca5[PO4]3) (Crenshaw, 2001). Given that 99 % of Ca in the 
body is found locked up with P within the bone matrix, regulation of P metabolism is heavily 
influenced by Ca intakes. Increasing dietary Ca negatively affects daily live weight gain 
(Létourneau-Montminy et al., 2012); the extent of which is more severe as Ca:P widens in 
marginal dietary P compared with P adequate diets (Reinhart and Mahan, 1986). This 
results from the reduction in P absorption across the small intestine, as excess Ca forms 
insoluble complexes in the chyme (Heaney and Nordin, 2002). Several studies have 
confirmed that intakes of Ca and P should be supplied in the diet at a ratio of around 1.0 to 
1.2 for maximal intestinal P absorption (Liu et al., 2000) and growth performance (Qian et 
al., 1996).  
 
Requirements for dietary digestible Ca are hard to predict since the digestibility is difficult 
to model, however, digestible P models are more accurate (R2 = 0.78 for Ca verses 0.90 
for P) (Létourneau-Montminy et al., 2011). Appropriate levels of dgP for newly weaned pigs 
are estimated to be 3.8 g/kg of diet (DM basis) (Whittemore et al., 2003), though this is 
formulated taking into account the risk of excess P output on the environment. Providing an 
appropriate Ca to P ratio is maintained, increasing dietary dgP above this level should 
provide additional weight gain up to the genetic potential of the pig. Conformation of where 
the limit of growth response to increasing dietary dgP is, in fast growing modern genotypes, 
would allow characterisation of non-P related effects (described by Selle and Ravindran, 
2008) in a subsequent phytase super dosing experiment.   
4.1. Objective 
This chapter aims to evaluate the growth performance response to increasing dietary 
digestible P above the recommended level of 3.8 g/kg in newly weaned pigs. This data will 
act as a platform for investigating ‘extra phosphoric’ effects of phytase. In addition, baseline 
data on mineral digestibility will characterise the typical response of modern UK genotypes. 
The first null hypothesis is that increasing dietary dgP above 3.8 g/kg will have no effect on 
pig growth performance or mineral ATTD. Secondly, widening Ca:P from 1.12 to 1.60 will 
have no effect on pig growth performance or mineral ATTD.       
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4.2. Materials and methods 
General materials and methods applicable to this section are described in chapter three. A 
dose response experimental design (graded levels of dgP) was set up to measure the 
performance and nutrient digestibility of pigs from weaning to three weeks post (designated 
trial SM1). 360 commercial type pigs (JSR Geneconverter 700 x JSR Genepacker 90 and 
PIC Camborough x PIC 337 genotypes) from three farrowing batches were sourced from 
the Harper Adams University high health status herd at weaning (~26 days of age) and 
balanced across treatments for genotype (50:50), sex (50:50) and selection weight. Animals 
were housed in pens of five pigs under commercial indoor conditions and fed one of eight 
treatment diets (Table 4.3) for 23 days. All diets were isoenergetic and isonitrogenous.   
 
4.2.1. Treatments 
Experimental diets (Table 4.3) were formulated to include seven levels of dgP, keeping a 
Ca:tP ratio of 1.12 (Primary Diets Ltd, UK). The lowest level of dgP was set at 2.8 g/kg (as 
fed), which is below the recommended level of 3.8 g/kg (air dried) suggested by Whittemore 
et al. (2003). Previous experimental results (not published) suggest that increasing levels 
to 5.8 g/kg dgP gives continuous improvement in pig performance. The diets were designed 
to increase incrementally by 1 g/kg up to a maximum of 8.8 g/kg. The final level was set to 
reflect the assumption that mega doses of phytase may release 2.83 g/kg additional 
inorganic P from diets containing 1 % PA, on top of the 5.8 g/kg dgP in the basal diet. It was 
important to establish that dgP at the max 8.8 g/kg does not provide any better performance 
due to the extra phosphorus than a lower 5.8 g/kg diet if extra phosphoric effects are to be 
detected. 
 
The relationship between Ca and P is such that P absorption is dependent upon Ca:P in P 
adequate diets, thus it would not be possible to keep Ca at a constant level and change 
only the dgP. It was therefore decided that a constant Ca:P should be maintained at 1.12, 
which would then allow the effects of the dgP level to be assessed. One problem with this 
treatment structure is that both Ca and P increase in step, making it impossible to tell if 
treatment differences are attributable to the rising level of Ca or P. An additional treatment 
(B) was proposed to help solve this paradox (Table 4.1), which had the same level of P 
(dgP) as treatment C (but a higher level of Ca) and the same level of Ca as treatment E (but 
a different level of P). This would allow a direct comparison of treatments where Ca 
remained static (but different levels of dgP) and where P remained static (but different levels 





Table 4.1: Summary of treatments B, C and E (as fed basis) fed to weaned pigs in 
experiment SM1 
Diet  B C E 
Level of dgP (g/kg) 3.8 3.8 5.8 
Level of P (g/kg) 6.3 6.3 8.9 
Level of Ca (g/kg) 10.0 7.1 10.0 
Ca:P 1.60 1.12 1.12 
Number of pens 12 12 8 
 
Treatment B serves a further purpose in that it can be used to indicate how widening the 
ratio from 1.12 to 1.60 affects pig performance and nutrient digestibility, when compared to 
diets C and E. 
 
A description of the treatments for the main experiment can be found in Table 4.2. Two 
batches of pigs (four replicate pens in each per treatment) were used to assess levels of 
dgP ranging from just below the recommended level (treatment A, 2.8 g/kg) up to the 
maximum level expected to be released through super and mega doses of phytase 
(treatment J, 8.8 g/kg). Increments of 1 g/kg were used for all intermediate treatments to 
give a total of seven levels of dgP with eight replicates per treatment (12 in the case of diet 
C), all with a Ca:P of 1.12.    
 
Table 4.2: Summary of dietary dgP treatment levels at Ca:P 1.12 (as fed basis) fed to 
weaned pigs in experiment SM1 
Diet A C D E G H J 
Level of dgP (g/kg) 2.8 3.8 4.8 5.8 6.8 7.8 8.8 
Level of P (g/kg) 5.0 6.3 7.6 8.9 10.2 11.5 12.8 
Level of Ca (g/kg) 5.6 7.1 8.5 10.0 11.4 12.8 14.3 
Ca:P 1.12 1.12 1.12 1.12 1.12 1.12 1.12 
Number of pens 8 12 8 8 8 8 8 
 
Pig performance was assessed by recording individual liveweight (LW) at day 0 (weaning), 
day 7, day 14 and day 23. These periods were designated as P1, P2 and P3 respectively. 
Feed disappearance was also recorded at these time points in order to estimate mean daily 
feed disappearance (DF), daily liveweight gain (DLWG) and the food conversion ratio (FCR) 










Table 4.3: Composition of raw ingredients (g/kg) for experimental diets fed to weaned 
pigs in trial SM1 
Raw ingredients A B C D E G H J 
Micronized barley 76 76 76 76 76 76 76 76 
Raw wheat (whole meal) 173 163 169 164 159 155 150 145 
Micronized wheat meal  174 163 169 164 159 155 150 145 
Micronized maize 25 25 25 25 25 25 25 25 
Supertherm oats  50 50 50 50 50 50 50 50 
Herring meal  31 31 31 31 31 31 31 31 
Soya (hypro) 100 100 100 100 100 100 100 100 
Full fat soyabean meal 122 122 122 122 122 122 122 122 
Premix1  5 5 5 5 5 5 5 5 
Skimmed milk powder 25 25 25 25 25 25 25 25 
De-lactosed whey 25 25 25 25 25 25 25 25 
Whey powder 123 123 123 123 123 123 123 123 
Sugar/sucrose 12.5 12.5 12.5 12.5 12.5 12.5 12.5 12.5 
L-lysine HCl 5.1 5.2 5.2 5.2 5.2 5.2 5.3 5.3 
Dl-methionine 2.6 2.6 2.6 2.6 2.7 2.7 2.7 2.7 
L-threonine 2.7 2.7 2.7 2.7 2.7 2.8 2.8 2.8 
L-tryptophan 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 
L-valine 1.2 1.2 1.2 1.3 1.3 1.3 1.3 1.4 
Crina 6932 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 
Vitamin E 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 
Titanium dioxide 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 
Sucram®3 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 
Benzoic acid (VevoVitall®) 5 5 5 5 5 5 5 5 
Limestone flour  5.15 12.1 4.29 3.43 2.58 1.72 0.86 0 
Dicalcium Phosphate 0.0 7.3 7.3 14.5 21.8 29.0 36.2 43.5 
Soya oil 32.8 39.1 35.4 38.5 41.5 44.3 47.2 50.0 
1Premix detailed in chapter three; 2Flavouring made from essential oils manufactured by 
DSM Nutritional Products (UK) Ltd; 3Sweetener manufactured by Pancosma SA  
 
4.2.5. Chemical analysis 
Samples of the experimental diets were taken over several periods during the nine weeks 
of the trial period and analysed as detailed in chapter three. Faeces were collected fresh 
from observed animals (minimum of three animals per pen) on days 22 and 23 of the trial 
and stored at -20 °C until analysis, described in chapter three.   
 
4.2.6. Data analysis 
All data was collated and calculations performed using Excel 2010/2013 (Microsoft 
Corporation, 2010).  Data points ± 3 SD were considered outliers and removed from the 
analysis. Data was subject to orthogonal polynomial contrasts based on the formulated level 
of dgP, using the general ANOVA procedure of GenStat (16th edition, VSN International 
Ltd), with genetic line as a blocking factor. Treatments B & C, B & E and C & E were then 
compared using contrast comparisons, blocked by genetic line. Mineral digestibility data 




During the trial, one pig in batch one on treatment H (7.8 g/kg feed dgP) died of an unknown 
cause at day 22 of the trial. One pig in batch two on treatment D (4.8 g/kg feed dgP) was 
removed from trial due to ill health (yellow scours).   
 
4.3.1. Diet analysis 
Following ICP-MS analysis, results for the certified reference material (Dairy feed, BER-
708) were shown to be within range, including for P and Ca. The P and Ca composition of 
the diets are detailed in Table 4.4.  
   
Table 4.4: Analysis of phytic acid, phytate-P, P and Ca (g/kg as fed basis) of 
experimental diets fed to pigs in trial SM1 
Diet A B C D E G H J 
Measured phytic acid content  5.7 5.9 5.4 4.8 5.2 4.4 4.7 4.1 
Measured phytate P 1.6 1.7 1.5 1.4 1.5 1.2 1.3 1.2 
Formulated total P  5.0 6.3 6.3 7.6 8.9 10.2 11.5 12.8 
Measured total P  5.4 6.9 6.8 8.1 9.1 10.9 12.6 12.9 
Formulated total Ca  5.6 10.0 7.1 8.5 10.0 11.4 12.8 14.3 
Measured total Ca  6.7 12.4 9.0 10.7 11.3 13.8 15.4 16.1 
Formulated Ca:tP 1.12 1.60 1.12 1.12 1.12 1.12 1.12 1.12 
Calculated Ca:tP 1.24 1.81 1.33 1.32 1.24 1.26 1.22 1.25 
 
Phytic acid content of the diets were typical and broadly similar at between 0.41 to 0.59%. 
Analysed tP was in general close to the formulated tP, though there was a 1.1 g/kg 
discrepancy for diet H (Table 4.4). Ca was consistently higher than that formulated by 
between 1.1 and 2.6 g/kg. Ca to tP ratios were similar to expected, with the desired wide 
ratio in treatment B compared to all other diets.    
 
4.3.2. Mineral digestibility  
There were four missing faecal samples out of 72 (unattainable collections). A further two 
samples (one in D and one in J) exceeded 3 SD and were excluded.  Calculated digestible 
P and Ca based on the concentration of Ti added to the feed is shown in Table 4.5.  
 
Table 4.5: Formulated and analysed digestible P and Ca content (g/kg diet as fed) of 
diets fed to weaned pigs in experiment SM1 
Diet A B C D E G H J 
Formulated digestible P  2.8 3.8 3.8 4.8 5.8 6.8 7.8 8.8 
Calculated digestible P  3.2 4.0 4.2 4.8 5.4 6.8 7.7 6.9 




Calculated dgP was very similar to formulated levels, except for diet J which was 1.9 g/kg 
lower than predicted (Table 4.5). When P output was expressed as g/kg DM of diet intake, 
there was a linear relationship with dietary P input (p<0.01) (Figure 4.1).  
 
 
Figure 4.1: Linear relationship between total faecal P output (g/kg DM diet intake) and 
dietary P input (g/kg DM) in pigs three weeks post weaning. Y=0.41x-0.18 (r2=0.89). 
Error bars indicate SEM.   
 
The regression analysis (Figure 4.1) had good explanatory power, accounting for 89% of 
the variation of the raw dataset. The Y intercept did not differ from zero (p=0.40) at -0.18. 








































Table 4.6: The effect of increasing digestible phosphorus on mineral apparent total tract digestibility in weaned pigs 
Formulated level of dgP (g/kg diet) 2.8 3.8 4.8 5.8 6.8 7.8 8.8 S.E.D. dgP L Q D 
Replication/treatment 8 11 8 7 7 8 7      
P 0.59 0.62 0.62 0.59 0.63 0.61 0.57 0.021 0.12 0.31 0.05 0.25 
Ca 0.66 0.70 0.63 0.59 0.61 0.57 0.54 0.022 0.00 0.00 0.48 0.01 
K 0.82 0.83 0.84 0.81 0.86 0.85 0.85 0.019 0.15 0.03 0.96 0.33 
Mg 0.37 0.37 0.39 0.35 0.43 0.36 0.36 0.028 0.07 0.92 0.25 0.03 
Fe 0.35 0.26 0.11 0.10 0.27 0.17 0.32 0.040 0.00 0.21 0.00 0.00 
Cu 0.14 0.04 0.13 -0.07 0.19 0.11 0.06 0.033 0.00 0.90 0.09 0.00 
Zn 0.06 0.19 0.19 0.12 0.30 0.24 0.18 0.036 0.00 0.00 0.00 0.00 
Co 0.27 0.30 0.22 0.22 0.34 0.35 0.46 0.037 0.00 0.00 0.00 0.05 
Mn 0.13 0.15 0.29 0.25 0.32 0.34 0.24 0.037 0.00 0.00 0.00 0.02 
Se 0.54 0.49 0.68 0.43 0.51 0.49 0.54 0.031 0.00 0.27 0.93 0.00 
Mo 0.72 0.68 0.77 0.78 0.76 0.76 0.77 0.052 0.29 0.08 0.51 0.43 




The level of dietary dgP significantly affected the ATTD of all minerals measured, except P, 
K and Mo (Table 4.6). These were complex relationships (deviations P≤0.05) in all cases. 
For Ca, there was an initial increase in digestibility, followed by a steady linear decrease, 
as dietary dgP increased. Mg digestibility also tended (p=0.07) to be affected by increasing 
dgP, peaking at 43 % in diets containing 6.8 g/kg dgP. The digestibility of Fe was the highest 
in the 2.8 g/kg dgP diet (35 %), steadily reducing to 10 % digestibility by 5.8 g/kg dgP, before 
increasing to 32 % in diets containing 8.8 g/kg dgP. ATTD of Co tended to be complex 
(p=0.05) but overall, increased in line with dietary dgP level from 27 % to 46 % in a 
linear/quadratic fashion. Mn digestibility was lowest in the 2.8 and 3.8 g/kg dgP diets (13 – 
15 %), increasing to a peak of 34 % in the 7.8 g/kg dgP diet, before reducing to 24 % at 8.8 
g/kg dgP. The ATTD of Cu remained low at <20 % and went negative in the 5.8 g/kg dgP 
diet, suggesting the animal was losing more Cu than the diet provided. In the lowest dgP 
diet, Zn ATTD was only 6 %, but increased up to 30 % in the 6.8 g/kg dgP diet, before 
reducing below 20 % as dgP increased further. Se ATTD fluctuated between 43 – 54 % in 
all treatments except 4.8 g/kg dgP, where it increased to 68 %.  
    
4.3.1. Growth performance  
In general, growth performance was as expected, with no evidence of a treatment effect on 
weight gain over the three week period (Table 4.7). Two pens in the first week of the trial 
and one pen in the third week had a higher than normal FCR (>3 SD), and were removed 
from the statistical analysis. Table 4.7 shows a dose response of dietary dgP on feed 
disappearance in the third week post-weaning (p=0.05), increasing from 633 g/day at 2.8 
g/kg dgP, up to 688 g/day at 5.8 g/kg dgP, before declining to 570 g/kg at 8.8 g/kg dgP 
(p=0.03). There also tended to be a treatment effect on feed disappearance over the whole 
trial period (p=0.05), with feed disappearance highest at the 5.8 dgP/kg feed and lowest at 







Table 4.7: The effect of increasing digestible phosphors on the growth performance of weaned pigs 
Formulated level of dgP (g/kg diet) 2.8 3.8 4.8 5.8 6.8 7.8 8.8 S.E.D. dgP L Q D 
Number of replicates 8 12 8 8 8 8 8      
Mean weaning weight (kg) 8.0 8.2 8.0 8.1 8.1 8.1 8.0 0.120 0.85 0.44 0.76 0.75 
Mean weight at day 7 (kg) 9.2 9.2 9.0 9.2 9.0 9.0 9.0 0.209 0.81 0.21 0.81 0.86 
Mean weight at day 14 (kg) 11.5 11.5 11.3 11.7 11.1 11.3 10.9 0.290 0.12 0.04 0.31 0.29 
Mean weight at day 23 (kg) 15.5 15.6 15.5 16.3 15.0 16.0 14.7 0.560 0.11 0.32 0.12 0.13 
Average DF (g)             
Day 0 – 7  195 187 189 206 184 197 182 16.10 0.78 0.77 0.59 0.59 
Day 7 – 14  417 375 371 422 345 386 342 34.30 0.14 0.10 0.84 0.14 
Day 14 – 23  633 631 646 688 618 674 570 35.90 0.05 0.37 0.03 0.11 
Overall 434 418 421 460 403 441 382 24.10 0.05 0.20 0.14 0.06 
Average DLWG (g)             
Day 0 – 7  162 151 146 167 141 138 141 21.80 0.79 0.26 0.93 0.77 
Day 7 – 14  333 322 316 357 289 329 273 32.20 0.19 0.12 0.32 0.25 
Day 14 – 23  440 462 468 504 439 468 422 41.10 0.53 0.63 0.11 0.68 
Overall 323 325 313 357 303 325 291 24.30 0.21 0.24 0.20 0.24 
FCR             
Day 0 – 7  1.25 1.38 1.26 1.30 1.39 1.65 1.35 0.206 0.50 0.24 0.92 0.42 
Day 7 – 14  1.26 1.19 1.17 1.19 1.21 1.20 1.26 0.078 0.83 0.82 0.15 0.97 
Day 14 – 23  1.45 1.40 1.40 1.32 1.43 1.46 1.38 0.081 0.65 0.87 0.48 0.46 
Overall 1.35 1.30 1.37 1.30 1.34 1.36 1.33 0.068 0.90 0.89 0.86 0.72 




4.3.2. Effect of dgP and Ca on growth 
Comparisons of growth performance between diets B, C and E were used to investigate 
whether increasing Ca influenced growth performance or if differences are likely due to 
increasing dgP (Table 4.8).  
 
Table 4.8: The effect of increasing dgP or Ca on the performance of weaned pigs 
Diet B C E p-value C1 C2 C3 SED 
Formulated level of dgP (g/kg) 3.8 3.8 5.8      
Formulated level of Ca (g/kg) 10.0 7.1 10.0      
Mean weaning weight (kg) 8.1 8.2 8.1 0.83 0.81 0.52 0.39 0.12 
Mean weight at day 7 (kg) 9.2 9.2 9.2 0.84 0.91 0.86 0.94 0.21 
Mean weight at day 14 (kg) 11.2 11.5 11.7 0.16 0.28 0.06 0.35 0.30 
Mean weight at day 23 (kg) 14.8 15.6 16.3 0.07 0.10 0.01 0.23 0.57 
Average DF (g)         
Day 0 – 7  198 187 206 0.83 0.41 0.61 0.21 16.5 
Day 7 – 14  369 375 422 0.17 0.83 0.09 0.13 33.5 
Day 14 – 23  608 631 688 0.05 0.44 0.02 0.09 36.2 
Overall 411 418 460 0.08 0.71 0.03 0.06 24.6 
Average DLWG (g)         
Day 0 – 7  152 151 167 0.86 0.97 0.45 0.44 21.5 
Day 7 – 14  287 322 357 0.14 0.19 0.02 0.24 32.0 
Day 14 – 23  403 462 504 0.23 0.08 0.01 0.26 40.8 
Overall 291 325 357 0.12 0.10 0.01 0.16 24.6 
FCR         
Day 0 – 7  1.35 1.38 1.30 0.53 0.82 0.78 0.63 0.194 
Day 7 – 14  1.31 1.19 1.19 0.44 0.06 0.09 0.99 0.075 
Day 14 – 23 1.48 1.40 1.32 0.43 0.19 0.03 0.27 0.077 
Overall 1.42 1.30 1.30 0.49 0.03 0.05 0.97 0.068 
C1 = Diet B verses C; C2 = Diet B verses E; C3 = Diet C verses E; S.E.D. represents that 
between minimum replication treatments.   
 
There was a tendency (p=0.07) for pigs on the diets containing the same quantity of Ca to 
weigh an average of 1.5 kg heavier by day 23 post-weaning (p=0.01), when dgP was 
increased from 3.8 to 5.8 g/kg (Table 4.8). The same effect was not observed when Ca:tP 
was equalised and dgP increased from 3.8 to 5.8 g/kg (p=0.23). Feed disappearance was 
higher in the third week post-weaning when dgP was increased to 5.8 g/kg and Ca:tP was 
reduced from 1.60 to 1.12 (p=0.02). There was also a tendency (p=0.09) for a dgP effect, 
since when the ratio remained constant at 1.12 Ca:tP, daily feed disappearance increased 
57 g/d when dgP increased from 3.8 to 5.8 g/kg (Table 4.8). This pattern was similar, though 





4.4. Discussion  
The levels of dgP fed in this experiment were considerably higher than typical commercial 
recommendations (Ekpe et al., 2002; Whittemore et al., 2003). This was to allow for the 
detection of any dgP associated growth performance that may explain the improved growth 
sometimes seen by super dosing phytase enzymes (Selle and Ravindran, 2008) in a 
subsequent trial. Formulating to excessive P levels has a major problem in that high levels 
of P are excreted into the environment from faeces and urine. In low P diets, P transport by 
Na-P co-transporter II is increased across the intestines, independent of Ca, into the blood 
(Crenshaw, 2001; Saddoris et al., 2010). Simultaneously, P excretion through the kidneys, 
also via a Na-P co-transport system (Werner et al., 1998), is reduced (Crenshaw, 2001). As 
dietary P becomes excessive, however, absorption across the intestine shifts mainly to 
paracellular transport via the tight junctions (Breves et al., 2007).  
 
Disposal of absorbed excess P is through the kidneys (urine), in addition to the faecal route 
for unabsorbed P (Fernández, 1995). While moderately restricted P diets stimulate active 
transport (Saddoris et al., 2010), apical Pi uptake into the enterocytes would appear to be 
the most limiting factor for P absorption, where P concentrations in the gut lumen are high 
(Breves et al., 2007). Getting P levels correct is thus a fine balancing act, since for rapidly 
growing pigs, a growth ceiling can be reached where P is deficient, but is easily overcome 
when P becomes adequate (Sands et al., 2001). Absorbed P beyond that needed for 
maintenance and growth can then either be excreted via urine or can be channelled into 
bone. This luxury bone store of P allows the pig to develop a robust skeletal frame, which 
is useful for breeding animals. Assessments of the effects of minerals on pig physiology can 
be conducted in a number of ways (Ammerman, 1995). For P and Ca, mineralisation of 
bone is widely used as a response criterial (Soares, 1995), whereas for Cu and Fe, liver 
concentration and biomarkers (e.g. superoxide dismutase) tend to be favoured (Hill and 
Link, 2009). Measurements of bone mineralisation as a response criteria would have been 
a useful addition to this experiment, but would have involved sacrificing pigs and would not 
have met the primary objective of this trial.  
 
4.4.1 Effects of Ca:tP ratio on pig growth 
Digestibility of P depends somewhat on the concentration of Ca in the lumen. As the ratio 
of Ca to P widens, so the digestibility of P significantly decreases, reducing growth 
performance (Reinhart and Mahan, 1986; Qian et al., 1996). This is largely because P 
absorption (but not Ca) in the small intestines is reduced (Liu et al., 2000), probably due to 
insoluble Ca-P complexes (Heaney and Nordin, 2002). These effects are more severe in 
low P diets, where ratios of 1.0 to 1.3 Ca:tP are recommended (Reinhart and Mahan, 1986; 
Qian et al., 1996). In high P diets, this ratio has been increased up to 2.0 before growth was 
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reduced (Reinhart and Mahan, 1986), though modern genotypes may not respond the 
same.  
 
Due to the design of this experiment, Ca levels increased in parallel to tP, to maintain a 
constant low ratio, thus facilitating absorption and preventing any adverse effects of high 
Ca doses at the top end of the range. The results showed there were no significant 
differences in DF or DLWG when calcium was varied but P was fed at the same level (Table 
4.8). This is a good indication that increasing dietary calcium (at least from 7.1 to 10.0 g/kg) 
does not seem to affect growth when P is fed at a reasonable rate (3.8 g/kg). Numerically 
the mean FCR (calculated over the whole experiment) was higher (1.42) in the wide Ca:tP 
diet compared to the narrow (1.12 Ca:tP) diet (1.3). While the contrast for this was significant 
(p=0.03), the overall F ratio was not high enough (p=49) to indicate a treatment effect in the 
dataset. An increase in FCR was expected based on the evidence of Qian et al. (1996), 
though given that dgP was adequate (3.8 g/kg), the magnitude of response may have been 
weak enough to not be detected statistically in the data (Reinhart and Mahan, 1986).   
 
Reducing the ratio from 1.6 to 1.12 Ca:tP by keeping Ca the same (10.0 g/kg) but increasing 
phosphorus, resulted in a number of significant differences in growth performance. The 
most striking was an increase of 1.5 kg in pig body weight at the end of the 23 day trial. This 
change in body weight was statistically supported as the ratio reduced (p=0.01) but not 
when the ratio was kept at 1.12 and dgP was increased by 2 g/kg (Table 4.8). This suggests 
there was no effect on bodyweight due to increasing dgP, but there was a ratio effect with 
pigs fed a diet with the narrower Ca:tP growing significantly better. Differences in feed 
disappearance became apparent during the second week of the trial (p=0.05) and tended 
to persist in the data when calculated over the whole three week period (p=0.08). These 
were noted to be a significant increase due to the reduction in ratio associated with 
increasing P (but not when P was 3.8 g/kg and Ca reduced to widen the ratio) and a 
tendency to increase due to higher dgP (Table 4.8). Although the DLWG contrast between 
the wide and narrow ratio diets (through increasing P) reflected that of DF, the overall 
statistical strength of the F test was not enough to support a treatment difference. Taken 
together, keeping the ratio of Ca to tP the same, should have allowed for maximal P 
absorption, giving this experiment the best possible chance of detecting growth responses 
to increasing dietary dgP levels.      
 




4.2.2. Digestibility of phosphorus 
There was a linear relationship between dietary P input and P output expressed as g/DM 
diet intake. This is in good agreement with Fan et al. (2001), however, true P digestibility 
was unable to be estimated, since endogenous losses could not be accurately predicted, 
as the intercept did not differ from zero (Figure 4.1). This may be a feature of the linear 
regression model, since other modelling techniques give differing estimates of endogenous 
losses, depending on how liner the line is (Schulin-Zeuthen et al., 2007). Extrapolating back 
to zero using a straight line model for high P diets (above 4.3 g/kg total P), may thus be 
inappropriate, as negative values would not be possible and are likely due to measurement 
and calculation associated error. Instead it would be expected that the intercept would be 
significantly greater than zero, representing endogenous losses, so that a diet containing 
zero P input would still contain traces of P from cellular and secretory sources (Fan et al., 
2001).  
 
The analysis of ATTD of P was as expected, showing no differences (Table 4.6), reflecting 
the constant bioavailability of dicalcium phosphate (DCP). Dietary total P concentration 
increased as formulated (Table 4.4) but no assessment could be made of its fate. It is likely 
that as more P was absorbed with increasing dietary concentration, some was incorporated 
into bone (as previously described), with the rest excreted via the kidneys. Providing all 
other nutrients were adequate and the pig was not exposed to stressors such as extremes 
of temperature (Weller et al., 2013) and pathogenic challenge (Pastorelli et al., 2012), 
additional P retention from higher dgP diets would have allowed the pig to meet its genetic 
potential for growth and bone development. The digestibility of Ca, while initially increasing 
from 66 to 70 %, showed a subsequent linear decline as dgP increased. Increasing Ca 
concentration in itself should not have reduced Ca ATTD (Poulsen et al., 2010) but could 
have reduced P ATTD (Stein et al., 2011). This is dependent on the form of P fed, as 
Poulson et al. (2010) found no effect of increasing dietary Ca on P ATTD when P was 
formulated from plant phytate, whereas Stein et al. (2011) found a linear decrease in P 
digestibility when formulated with monosodium phosphate. In this study, Ca and P levels 
were adjusted with a mix of DCP and limestone, which may have influenced Ca digestibility 
in the presence of increased P.           
 
4.2.3. Effect of increasing dgP on growth performance 
Increasing the content of dgP tended (p=0.05) to increase feed disappearance quadratically 
(p=0.03) in the final growth period (Table 4.7). Though the pigs in this study were only ~15 
kg at the end of this period, Arouca et al. (2012) also report this trend for pigs of between 
15 – 30 kg. Despite the effect on feed disappearance, there were no differences found in 
DLWG or body weight. This differs from Arouca et al. (2012) who report a quadratic effect 
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in line with their growth results. There was however, a strong correlation in our results 
between overall DF and DLWG (r=0.84, p<0.001), also reflected in the statistically non-
significant FCR values, so that numerically, the mid-range dose of 5.8 g/kg dgP gave best 
performance. At the top end of the scale, 8.8 g/kg dgP numerically gave the worst 
performance, with FD being low, resulting in poor DLWG. This would indicate that dietary 
dgP was so excessive at this level, it was depressing appetite. 
  
Since there was no statistical effect of increasing dgP on growth performance, it might be 
assumed that the animals’ genetic potential had been met at 2.8 g/kg dgP, which does not 
reflect the data of Arouca et al. (2012). Their pigs had, however, been selected to have 
genetically high meat deposition characteristics and as such were commercial hybrids. 
Differences in genetic potential are well known to influence P requirements (CEFIC, not 
dated), making it all the more important that genotype is considered when setting P 
standards. In another study, the authors only began to notice an effect of increasing 
available P on DLWG from day 22 post-weaning (Kegley et al., 2001). As this study ended 
by day 23 post-weaning, it is possible to have missed a dgP effect that may have been 
detected if the study had been extended. This trial was designed to only focus on the three 
weeks post-weaning period, since subsequent phytase experiments will investigate 
alleviating the post-weaning growth check, based on this time period.   
 
The form P is fed in is well known to influence pig growth rates. When Sands et al. (2001) 
fed diets containing 4.0 and 5.5 g/kg tP formulated with monosodium phosphate (MSP), 
they found an increase in plasma P concentration, as expected, but no effect on growth 
performance. In the same experiment, when the diets were formulated to the same level of 
P using high available P corn, both DLWG and daily feed intake were significantly improved. 
This was observed despite the higher bioavailability of MSP they reported. Arouca et al. 
(2012) found a quadratic effect on weight gain and feed intake of 15 – 30 kg pigs with diets 
formulated with DCP. Weight gain in their study increased from 526 g/d to 839 g/d in diets 
containing 1.03 g/kg to 4.24 g/kg available P with maximal growth response calculated to 
be at 5.34 g/kg. Thereafter growth plateaued up to their maximal inclusion level of 6.38 g/kg 
available P. A quadratic relationship was also reported by Wu et al. (2008) using DCP but 
they found peak DLWG occurred at only 3.1 g/kg available P, though there pigs were in 
measured over the body weight range of 21 – 40 kg.      
 
Pharmaceutical levels (~2500 mg/kg) of zinc oxide (ZnO) fed post-weaning are beneficial 
in reducing the incidences of post weaning diarrhoea and improving DLWG (Poulsen and 
Carlson, 2008; Sales, 2013). At levels exceeding 1500 mg/kg, Zn can, however, inhibit 
phytase activity and reduce the available P levels in the diet through the reduction in phytate 
hydrolysis (Augspurger et al., 2004). There is also suggestion of Ca-Zn-P precipitate 
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forming in the small intestine at pharmaceutical ZnO levels, as seen indirectly by reduced 
serum P and Ca due to increasing ZnO dose (Walk et al., 2013). Together, this may mean 
more supplemental inorganic P is required to maintain growth – hence a growth response 
to increasing dgP would become apparent. In this study, ZnO was not included in the diet, 
which may have influenced our growth response to supplemental dgP. For example, the 
quadratic response in DLWG seen in the experiment of Arouca et al. (2012) was in the 
presence of 2790 mg/kg Zn. Although pharmaceutical levels of Zn were not present in the 
study of Wu et al. (2008), who also report a quadratic DLWG response, they only saw a 
response to below 2.3 g/kg available P before it plateaued. These diets in experiment SM1 
began at 2.8 g/kg dgP and thus should have already plateaued at that point, if this data 
followed that pattern.           
 
4.2.4. Digestibility of other minerals 
The polynomial contrasts allowed for an assessment of the relationship complexity between 
increasing level of dgP and the digestibility of minerals under test. In this study, most 
minerals did not follow any recognisable pattern in relation to increasing dgP level (Table 
4.6). In reality, there are a number of complex biological processes being undertaken in the 
gut of the pig during digestion and absorption. For example, phytic acid is well known to 
influence the ATTD of minerals (Woyengo et al., 2009) by binding them into insoluble 
phytate salts. The formation of insoluble phytate-mineral complexes are influenced by pH 
and by the concentration of other nutrients (the molar ratios of Zn and Cu to phytate in 
particular) in the chyme and digesta (Champagne, 1988). Additionally, mineral absorption 
is often dependent on active transporters (Hill and Link, 2009), some of which rely on co-
transport mechanisms, thus requiring the availability of other minerals and nutrients (such 
as the Na-P co-transport system). Endogenous losses into the lumen is a particular problem 
that generally requires labelling minerals of feed origin with either a radio or stable isotope 
in order to distinguish dietary minerals from endogenous. The measure of ATTD is therefore 
largely nonsensical for trace minerals with high endogenous losses such as Zn and Cu and 
the complex digestibility patterns observed (Table 4.6) in relation to increasing dietary dgP 
are therefore not surprising. Importantly, the statistical evidence for P effects noted in this 
study suggest that the concentration of dgP is important for the digestion of trace minerals, 
but other factors are also involved and balance studies would be required to obtain 







In conclusion, pig growth performance was not influenced by increasing dgP for the first 
three weeks post-weaning, when a narrow ratio of Ca to tP was maintained and all diets 
were adequate in P. The nature of mineral digestibility in pigs is complex and may depend 
on the matrix and availability of other minerals and nutrients available for co-transport, 
endogenous secretions and enzyme function. The mechanisms of improved growth 
performance associated with increasing dgP through phytase enzymes remain unclear and 






Effects of mega dosing dietary phytase on the growth 
performance, nutrient digestibility and physiology of weaner pigs 
 
5.0. Introduction 
Chapter four clearly showed there were no significant effects of increasing dietary digestible 
P on the growth performance of weaned pigs. In the last decade, studies into the use of 
modern phytases have begun to highlight other beneficial effects, including improved 
growth performance, when phytases are fed at super doses (Augspurger and Baker, 2004; 
Veum et al., 2006; Pirgozliev and Bedford, 2013). These studies have mainly been 
conducted in P deficient diets and compared to a positive control, as the authors tended to 
investigate P bioavailability. Several studies, however, have shown significant 
improvements in growth performance in diets where P and Ca were adequate (Walk et al., 
2013; dos Santos et al., 2013), suggesting that phytase has benefits in addition to its primary 
use of enhancing P digestibility. Currently, there is no data on the maximum dose of phytase 
that is effective at producing increased growth performance, since Veum et al. (2006) did 
not reach a growth plateau at 12500 FTU/kg. 
 
Below the isoelectric point of cereal proteins, such as in the conditions found in the stomach 
of the pig (pH range 2.5 to 3.8), dietary protein aggregates can form binary complexes with 
phytic acid (Kies et al., 2006b). Given that Yu et al. (2012) clearly demonstrated an inverse 
relationship between phytic acid concentration and relative pepsin activity, it is likely that 
protein digestion could thus be impacted. A review by Selle et al. (2012) suggests that the 
anti-nutritional effects of phytic acid on protein digestion may not be limited to binary 
complexes, but may also extend to ternary complexes formed through cationic bridges 
above the protein isoelectric point. These would be difficult to breakdown in the small 
intestines leading to reduced protein digestibility. The formation of lower inositol products 
occurring in the lumen of the duodenum in high phytase diets may therefore ensure a 











Fluctuations in the free nutrient contents of digesta within the lumen is associated with 
modulations in intestinal nutrient transporter expression. In particular, there are significant 
increases in ileal peptide transporter 1 and expression changes in several genes relating to 
Ca transport/binding (Vigors et al., 2014) and sodium/glucose transport (Woyengo et al., 
2011). In both studies, responses were shown to differ depending on the site measured 
along the small intestines; a feature of the intestines which has now been mapped (van der 
Wielen et al., 2014). These differences may be, in part, an explanation for the complex 
ATTD of minerals other than P, Ca, K and Mo reported in chapter four, based on differing 
concentrations in the digesta. Furthermore, there is strong evidence that dietary phytic acid 
not only binds up dietary minerals but also increases endogenous mineral loss, through at 
least four different mechanisms (Woyengo and Nyachoti, 2013). These relate to increases 
in bile salts to neutralise stomach acid, the binding of enzyme co-factors, direct binding to 
endogenous minerals and binding of mineral co-transporters. When phytase is super dosed, 
the release of chelated minerals from phytate will thus modulate the digesta mineral 
composition, in addition to preventing endogenous mineral interactions, thereby changing 
the amount of mineral digestion and absorption.  
 
It is possible that ‘extra phosphoric’ benefits may be related to the release of chelated 
minerals and nutrients (Kies et al., 2006b; Woyengo and Nyachoti, 2013) or from physical 
changes in the gut, such as prevention of crypt shrinkage (Woyengo et al., 2011). Cooper 
and Growing (1983) found endogenous phytase in the brush border membrane of rat 
intestines and hypothesised that because of its location, it may play a role in facilitating 
metal absorption from dietary phytate. Similar observations were made by Maenz and 
Classen (1998) in chickens, who found brush border phytase activity mostly occurs only in 
the pH range 5.5 to 6.5 – the normal range for digesta in the small intestines. In both studies, 
the authors reported the highest phytase activity taking place in the upper sections of the 
small intestines. The levels they observed were, however, very low given that extra 
phosphoric effects have mostly been associated with super dosing phytase (>1500 
FTU/kg).  
 
Alternatively, the far greater levels of phytase activity associated with dietary 
supplementation may offer another explanation for the extra phosphoric effects. Kemme et 
al. (2006) investigated phytate degradation in the upper gastrointestinal tract of the pig using 
up to 900 FTU/kg of a 3-phytase derived from Aspergillus niger. Their evidence, based on 
using cannulated weaned pigs fed a maize/soybean diet, indicated a difference in the 
quantitative pattern of lower inositol phosphate products. They noted high formation of IP5 
and IP4 in the duodenum at low phytase levels (186 FTU/kg), which then shifted to the 





of IP2, at a phytase dose of 1000 FTU/kg. This leads to another hypothesis to explain ‘extra 
phosphoric’ effects associated with super dosing phytase, that lower inositol phosphates 
may influence cellular signalling pathways in mammalian cells (Miller et al., 2008; Watson 
et al., 2012; Porciello et al., 2016).  
 
The gut is a major interface between antigens and the blood, thereby assuming a major role 
in immunity. As such, there are a number of features that provide this functionality (e.g. 
Peyer’s patches full of immune cells, production of cytokines and a network of dendritic 
cells). Several studies have looked into the role of dietary phytase on immune function in 
chickens (Liu et al., 2008; Ghahri et al., 2012) and pigs (Almeida et al., 2007), with mixed 
conclusions. These authors only fed up to 1000 FTU/kg phytase, looking at various immune 
responses (e.g. antibody production, cell mediated response and ratios of immune cells) 
but not specifically in the gut. Following a recent review (Heyer et al., 2015), it seems that 
there are negative consequences of feeding low P diets to pigs but a very unclear picture 
as to the role of the lower inositol phosphates generated from phytase supplemented diets. 
For example, there is certainly evidence that IP3 in particular is involved with T lymphocyte 
regulation and function (Porciello et al., 2016), though whether this can be modulated 
directly through dietary derived IPx is unknown. This is therefore an area for further 
investigation.  
           
5.1. Objective 
The objective of this chapter is to investigate the ‘extra phosphoric’ effects on growth 
performance of newly weaned pigs associated with super dosing phytase, now that chapter 
four has ruled out increasing dgP as a cause. Specifically, mechanisms of intestinal nutrient 
transporter, gut histomorpholgy, enhanced immunity and phytate destruction will be 
considered. The general hypotheses to be tested are: 
 
1. Increasing dietary phytase inclusion level will significantly improve pig growth 
performance in a dose response manner, above negative and positive controls. 
2. Increasing dietary phytase inclusion level will significantly modify mineral digestibility 
and bone mineral content in a dose response manner, above a zero phytase control. 
3. Increasing dietary phytase inclusion level will significantly modify mineral transporter 









5.2. Materials and methods 
General materials and methods relating to housing and analytical techniques can be found 
in chapter three. A dose response design (graded levels of phytase) was set up to measure 
growth performance, nutrient digestibility and immune response of pigs from weaning to 
three weeks post (designated trial SM2). 240 commercial type pigs (JSR Geneconverter 
400 x JSR Genepacker 90 and PIC Camborough x PIC 337 genotypes) from two farrowing 
batches were sourced from the Harper Adams University high health status herd at weaning 
(~26 days of age) and balanced across treatments for genotype (50:50), sex (50:50) and 
selection weight. Animals were housed in pens of five pigs (mixed sex) under commercial 
indoor conditions and fed one of eight treatment diets (Table 5.1) for 23 days. All diets were 
isoenergetic and isonitrogenous.   
 
5.2.1. Treatments 
Experimental diets (Table 5.2) were formulated to include seven levels of phytase, based 
on diet E of chapter four, as this diet had given the best numerical growth performance. This 
base diet was thus formulated to contained 5.8 g/kg dgP with a Ca:tP of 1.16, with no 
adjustment for P released by the exogenous phytase. An eighth diet (B) containing high 
dgP (7.8 g/kg) was included as a control to ensure effects were not related to increasing 
dietary P content.  
 
Table 5.1: Overview of dietary treatments relating to a phytase dose response 
experiment, plus a high P control, designated trial SM2 
Diet A B C D E G H J 
Phytase (FTU/kg) 0 0 125 500 1000 2000 8000 32000 
dgP (g/kg) 5.8 7.8 5.8 5.8 5.8 5.8 5.8 5.8 
Ca:tP 1.16 1.16 1.16 1.16 1.16 1.16 1.16 1.16 
Number of replicates 6 6 6 6 6 6 6 6 
 
The treatment diets (Table 5.1) were formulated to contain: only intrinsic phytase activity 
(<50 FTU/kg), low levels (125 FTU/kg), commercial levels (500 and 1000 FTU/kg), super 
doses (2000 and 8000 FTU/kg) and a mega dose (32000 FTU/kg) of a third generation 
Escherichia coli derived 6-phytase enzyme (EC 3.1.3.26) expressed in Trichoderma reesei 
(Quantum Blue, AB Vista Feed Ingredients, Marlborough, UK). Permission to use Quantum 
Blue in this experiment was granted by the Food Standards Agency and all experimental 
procedures were approved by Harper Adams University Research Ethic Committee. Two 
batches of pigs (three replicate pens in each batch per treatment) were used to assess the 






Pig growth performance was considered the main measure to detect ‘extra phosphoric’ 
effects in this experiment and was assessed by recording individual liveweight (LW) at day 
0 (weaning), day 7, day 14 and day 21. These periods were designated as P1, P2 and P3 
respectively. Feed disappearance was also recorded at these time points, in order to 
estimate mean daily feed disappearance (DF), daily liveweight gain (DLWG) and the food 
conversion ratio (FCR) on a pen basis. Over days 22 and 23 post weaning, one pig (closest 
to the mean average weight for that pen) from each pen was blood sampled alive, then 
euthanized by captive bolt, followed by destruction of the brain stem. Carcases were briefly 
washed in hot water and tissue samples collected as detailed in chapter three.  
 
Table 5.2: Composition of raw ingredients (g/kg) for all experimental pig diets relating 
to chapter five (experiment SM2) 
Ingredients  A B C D E G H J 
Micronized barley 76 76 76 76 76 76 76 76 
Raw wheat (whole meal) 159 150 159 159 159 159 157 150 
Micronized wheat meal 159 150 159 159 159 159 159 159 
Micronized maize 25 25 25 25 25 25 25 25 
Supertherm oats 50 50 50 50 50 50 50 50 
Herring meal 31 31 31 31 31 31 31 31 
Soya (hypro) 100 100 100 100 100 100 100 100 
Full fat soybean meal 122 122 122 122 122 122 122 122 
Premix1 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 
Skimmed milk powder 25 25 25 25 25 25 25 25 
De-lactosed whey  25 25 25 25 25 25 25 25 
Whey powder 123 123 123 123 123 123 123 123 
Sugar/sucrose 13 13 13 13 13 13 13 13 
L-lysine hydrochloride 5.2 5.3 5.2 5.2 5.2 5.2 5.2 5.2 
DL-methionine 2.7 2.7 2.7 2.7 2.7 2.7 2.7 2.7 
L-threonine 2.7 2.8 2.7 2.7 2.7 2.7 2.7 2.7 
L-tryptophan 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 
L-valine 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 
Crina 6932 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
Vitamin E 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
Titanium dioxide 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 
Quantum Blue phytase 0.000 0.000 0.025 0.100 0.200 0.400 1.600 6.400 
Sucram®3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
Benzoic acid (VevoVitall) 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 
Limestone flour 2.6 0.9 2.6 2.6 2.6 2.6 2.6 2.6 
Dicalcium phosphate  22 36 22 22 22 22 22 22 
Soya oil 42 47 42 42 42 42 42 44 
1Premix detailed in chapter three; 2Flavouring made from essential oils manufactured by 





5.2.2. Mineral and phytate digestibility 
Detailed methodology on all procedures can be found in chapter three. The digestion of a 
range of minerals were of high interest, given that the main role of phytase is to break down 
phytate, releasing complexed minerals and possibly preventing the re-formation of other 
phytates. Digestibility of minerals were therefore measured as ATTD and in ileal digesta, 
using TiO2 (3 g/kg) as an insoluble marker (see section 3.3). The increase in P digestibility 
is the result of IP6 destruction, leading to lower inositol phosphate product formation. Inositol 
phosphates (IP6-3) and inositol concentration were thus also quantified in freeze dried ileal 
digesta using HPLC, to characterise this degradation (sections 3.2.6 and 3.2.7). Lower 
inositol phosphates (IP2-1) were not determined due to the unreliability of the HPLC method 
in this range. Mineral absorption was assessed through stores in blood plasma, bone ash 
and liver samples (see sections 3.2.5 and 3.4.2). Bone strength is a response criterion often 
associated with bone mineralisation (Veum et al., 2006; James et al., 2008; Zeng et al., 
2014) and was used to verify P absorption (see section 3.7.1).  
  
5.2.3. Gut histomorphology and function 
Data from Woyengo et al. (2011) indicated that phytic acid supplementation (2 %) likely 
restricted nutrient supply in the small intestine, resulting in significantly lower crypt depth in 
the jejunum. This was not remedied when 500 FTU/kg phytase was added to the diet, 
however, super dosing might have a statistically stronger effect. The physical structures of 
the gut were therefore assessed by fixing and staining (Heamatoxylin and Eosin) a sample 
from each area of the small intestines, and viewing under optical light microscopy. Each 
histological sample was measured for villus height, crypt depth and length of an average 
mucosal gland, using digital software, calibrated with a certified scale bar (see section 3.5). 
Sialic acid concentration as a marker of endogenous losses was also measured in ileal 
digesta according to the method described in section 3.9.    
 
There are also records of phytic acid influencing active transporters (Woyengo et al., 2011; 
Vigors et al., 2014), another indication of gut disruption. While 500 FTU/kg increased the 
expression of SGLT1 from high PA supplemented diets (Woyengo et al., 2011), it is unclear 
if this may be the case in diets containing naturally occurring quantities of phytate. Gene 
expression of SGLT1 was therefore chosen as a target in this experiment, in addition to 
ZIP4, since zinc should be more available in phytase supplemented diets and ZIP4 is the 
main zinc transporter into the enterocytes. The expression of alkaline phosphatase (ALPI) 
was also measured, as Lei et al. (1993) found interactions between blood plasma ALP and 
zinc, in phytase supplemented diets. Intestinal ALP is mainly implicated with the release of 





plays a role in intestinal homeostasis and gut immunity (Lallès, 2010), making it a target of 
interest. Quantification of gut transporters (SGLT1 and ZIP4) and intestinal ALP (ALPI) was 
performed on whole intestinal wall samples, using RT-qPCR (see section 3.6.3, experiment 
SM2) with the following assays (Table 5.3) and normalised to GPI (glucose phosphate 
isomerase) and GSR (glutathione reductase) as specified in Table 3.11.  
 
Table 5.3: Assay details for qPCR primers designed to detect SGLT1, ALPI and ZIP4 









SLC5A1 SGLT1 NM_001164021 
S – TTCACCAAGCCCATTCCAG 
A – CATCCAGGTCAATACGCTCC 
85 
ALPI ALPI XR_131141 
S – AAGACATACAACGTGGACAGAC 
A – CGACTTCCCTGCTTTCTTGG 
186 
SLC39A4 ZIP4 XM_001925360 
S – AGACCTGGTGGAAGAAGAGAG 
A – AGACCATCAGCGAAGTTGTG 
126 
S = Sense primer, A = Anti-sense primer    (Source: qStandard, 2015) 
 
5.2.4. Gut health and immunity 
Immune status of the intestines was assessed by measuring the expression levels of key 
cytokines at three points (duodenum, jejunum and ileum), using RT-qPCR (see section 
3.6.3). These were the same whole intestine samples as used for SGLT1, ZIP4 and ALPI. 
The interleukins (IL) are a family of cytokines that play important roles in mediating 
responses between immune cells (Tizard, 2013). In particular, IL-2 secretion is associated 
with a Th1 polarisation and IL-4 with a Th2 response (Mosmann and Sad, 1996), 
responsible for eradication of intracellular pathogens and activation of B cells respectively 
(Vernal and Garcia-Sanz, 2008). These cytokines were therefore chosen to characterise 
the type of immune response, if any, observed in the intestine which may be modulated 
through increasing dose of phytase. In addition, there is evidence that IL-17 may be a major 
player in gut inflammation (Katoh et al., 2004; Mensikova et al., 2013), and thus useful as 
another measure of gut health. Details of the cytokine assays are given in Table 5.4., which 











Table 5.4: Assay details for qPCR primers designed to detect, IL-2, IL-4 and IL-17A 









IL2 IL-2 NM_213861 
S – TGGATTTACAGTTGCTTTTGAAGG 
A – CCCTCCAGAGCTTTGAGTTC 
148 
IL4 IL-4 NM_214123 
S – ACCTTGAACATTCTCACAGCG 
A – GTGTCTGTAGATGTGCCGAAG 
138 
IL17A IL-17A NM_001005729 
S – GAGAAACTACGATGACTCCTGTG 
A – ATGCTGAGGGAAGTTCTTGTC 
143 
S = Sense primer, A = Anti-sense primer    (Source: qStandard, 2015) 
 
Natural levels of cytokines are very low (Katial et al., 1998), though transcripts are still 
detectable through RT-qPCR (Parra et al., 2013) and protein through ELISA (Katial et al., 
1998), but increase many times when stimulated (Katial et al., 1998). For this experiment it 
was important to assess the basal levels of the immune system, to determine if increasing 
phytase dose protected against inflammation, rather than modifying cell mediated response. 
Tissue cells were therefore not cultured/stimulated. The criterion for an immune response 
was defined as a significant increase in the log10 gene expression (see section 3.6.3, 
experiment SM2).   
     
5.2.5. Data analysis 
All data was collated and calculations performed using Excel 2010/2013 (Microsoft 
Corporation, 2010/2013). Data points ± 3 SD were considered outliers and removed from 
the analysis. Data was subject to orthogonal polynomial contrasts based on the formulated 
level of phytase, using the general ANOVA procedure of GenStat (16th edition, VSN 
International Ltd), with batch as a blocking factor. Treatments A and B, were then compared 
using contrast comparisons, blocked by batch. The control diet verses those containing 
phytase were also analysed using a contrast comparison.  Body weight change at the end 
of each period for the comparison data were adjusted for starting weight as a covariate but 













All animals completed the trial in good health and were assessed by a qualified veterinary 
surgeon prior to release from the Animals (Scientific Procedures) Act 1986.  
 
5.3.1. Diet analysis  
Following ICP-MS analysis, results for the EU certified reference materials (Dairy feed, 
BER-708 and Hay powder BCR-129) were shown to be within range, except P which was 
marginally higher than the expected range (0.6 g/kg higher). The P, Ca and phytase analysis 
of the diets are detailed in Table 5.5. 
 
Table 5.5: Analysis of phytic acid, phytate-P, P, Ca (g/kg as fed basis) and phytase 
activity (FTU/kg) of experimental diets fed to pigs in trial SM2  
Diet A B C D E G H J 
Measured phytic acid  6.5 4.5 5.8 6.8 5.8 5.5 4.9 4.5 
Calculated phytate P 1.8 1.3 1.6 1.9 1.6 1.6 1.4 1.3 
Formulated total P  8.9 11.5 8.9 8.9 8.9 8.9 8.9 8.9 
Measured total P  11.2 13.1 10.3 9.6 10.8 10.8 10.1 11.0 
Formulated total Ca  10.3 13.4 10.3 10.3 10.3 10.3 10.3 10.3 
Measured total Ca  10.4 11.8 9.3 8.1 11.0 11.0 10.6 10.7 
Formulated Ca:tP 1.16 1.16 1.16 1.16 1.16 1.16 1.16 1.16 
Calculated Ca:tP 0.93 0.90 0.90 0.85 1.02 1.02 1.05 0.98 
Formulated phytase activity  0 0 125 500 1000 2000 8000 32000 
Measured phytase activity  <50 <50 262 532 1060 2030 6320 32500 
 
The analysed tP was consistently higher than the formulated tP, by ~1.6 g/kg when 
analysed by ICP-MS (Table 5.5). There was, however, a 2 g/kg difference between diets A 
and B, as expected. Phytase activity was similar to that formulated, though there was twice 
the activity expected in diet C and diet H was lower than expected. Despite the deviation 
from that formulated, the phytase activity still represented low, normal, high, super and 
mega doses. The analysed IP content of the diet is detailed in Table 5.6.     
  
Table 5.6: Analysis of inositol phosphate content of experimental diets (nmol/g DM) 
fed to pigs in experiment SM2 
Diet A B C D E G H J 
IP6 9262 9915 9937 9676 9405 10152 10931 6785 
IP5 270 329 318 356 303 402 1266 1129 
IP4 1400 1344 1630 1166 1421 1519 1493 1637 
IP3 134 73 113 108 127 113 212 124 
Inositol 321 428 430 334 451 285 397 396 






While there was a variation in phytic acid content of the diet ranging from 4.5 – 6.8 g/kg 
(Table 5.5), there was a remarkably consistent IP composition across treatments. IP6 levels 
did appear do diminish in the mega dosed phytase diet though (diet J), and IP5 levels were 
higher in both diets H and J, which contained the highest phytase levels.   
 
5.3.2. Growth performance 
Growth rates were good, with average live weights in excess of 15 kg by three weeks post-
weaning. Though increasing dietary dgP from 5.8 g/kg to 7.8 g/kg had no effect on growth 
performance from weaning to three weeks post (Table 5.7), the addition of dietary phytase 
did significantly affect a number of growth performance parameters (Table 5.8).  
  
Table 5.7: Comparison between 5.8 and 7.8 g/kg dietary digestible phosphorus on 
weaner pig growth performance from weaning (4 weeks of age) to 3 weeks post  
Digestible phosphorous (g/kg) 5.8 7.8 S.E.D. P - VALUE 
Mean start weight (kg) 8.6 8.6 0.20 NS 
†Mean weight at day 7 (kg) 9.3 9.4 0.15 NS 
†Mean weight at day 14 (kg) 11.6 11.5 0.42 NS 
†Mean weight at day 21 (kg) 15.4 15.2 0.70 NS 
Overall DF (g) 389 384 36.7 NS 
Overall DLWG (g) 323 315 33.1 NS 
Overall FCR 1.21 1.22 0.071 NS 
† Means adjusted for covariate; S.E.D. = standard error of the difference of means    
 
Overall, the exogenous addition of phytase increased DLWG (p=0.03) compared to the no 
added phytase control (diet A), leading to significantly increased body weights of pigs at the 
end of the first week post-weaning (p=0.004) by 0.5 kg and by ~1 kg in the second (p=0.006) 
and third (p=0.03) weeks. These were strongly phytase dose dependent in the first two 
weeks post-weaning (p<0.01) and also tended to be a dose response in the third week 
(Table 5.6). The effect of phytase on bodyweight corresponded to a linear increase (p<0.05) 
in period one DF and deviated responses in DLWG (p=0.01), resulting in deviated 
responses in FCR (p=0.008). This pattern was consistent through to the end of week two, 
where increasing dietary phytase also improved bodyweight (p=0.006) and DLWG 
(p=0.026) but not DF, resulting in more than one point of inflection for the FCR model 
(CD<0.001). The first of these points were due to a sharp increase in performance from the 
control diet (diet A) to when a low dose of phytase was included (diet C). Performance then 
dipped back to control levels over the range 500 – 1000 FTU/kg phytase, before increasing 





Table 5.8: The effect of increasing level of exogenous dietary 6-phytase on the growth performance of newly weaned commercial pigs  
Phytase activity (FTU/kg) <50 125 500 1000 2000 8000 32000 
S.E.D. 
p-values  
Log10+25 of phytase activity 1.4 2.1 2.7 3.0 3.3 3.9 4.5 Phytase CL CQ CD 
Mean weaning weight (kg) 8.6 8.6 8.6 8.5 8.6 8.6 8.7 0.20 0.990 0.888 0.609 0.969 
Mean weight at day 7 (kg) 9.3 10.0 9.6 9.5 10.0 9.8 9.8 0.20 0.005 0.062 0.276 0.005 
Mean weight at day 14 (kg) 11.6 12.8 12.0 11.9 12.9 13.1 12.4 0.42 0.006 0.017 0.242 0.014 
Mean weight at day 21 (kg) 15.4 16.9 15.9 15.9 17.1 17.3 16.5 0.71 0.077 0.068 0.365 0.106 
Average DF (g)             
Day 0 – 7  158 208 197 175 224 198 204 18.7 0.030 0.045 0.144 0.069 
Day 7 – 14  352 394 426 392 444 443 392 46.1 0.411 0.179 0.118 0.764 
Day 14 – 21  657 701 749 701 764 772 755 65.9 0.550 0.072 0.492 0.895 
All growth periods 389 434 457 423 477 471 450 37.7 0.276 0.055 0.200 0.692 
Average DLWG (g)             
Day 0 – 7  102 199 146 136 196 173 164 26.0 0.008 0.063 0.087 0.014 
Day 7 – 14  324 392 343 352 422 469 374 42.5 0.026 0.032 0.352 0.047 
Day 14 – 21  542 591 554 563 597 601 575 52.3 0.889 0.438 0.680 0.831 
All growth periods 323 394 348 350 405 414 371 34.2 0.100 0.079 0.302 0.145 
FCR             
Day 0 – 7  1.49 1.06 1.40 1.36 1.17 1.19 1.28 0.115 0.011 0.095 0.210 0.008 
Day 7 – 14  1.09 1.02 1.17 1.12 1.06 0.94 1.06 0.044 <.001 0.087 0.305 <.001 
Day 14 – 21  1.23 1.19 1.35 1.15 1.31 1.29 1.31 0.100 0.413 0.293 0.949 0.296 
All growth periods 1.21 1.11 1.27 1.22 1.19 1.14 1.21 0.070 0.315 0.988 0.941 0.143 





5.3.3. Mineral digestibility 
Calculated dgP, based on the concentration of Ti added to the feed, was lower compared 
to formulated levels (Table 5.9), assuming 40 % digestibility. This was especially the case 
in the lower phytase supplemented diets. 
 
Table 5.9: Formulated and analysed digestible P and Ca content (g/kg diet as fed) of 
weaner pig experimental diets (trial SM2) 
Diet A B C D E G H J 
Formulated digestible P  5.8 7.8 5.8 5.8 5.8 5.8 5.8 5.8 
Calculated digestible P  4.1 4.3 3.7 4.8 5.5 5.5 5.0 5.5 
Calculated digestible Ca  2.1 1.6 1.5 2.8 4.5 4.1 3.6 3.7 
 
Levels of Ti measured in the feed samples varied more than expected (Table 5.10), resulting 
in artificially inflated/deflated digestibility coefficients. In the case of P, excluding the most 
severely affected treatment (diet D) from the statistical analysis did not significantly change 
the shape of the curve from that generated using a mean average dietary Ti value to 
normalise all coefficients (Table 5.10).  
 
Table 5.10: Quantification of titanium by ICP-MS analysis of 49Ti in pig experimental 
diets for trial SM2  
Diet A B C D E G H J 
Ti (g/kg) 1.24 0.94 1.27 0.82 1.08 1.01 0.97 1.16 
 
Normalised ATTD of the minerals were mostly complex, except for P which exhibited a 
linear (p=0.01) increase and Zn which exhibited a liner (p<0.001) decrease in response to 
increasing phytase (Table 5.11). While the ANOVA model for phytase probability for P is 
given as 0.08 in Table 5.11, there is one low value in diet G that is ~1.98 SD from its 
treatment group mean. Removing this outlier reduces the model F probability to <0.05 for 
phytase effect, linear and quadratic contrasts for P. There was no phytase effect on the 





Table 5.11: The effect of increasing level of exogenous dietary 6-phytase on mineral apparent total tract digestibility in weaned pigs 
Phytase activity (FTU/kg) <50 125 500 1000 2000 8000 32000 S.E.D.  
 
p-values 
Log10+25 of phytase activity 1.4 2.1 2.7 3 3.3 3.9 4.5 Phytase CL CQ CD 
P 0.37 0.41 0.50 0.50 0.51 0.50 0.49 0.06 0.08 0.01 0.06 0.93 
Ca 0.28 0.35 0.42 0.42 0.36 0.35 0.35 0.07 0.31 0.31 0.05 0.72 
K 0.75 0.78 0.66 0.76 0.79 0.76 0.77 0.031 0.00 0.48 0.34 <.001 
Mg -0.10 -0.01 -0.16 0.00 -0.05 -0.11 -0.14 0.077 0.21 0.46 0.27 0.15 
Fe -0.17 -0.22 -0.45 -0.25 -0.19 -0.25 -0.33 0.077 0.01 0.17 0.32 0.01 
Cu 0.14 0.31 0.05 0.10 0.11 -0.05 0.03 0.062 <.001 <.001 0.60 <.001 
Zn 0.03 0.08 -0.11 -0.05 -0.05 -0.16 -0.15 0.074 0.02 <.001 0.98 0.25 
Co 0.05 0.05 -0.18 0.08 0.05 -0.10 -0.10 0.073 0.00 0.03 0.86 0.00 
Mo 0.70 0.70 0.56 0.62 0.72 0.68 0.56 0.084 0.216 0.2 0.921 0.155 











Digestibility of P in the control diet (diet A) was similar to the expected 40 % at 37 % (Table 
5.11). The addition of phytase to this diet tended to improve P ATTD (p=0.08) in a linear 
and quadratic increase to around 50 % ATTD. This was not the case for Ca, though there 
was a tendency for a quadratic relationship (p=0.05), with the un-supplemented diet 
containing 28 % digestible Ca, increasing to ~35 – 42 % in diets containing phytase. Dietary 
phytase inclusion also increased the ash content of both the third (p=0.02) and fourth 
(p=0.02) metacarpals over the control diet but in a complex way (Figure 5.1). When the 
control diet was considered as a 0 FTU/kg dose, then there were only tendencies for a 
quadratic relationship of phytase on the 3rd metacarpal (p=0.09) (ANOVA model p=0.06) 
and linear (p=0.08)/deviations (p=0.08) on the 4th metacarpal (ANOVA model p=0.04).    
 
Figure 5.1: The effect of dietary phytase dose on the ash content of the third and 
fourth metacarpals (light grey square and dark grey diamond respectively) of pigs 
three weeks post weaning. Means presented with common standard error of mean. 
 
The increased bone mineralisation relating to increasing dietary phytase content (Figure 
5.1) did not affect bone shear strength (Table 5.12) or bone mineral composition (Table 
5.13) but there was a significant quadratic increase on compression strength of the tibia 

























Table 5.12: The effect of increasing level of exogenous dietary 6-phytase on bone characteristics of pigs three weeks post-weaning 
CL= Contrast for linear; CQ=Contrast for quadratic; CD=Contrast for deviation; *Freeze dried prior to testing; §Tested wet 
Phytase activity (FTU/kg) <50 125 500 1000 2000 8000 32000 
S.E.D. 
p-values 
Log10+25 of phytase activity 1.4 2.1 2.7 3 3.3 3.9 4.5 Phytase CL CQ CD 
Length of 3rd metacarpal (mm) 46.7 46.2 47.0 46.7 46.3 47.5 47.8 1.199 0.80 0.21 0.43 0.93 
Length of 4th metacarpal (mm) 44.3 44.5 45.3 44.0 44.2 45.7 44.2 1.099 0.66 0.81 0.70 0.43 
Area (mm2) of 3rd metacarpal 153 158 154 156 167 148 158 14.92 0.93 0.89 0.71 0.79 
Area (mm2) of 4th metacarpal 136 140 139 147 156 154 134 15.17 0.68 0.58 0.22 0.71 
Breaking strength (N) of 3rd metacarpal§ 805 853 769 700 747 707 1005 163.20 0.55 0.59 0.13 0.68 
Breaking strength (N) of 4th metacarpal* 669 482 766 616 611 694 658 130.50 0.50 0.60 0.88 0.30 
Shear stress (N/mm2) of 3rd metacarpal 5.30 5.56 5.16 4.80 4.56 4.87 6.39 1.162 0.77 0.70 0.20 0.83 









Table 5.13: The effect of increasing level of exogenous dietary 6-phytase on the bone mineral concentration of pigs three weeks post-weaning 
CL= Contrast for linear; CQ=Contrast for quadratic; CD=Contrast for deviation 
 
 
Phytase activity (FTU/kg) <50 125 500 1000 2000 8000 32000 S.E.D. p-values 
Log10+25 of phytase activity 1.4 2.1 2.7 3.0 3.3 3.9 4.5  Phytase CL CQ CD 
Mg (g/kg) 6.95 6.99 7.41 7.23 7.44 7.18 7.27 0.140 0.12 0.06 0.09 0.38 
P (g/kg) 200 200 202 201 204 204 203 2.276 0.71 0.15 0.69 0.83 
K (g/kg) 1.72 1.89 1.79 1.78 2.08 1.62 1.75 0.143 0.42 0.78 0.29 0.31 
Ca (g/kg) 391 391 394 391 394 397 396 3.670 0.88 0.25 0.89 0.92 
Fe (mg/kg) 185 206 214 200 201 210 204 15.490 0.91 0.47 0.47 0.92 
Co (mg/kg) 0.33 0.32 0.35 0.38 0.35 0.35 0.33 0.023 0.64 0.68 0.20 0.66 
Cu (mg/kg) 14.7 13.3 9.9 17.5 28.1 22.2 18.2 10.570 0.92 0.49 0.87 0.84 
Zn (mg/kg) 258 250 271 258 249 251 257 8.410 0.59 0.72 0.87 0.36 






Figure 5.2: The effect of dietary phytase dose on the compression strength of the 
oven dried tibia and femur (light grey square and dark grey diamond respectively) of 
pigs three weeks post weaning. Means presented with common SEM. 
 
Increasing dietary phytase up to 2000 FTU/kg significantly affected the compression 
strength of both the tibia (p=0.03) and femur (p=0.006) in a quadratic manor (Figure 5.2). 
As expected, blood plasma levels of Ca and P were strongly positively correlated (p<0.001), 
with a moderate positive correlation for P and Mg (p=0.002), P and Fe (p<0.001) and P and 
K (p<0.001) (Table 5.14).  There was, however, no significant phytase (FTU/kg) correlation 
for any measured plasma mineral except Mo (p=0.03) (Table 5.14).   
 
Table 5.14: The associations (correlation coefficents) between blood plasma mineral 
concentrations in weaned pigs 


































Mineral Correlation coefficients 
Ca 0.02           
Co -0.14 -0.08          
Cu -0.10 0.04 0.38         
Fe 0.15 0.52 -0.15 -0.05        
K -0.02 0.68 0.07 0.20 0.56       
Mg 0.04 0.40 0.34 0.28 0.27 0.52      
Mn -0.12 -0.38 0.52 0.35 -0.19 -0.15 0.20     
Mo 0.33 0.08 -0.13 0.01 0.18 0.05 0.22 -0.02    
P -0.04 0.80 -0.20 -0.03 0.51 0.57 0.47 -0.34 0.17   
Ti -0.09 -0.08 0.13 0.23 -0.15 -0.15 -0.11 0.40 0.10 -0.17  
Zn -0.13 -0.08 -0.06 -0.09 0.17 0.12 0.01 0.08 0.01 0.02 -0.13 





5.3.4. Inositol phosphate breakdown 
The concentration of IP esters (6-3) and inositol in the ileal digesta of pigs was similar when 
fed the basal diet containing either 5.8 g/kg dgP or 7.8 g/kg dgP (Table 5.15). Dietary 
phytase supplementation did, however, influence ileal IP concentration (Table 5.16).   
 
Table 5.15: Comparison of the inositol phosphate product concentration (log10+1 
nmol/g DM) in weaner pig ileal digesta in response to increasing digestible 
phosphorus from 5.8 g/kg to 7.8 g/kg 
Digestible phosphorous (g/kg) 5.8 7.8 SED P - VALUE 
Phytic acid (IP6) 4.34 (24487) 4.24 (19602) 0.198 NS 
IP5 3.43 (2968) 3.39 (2948) 0.176 NS 
IP4 3.46 (3108) 3.48 (3796) 0.134 NS 
IP3 2.42 (286) 2.29 (206) 0.106 NS 
Inositol 2.79 (895) 2.74 (635) 0.192 NS 
Untransformed means presented in brackets (nmol/g DM) 
 
The graded increase in exogenous phytase level resulted in a significant (p<0.001) linear 
decrease (p<0.001) in ileal digesta phytic acid and IP5 concentrations and a corresponding 
linear increase (p<0.001) in inositol concentration (Table 5.16). This resulted in the phytic 
acid to inositol ratio reducing from 28:1 down to 0.7:1. The digestibility of IP6 in the ileal 
digesta increased significantly (p=0.002) and linearly (p<0.001) as dietary phytase level 
increased. While phytase did not have a significant effect on ileal IP3 concentration, it did 
significantly (p<0.001) affect the IP4 concentration in a complex way (CD=0.03) with linear 
(p<0.001) and quadratic (p<0.001) components. The complex relationship between 
increasing phytase and the ATTD of certain minerals such as iron and copper may depend 
on the concentration of lower inositol phosphates in the intestinal lumen. There is a strong 
inverse quadratic relationship between IP3 and Fe but this is dependent on treatment group 





Table 5.16: The effect of increasing exogenous dietary 6-phytase level on the breakdown and digestibility of phytic acid (log10+25) in weaner pig 
ileal digesta (log10+1 nmol/g DM) 
CL= Contrast for linear, CQ=Contrast for quadratic, CD=Contrast for deviations, ‡Values transformed (log10+1) with untransformed means in parentheses
Phytase activity 
(FTU/kg) 




CL CQ CD 
Log10+25 of phytase 
activity 
1.4 2.1 2.7 3.0 3.3 3.9 4.5 
Phytic acid (IP6) 4.4(24487) 4.0(13864) 3.9(10081) 3.8(7769) 4.0(11638) 3.4(4060) 3.3(3047) 0.20 <0.001 <0.001 0.579 0.450 
IP5 3.4(2968) 3.1(1595) 3.1(1749) 2.8(596) 2.8(865) 2.6(454) 2.7(584) 0.17 <0.001 <0.001 0.190 0.302 
IP4 3.5(3108) 3.6(3836) 3.8(7841) 3.4(2861) 3.5(3228) 3.3(1884) 3.1(1440) 0.13 <0.001 <0.001 0.001 0.029 
IP3 2.4(286) 2.4(261) 2.3(230) 2.5(297) 2.4(246) 2.4(250) 2.5(338) 0.11 0.849 0.790 0.441 0.747 
Inositol 2.8(895) 3.2(2710) 3.3(2344) 3.4(2527) 3.5(4202) 3.4(3140) 3.6(4311) 0.20 0.009 <0.001 0.160 0.943 






Figure 5.3: The polynomial relationship (p=0.01) between the mean concentration of 
IP3 in pig ileal digesta and the mean apparent total tract digestibility coefficent of Fe 
at graded levels of dietary exogenous phytase ranging from 0 – 32000 FTU/kg of diet 
(as indicated by the lables).      
 
Although there was no effect of phytase supplementation on IP3 ileal digesta concentration 
(Table 5.16), there was a negative polynomial relationship (p=0.01) between the IP3 ileal 
digesta concentration and the ATTD of iron when analysed by phytase group (Figure 5.3).  
The partial correlation of phytase group average IP3 concentration and mineral ATTD was 
always negatively correlated and particularly strong for Mo (r=-0.88, p=0.009) and K (r=-
0.79, p=0.03) but moderate for all other minerals tested (r>-0.40, p>0.05). Conversely, IP4 
concentration was always positively correlated, with strong coefficents for Mn (r=0.81, 
p=0.03) and Zn (r=0.80, p=0.03).  
 
5.3.5. Gut transporters and alkaline phosphatase transporter expression 
Normalised mRNA copy numbers of SGLT1, ZIP4 and ALPI transcripts did not differ 
significantly due to phytase treatment in either the duodenum or the ileum but increasing 
dietary phytase did significantly influence ALPI expression in the jejunum (p=0.02) both 










































Figure 5.4: The effect of exogenous dietary phytase on jejunal expression of sodium-
glucose linked transporter 1 (SGLT1), zinc transporter (ZIP4) and intestinal alkaline 
phosphatase (ALPI) gene expression in pigs three weeks post weaning. Means 
presented with common Log10 SEM bars. 
 
The levels of mRNA transcripts detected per standardised reaction were good, with the 
numerically highest expression of ALPI, SGLT1 and ZIP4 all found in the jejunum (Table 
5.17). Despite the relatively high CV% of the normalised copy numbers, these were all 
reduced to ≤7.2% after the log10 transformation. Around 10 % of the samples had a second 
RT run, with a rate of only 10 % exceeding 0.7 cycles difference (2 for ALPI and 3 in ZIP4).  
   
Table 5.17: Summary of ALPI, SGLT1 and ZIP4 gene expression in the duodenum, 
jejunum and ileum sections of pig intestines three weeks post-weaning in 10 µl RT-
qPCR reactions  










12764 12780 4526 35 
Jejunum 20376 19717 10847 53 
Ileum 17219 16499 8749 51 
Duodenum 
SGLT1 
227658 167107 165049 73 
Jejunum 1069188 790001 954512 89 
Ileum 565034 510919 309988 55 
Duodenum 
ZIP4 
36966 35198 11133 30 
Jejunum 64010 49935 39608 62 
Ileum 39913 37022 18930 47 










































Dietary phytase inclusion (Log10+25 FTU/kg) 





5.3.6. Effect of phosphorus and phytase level on gut histomorphology 
While there were no significant differences in growth performance and ileal digesta IP 
concentration between pigs fed the basal diet containing 5.8 g/kg dgP and those fed the 
higher rate of 7.8 g/kg dgP, there tended to be a reduction in total villus height (p=0.07) and 
an increase in the average mucosal gland length (p=0.07) in those fed the higher dgP 
concentration. This also resulted in a significant reduction in villi to mucosal gland length 
ratio (p=0.002) (Table 5.18).        
 
Table 5.18: Comparison between 5.8 and 7.8 g/kg digestible phosphorous on jejunum 
histomorphology of the weaner pig  
Digestible phosphorous (g/kg) 5.8 7.8 S.E.D. P - VALUE 
Total villi/crypt length (µm) 841 747 51.2 0.073 
Mucosal gland length (µm) 161 216 28.6 0.066 
Villi height : gland length 5.88 3.89 0.608 0.002 
 
A reduction in total villi/crypt length was not observed in relation to phytase dose 
supplementation (Table 5.19) but increasing phytase level did tend to reduce villi to mucosal 
gland length ratio (p=0.08) in a linear (p=0.007) fashion (Table 5.19). Sialic acid 
concentration in the ileal digesta (mean concentration 2.6 ± 0.87 µmol/g DM) was not 
influenced by phytase but did tend (p=0.06) to be weakly correlated (0.29) to the ratio of villi 





Table 5.19: The effect of 6-phytase on the histomorphology of the weaner pig jejunum at three weeks post weaning   
Phytase activity (FTU/kg) <50 125 500 1000 2000 8000 32000 
S.E.D. p-Value CL CQ CD 
Log10+25 of phytase activity 1.4 2.1 2.7 3.0 3.3 3.9 4.5 
Total villi/crypt length (µm) 841 751 765 820 779 772 774 48.3 0.514 0.348 0.486 0.430 
Mucosal gland length (µm) 161 189 187 229 196 211 229 29.0 0.232 0.020 0.646 0.660 
Villi height : gland length 5.88 4.36 4.54 4.12 4.39 4.11 3.99 0.624 0.076 0.007 0.135 0.693 
CL= Contrast for linear, CQ=Contrast for quadratic, CD=Contrast for deviation 
105 
 
5.3.7. Effect of phytase on gut health 
Levels of cytokine mRNA transcripts per reaction were very low or undetectable in many 
cases. This resulted in data with many missing values, which was analysed by unbalanced 
ANOVA. IL-17A expression in the ileum tended to be influenced by phytase (p=0.08) and 
so was further tested with orthogonal polynomial contrasts. The addition of increasing 
phytase significantly affected the levels of IL-17A mRNA transcripts (p=0.03) with multiple 
points of inflection (CD=0.01) over the log10+25 phytase dose range tested (Figure 5.5).  
 
Figure 5.5: The effect of exogenous dietary phytase on ileal expression of interleukin 
2 (IL-2), interleukin 4 (IL-4) and interleukin 17A (IL-17A) gene expression in pigs three 
weeks post weaning. Means presented with common Log10 SEM bars. 
 
The expression of all other cytokines (except ileal IL-17A) were either non-significant for a 
phytase treatment effect by unbalanced ANOVA or did not meet the assumptions of the 
ANOVA and were deemed unreliable for inferential analysis. Around 10 % of the samples 
had a second RT run, with a rate of 27 % exceeding 0.7 cycles difference (3 for IL-2, 6 for 
IL-4 and 4 for IL-17A). While the CV % in Table 5.20 is relatively high for IL-17A, the log 
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Table 5.20: Summary of IL-2, IL-4 and IL-17A cytokine gene expression in the 
duodenum, jejunum and ileum sections of pig intestines three weeks post-weaning, 
in 10 µl RT-qPCR reactions  
Intestinal section Gene Median copy numbers IQR 25 IQR 75 CV% 
Duodenum IL-2 54 34 80 84 
Jejunum  28 23 45 87 
Ileum  51 39 92 79 
Duodenum IL-4 19 11 26 90 
Jejunum  43 20 118 211 
Ileum  65 43 182 173 
Duodenum IL-17A 42 24 79 103 
Jejunum  60 37 363 279 
Ileum  93 37 161 363 
Median copy numbers per reaction are normalised to GSR and GPI reference genes. 
 
There was a slight polarisation of 2.9:1 towards a Th1 balance (IL-2 : IL-4) in the duodenum 
but no evidence of any bias towards either a Th1 or Th2 response in either of the other 
intestinal sections (Table 5.20).      
 
5.4. Discussion  
Phytase was clearly shown to be effective at breaking down phytic acid into lower inositol 
phosphates and pure inositol by the time feed had reached the terminal ileum (Table 5.16). 
This is in agreement with the results of Kemme et al. (2006) who showed a 65 % 
disappearance of phytic acid in ileal digesta when calculated relative to that fed, compared 
to the 68 % reduction in phytic acid found in this study (dietary phytase activity 959 vs 1060 
FTU/kg respectively). The analysed levels of IP3-6 were similar to those reported by Laird et 
al. (2016), where ileal IP6 concentration without phytase supplementation was between 
21000 – 25000 nmol/g DM and reduced thereafter due to phytase inclusion. For IP4 
concentration however, in the study of Laird et al. (2016), the levels were similar to those in 
Table 5.16 up until a dose of 8000 FTU/kg phytase, when IP4 concentration reduced 
dramatically. This was not seen in the present study, nor was the similar effect on IP3 
concentration observed. While IP3 concentrations were not affected by phytase in this 
experiment, it was IP2 ileal concentrations in Laird et al.’s study where phytase had no 
effect. This suggests that even a third generation phytase fed at super doses struggles to 









It is important that there is a rapid dephosphorylation of IP6 to IP2 in order prevent pepsin 
inhibition (Yu et al., 2012) and thus reduce the risk of phytate-mineral-protein complex 
indigestibility in the stomach. While in this chapter it was not possible to show the dynamics 
of phytic acid destruction in the stomach and along the small intestines, the inositol 
phosphate quantification pattern in the ileal digesta did closely matched that of Kemme et 
al. (2006). Assuming therefore that phytic acid destruction in the duodenum also matched 
their findings, it can be speculated that super doses of phytase ensure this rapid destruction 
of IP6, thus reducing the risk of reduced protein digestibility. This may in turn account for 
some of the differences observed in growth. 
 
5.4.1. Growth performance     
The results of this chapter confirm the observation of chapter four, that there was no effect 
from increasing dietary dgP level on the growth performance of pigs under these 
experimental conditions (Tables 4.7 and 5.7). All subsequent effects seen on growth 
performance are therefore likely to be ‘extra phosphoric’ in nature and due to the 
supplementation of phytase. The addition of the ultra-low dose (125 FTU/kg) of phytase 
compared to the control, resulted in a 44 % reduction of IP6 in the gut lumen (Table 5.16), 
representing a big reduction in a potent ANF. This may help to explain why the addition of 
phytase at any level resulted in the pronounced biological growth response over the 
unsupplemented group seen in Table 5.8. The main effects of phytase on the performance 
of the weaner pigs was observed to be in the first two weeks post-weaning (Table 5.8). This 
suggests that the inclusion of phytase helped to ensure nutrient intakes were sufficient, thus 
maintaining growth through this period (supported by the significantly increased feed intake 
in period 1). Pigs on the 8000 FTU/kg super dose were on average 1.9 kg heavier at day 
21 post-weaning than those not fed a phytase supplemented diet. Phytase at low or super 
levels may therefore be useful in mitigating the post-weaning growth check by promoting 
nutrient intake in the first week post-weaning (Table 5.8).  
 
Veum et al., (2006) conducted a similar dose response study using a predecessor second 
generation Escherichia coli derived 6-phytase enzyme expressed in Pichia pastoris. They 
reported a significant linear and quadratic response in pig growth performance over the 
range 0 – 12500 FTU/kg but did not test for higher order polynomials. If the third order 
contrasts are excluded from this data, the results would agree, as in this experiment the 
lowest dose (125 FTU/kg) is largely responsible for the significant deviations. This is 
unlikely, however, to have a strong enough influence on the polynomial fitted line to 
significantly affect the shape of the curve. In addition, here diets fed exceeded BSAS 





Veum et al. (2006) were from pigs fed P inadequate diets. This may account for the stronger 
response they observed at the latter stage of their experiment, as pigs on their positive 
control diet without phytase performed significantly better that those on their 0 FTU/kg 
added phytase control. This suggests that some of the response that they attributed to the 
effects of phytase may actually be due to the improvement in P status. In this current study, 
no such additional benefits in performance from the high P control over the 0 FTU/kg added 
phytase dose for any response criteria were observed. This may infer that the benefits 
measured from pigs fed the phytase supplemented diets were not related to the release of 
P, and were maybe due to the reduction of the anti-nutritional influence of phytate.  
 
5.4.2. Mineral and inositol phosphate digestibility 
Faecal mineral digestibility was measured as ATTD rather than STTD, since it was shown 
in chapter four that diets containing excessive P, such as the experimental diets used in this 
study, do not allow for accurate estimations of endogenous P losses. Titanium dioxide was 
chosen as a suitable in feed marker due to favourable reviews by Jagger et al. (1992) over 
chromic oxide and previous successful use in the experiment of chapter four. Analysis was 
carried out as in chapter four using ICP-MS to quantify 49Ti, due to known interferences of 
Ar with the more common 48Ti isotope. The accuracy of Ti quantification was verified with a 
certified EU reference sample (BCR® - 129 hay powder) and measured 3.9 mg/kg compared 
to the 3.8 mg/kg certified value, indicating reliable results. Samples of feed that had been 
sub-sampled from 25 kg bags throughout the trial were homogenised and analysed for Ti, 
which was found to be particularly low in diet D (Table 5.10). This low value is likely due to 
the sampling, since the manufacturer’s records show the inclusion of TiO2 had been 
accurate and consistent at the point of manufacture. If the individual diet Ti levels from the 
samples are used to calculate digestibility, then the values for diet D in particular is artificially 
inflated, defying the point of using polynomial contrasts to assess dose response. Using the 
average dietary Ti concentration of 1.08 g/kg as a common marker value for all diets 
formulated to 5.8 g/kg dgP, corrected for this discrepancy and allowed the dose response 
of phytase to be assessed.  
 
The relationship between the level of phytase and the ATTD of minerals such as Fe and Cu 
is very complex (Table 5.11). Each one is known to be absorbed and secreted in a particular 
manner and are generally influenced by the form fed, the age and physiological state of the 
animal and the presence of dietary antagonists and agonists. This presents particular 
challenges in assessing their bioavailability, as discussed in chapter four. It is, however, 
appropriate (and the industry norm) to use indigestible markers to quantify ATTD (or STTD) 





levels. As expected, phytase increased the ATTD of P in the unsupplemented diet from 37 
% to ~50 % in diets containing above 500 FTU/kg phytase (Table 5.11). While the statistical 
evidence for the phytase effect for P is given as 0.08 in Table 5.11, there is one low value 
in diet G that is ~1.98 SD from its treatment group mean. Removing this outlier reduces the 
model F probability to <0.05 for phytase effect, linear and quadratic contrasts. This confirms 
that phytase up to 500 FTU/kg is adequate for achieving the traditional goal of enhancing 
ATT phosphorus digestibility. There are, however, advantages to increasing phytase 
supplementation to 8000 FTU/kg, since only 65 % of phytic acid had been 
dephosphorylated at the terminal ileum with a 500 FTU/kg dose but this increased to 88 % 
at the super level (Table 5.16).  
 
Both copper and zinc are poorly absorbed in the pig with a balance study suggesting 
retention levels of 7.2 % of intake for Cu and 19 % of intake for Zn (Adeola, 1995). High 
levels of dietary P and Ca, such as in this study, would likely reduce the bioavailability of 
these minerals further (Atkinson et al., 1993). Where ATTD of these minerals are reported 
in the literature, phytase supplementation has inconsistent effects on digestibility. For 
example, Rutherfurd et al. (2014) showed that apparent digestibility of Zn and other trace 
minerals varies by the GI site measured but phytase supplementation up to 2215 FTU/kg 
did not influence Zn digestibility, or that of any other trace elements measured, in low P corn 
diets. In contrast, at 500 FTU/kg phytase supplementation, Bikker et al. (2012) showed 
increased digestibility from similar levels reported in this chapter up to ~10 %. Results from 
this chapter show that while there was an initial increase in Zn ATTD to 8 % with the lowest 
level of phytase, all higher doses (including 500 FTU/kg) resulted in negative digestibility up 
to 16 % (Table 5.11). This may be due to hindgut processes (e.g. metabolism processes 
and modulation from the microbiota (Metzler-Zebeli et al., 2010) and homeostatic 
regulation) rather than small intestinal absorption, since there was no change in ZIP4 mRNA 
expression in any section of the small intestine (Figure 5.4) in this study.    
 
There does, however, appear to be some high correlations between the concentrations of 
lower inositol phosphate esters (especially IP3 and IP4) in the ileal digesta and ATT mineral 
digestibility, depending on the level of phytase fed (Figure 5.3). Given that there was no 
phytase effect on the ileal digesta concentration of IP3 and a significant but complex 
response for IP4 (Table 5.16), it is likely that it is the concentrations of these lower esters 
that is important for the interaction with minerals (Bedford and Walk, 2016), rather than 
phytase per se in this IP range. This is supported by a number of studies that report strong 
interaction with lower inositol phosphates and metal ions in vitro solutions (Persson et al., 
1998) and even in human intestinal cell lines (Han et al., 1994). So even though IP6, which 





digesta, the inhibitory mechanism of the lower inositol phosphates may still pose a problem 
for absorption of some metal ions (including Fe, Zn and Cu). The influence of phytase on 
these lower inositol phosphate products in the gut is thus less than that for IP5-6, which are 
readily catalysed by phytase. This reduction in efficiency is likely to be multi-factorial, arising 
from reduction in phytase activity in the lower small intestines, the pH optimum of the 
phytase and dietary factors such as the concentration of minerals and the ratio of Ca:P 
(Dersjant-Li et al., 2014).   
 
5.4.3. Nutrient transport 
Dietary inclusion of 2 % phytic acid has been associated with a range of negative effects in 
young pigs, including histomorphological changes (Woyengo et al., 2011), nutrient 
digestibility and absorption modulation (Woyengo and Nyachoti, 2013) and a reduction in 
growth performance (Woyengo et al., 2012). It has also been shown to reduce the mRNA 
expression of SGLT1 in all three sections of the small intestines by between 1.1 and 5.4 
fold, depending on site measured (Woyengo et al., 2011). In PA unsupplemented diets 
however, there is often no effect of dietary phytase supplementation on either the mRNA 
expression (Vigors et al., 2014) or SGLT1 protein levels (Woyengo et al., 2012). This is 
confirmed in this study, where there were no phytase effects on the mRNA expression levels 
at any site in the small intestine, despite good expression levels being detected (Table 5.17). 
Supplementary phytase was shown to influence SGLT1 when in combination with high 
levels of dietary PA (Woyengo et al., 2011) but the results were inconsistent with the 
hypothesis that phytase should help restore expression levels throughout the small 
intestines to when no PA is present in the diet. Based on this evidence, at background levels 
of PA (0.5 %) found in weaner pig feeds (Table 5.5), it is unlikely that phytase would be 
effective at increasing glucose transport via the Na co-transporter and therefore not capable 
of significantly influencing net energy by this route.   
 
The expression of intestinal alkaline phosphatase was significantly modulated by phytase 
supplementation in the jejunum section only (Figure 5.4). Doses of phytase up to 2000 
FTU/kg did not appear to negatively impact ALPI expression but there was a decline in ALPI 
expression at mega doses. Alkaline phosphatase plays a number of diverse roles in the 
intestine (Lallès, 2010) but is especially useful in the release of P from lower inositol 
phosphates (KEGG, 2015) and a reduction in the expression levels at high phytase doses 
may slightly reduce the effectiveness of IP1 hydrolysis at the D-2 position. There did not 
appear to be any major impacts on phytate destruction though, as indicated by the linear 
response in Table 5.16. It was expected that there would be a significant phytase effect on 





strongly (Champagne, 1988; Persson et al., 1998) and the reduction in phytate should 
increase the availability of Zn for absorption. This was not found to be the case in the small 
intestine suggesting that Zn absorption is tightly regulated. The naturally low Zn absorption 
levels reported by Adeola (1995), may indicate that there is a limit on intestinal zinc 
transport, though this could be breed dependent since there is a known mutation in the 
porcine Zip4-like zinc transporter used in the current study that results in differences in Zn 
absorption ability (Siebert et al., 2013). It is possible that phytase may be more effective at 
influencing Zn absorption in certain breeds but this has not been well characterised.              
 
5.4.4. Bone structure and mineralisation 
Bone ash content in the third metacarpal is known to be strongly associated (R2=0.91) with 
the Ca content of the diet (Kääntee, 1983), of which the level was held static in the current 
study. Regardless, bone ash increased significantly with phytase dose from ~34 % in the 
third and fourth metacarpals from the unsupplemented diet, to a maximum response at 1000 
FTU/kg dietary phytase of ~39 %, and a decline to ~36 % at higher phytase doses (Figure 
5.1). These levels are consistent with other studies; for example Yáñez et al. (2013) 
reported bone ash contents of 36 % in phytase untreated third metacarpals, increasing to 
38 % with 500 FTU/kg phytase. Ash content of metatarsals, in similar age pigs, have also 
been shown to increase to ~31 % with 2000 FTU/kg supplemental phytase, compared to 
~27.5 % in 0 phytase control (Pagano et al., 2007). The quadratic response may be related 
to the ATTD of Ca which, while not significantly affected by phytase dose per se, exhibited 
a quadratic tendency peaking at 1000 FTU/kg phytase and then reducing at higher phytase 
inclusion levels (p=0.05, Table 5.11). Despite this increase in ash content, the mineral 
composition of the ash remained consistent regardless of phytase addition (Table 5.13) with 
a mean Ca:P of 1.95 (SD=0.008). This was very similar to the data on metatarsal minerals 
(with up to 2000 FTU/kg phytase) published by Pagano et al. (2007), who also did not find 
significant phytase effects on Ca, P, Mg, Fe or Zn composition.         
 
Increased mineralisation does not always mean improved structural integrity (NRC, 2012), 
as noted in this chapter with the increase of bone ash but no resulting change in shear 
strength (Table 5.12). This may partly be down to the way in which bone strength is 
assessed and reported. The last major review on the topic was published by Crenshaw et 
al. (1981) and noted that many authors were incorrectly confusing bone bending moment 
(a measure of force required before structural failure, adjusting for bone length) with bone 
strength (force per unit of area). While the former allows some adjustment for different bone 
lengths, only the latter takes into account different shapes of bone. Although these 





in reported methods with a database search (Web of Science with the terms: bone, strength, 
pig*, swine) from 2010 to 2016 returning 69 hits, of which 13 had used bone strength as a 
response criterion to nutrition. Of these, only two had investigated techniques other than 3-
point bending. In this chapter, bone strength is reported as a modified version of the shear 
strength proposed by Combs et al. (1991), where shear strength is defined as maximum 
shear force (N) divided by the total area of the bone at the shear site. This gives a measure 
independent of the length of the bone.   
  
 
Bone is comprised of a complex biphasic polymer containing collagen and mineral crystals. 
The use of shear or flexure (3-point bending) techniques may not therefore be sufficient to 
describe the mechanical properties adequately for use in nutrition. Nikodem et al. (2012) 
proposed a range of mechanical tests on pig femur bones to address this problem using 
different sources of Ca and P. These included compression strength and assessments of 
hardness. Given that phytase increases the bone mineralisation (Table 5.11), compression 
testing is likely to be a more sensitive method for identifying differences due to 
mineralisation, as there is less emphasis on shearing collagen fibres. Indeed, Figure 5.2 
confirms this and shows that phytase quadratically increased bone compression strength 
up to the 2000 FTU dose tested. The peak bone ash content corresponds to the peak 
compression strength at a phytase level of 1000 FTU/kg, which was not detectable with the 
assessment of shear strength alone.        
 
5.4.5. Intestinal health and histomorphology 
Intestinal histomorphology in relation to dietary phytase supplementation has not been well 
characterised in the pig. Woyengo et al. (2011) did however find that the addition of dietary 
phytic acid reduced jejunal crypt depth while having no effect on villus height or villi – crypt 
ratio. In the current study there is a tendency (p=0.076) that dietary phytase addition linearly 
reduced jejunal villi – mucosal gland ratio, possibly because of the linear increase in 
mucosal gland length (although the effect of phytase was not statistically significant, 
p=0.232, there was a significant linear contrast at p=0.02), and a lack of any effect on villus 
height. The increase in mucosal glands should result in more secretions into the gut lumen, 
which was assessed through the measurement of sialic acid in digesta (data not shown). 
There did indeed tend to be a weak positive correlation (r=0.29, p=0.06) between jejunal 
villi to mucosal gland ratio and the concentration of sialic acid as measured in ileal digesta. 
This may have been more in response to the slight Th1 polarisation noted in the upper 
section of the intestine which suggests some gut inflammation, of which mucin production 





reported in Table 5.20 were very low despite the good quality RNA (checked for purity by 
nanodrop and integrity by Bioanalyzer) and PCR reaction conditions. This data was 
normalised to GPI and GSR which had previously been identified as a suitable combination 
of reference genes through a pilot geNorm analysis (see section 3.6.2).Taking both studies 
together, it is likely that phytase may be alleviating the negative effect of phytic acid on crypt 
and mucosal gland length, rather than any influence of phytase causing extended villi. 
Further work may therefore be needed to ascertain the effects of phytic acid and phytase 
on intestinal histomorphology. This may include assessment of the expression of a number 
of mucin genes to confirm secretions are elevated and assessment of B cells and antibody 
levels to exclude inflammation as the cause.  
 
5.5. Conclusions 
In conclusion, the addition of a third generation E. coli derived phytase (expressed in 
Trichoderma reesei) fed to newly weaned pigs in this study was effective at phytate 
hydrolysis, resulting in an 84 % digestion of ileal digesta phytic acid concentration at the 
highest dose of 32000 FTU/kg. Super dosing (>2000 FTU/kg) of this phytase significantly 
improved pig weight gains in the first two weeks post-weaning over unsupplemented pigs, 
resulting in pigs that were 11 % heavier at the end of the three week trial period. Pigs fed 
diets containing the mega dose of 32000 FTU/kg did not show any better growth 
performance than those fed the super dose of 8000 FTU/kg, suggesting a plateau had been 
reached between these ranges. It is likely that the observed effects are not related to any 
additional release of phosphorous from the hydrolysis of phytic acid, as there were no 
significant effects on growth performance or phytic acid breakdown patterns detected 
between the 0 FTU/kg added phytase dose and a high digestible phosphorus control. 
Phytase supplementation of 500 FTU/kg was sufficient to increase ATTD of P from 37 % to 
50 % but there were no further benefits beyond this phytase level, though increasing the 
dose to 8000 FTU/kg resulted in maximum phytate digestibility. Maximum bone 
mineralisation and subsequent compression strength was met by the supplementation of a 
super dose of 1000 FTU/kg dietary phytase. Recommendations for phytase 
supplementation in weaner pig diets based on these results would be feeding a super dose 
of 8000 FTU/kg for the first two weeks post-weaning to maximise growth performance and 
the hydrolysis of phytate in the small intestines; reducing to 1000 FTU/kg in the third week 




Interaction of dietary phosphorus, phytase and pharmaceutical 
ZnO on growth performance and health status of the weaner pig    
 
6.0. Introduction 
The addition of zinc in animal feeds has been under scrutiny from the EU for some time due 
to the potential environmental consequences of soil and water contamination arising from 
animal waste (SCAN, 2003). Although physiological requirements for zinc in pigs is 
relatively low (estimated to be 100 mg/kg of diet (90% DM) for piglets, decreasing to 80 
mg/kg post-weaning and even lower in growing pigs (50 mg/kg) (NRC, 2012)), 
supplementary levels of up to 250 mg/kg of complete feed have been authorised by the EU 
since 1970 (Council Directive (EEC) No 70/524/EEC). This limit was reviewed and reduced 
to 150 mg/kg of feed in 2003 (Commission Regulation (EC) No 1334/2003) and the 
definitions updated in 2016 (Commission Implementing Regulation (EU) No 2016/1095), in 
line with reported typical industry practices (FEEDAP, 2014). Despite this, ZnO 
supplementation of between 2000 and 6000 mg/kg were noted as reportedly having 
therapeutic effects by the Scientific Committee for Animal Nutrition as far back as 2003, 
although they were not wholly convinced (SCAN, 2003). In 2006 though, the EU ban on 
antibiotic growth promoters (Commission Regulation (EC) No 1831/2003) came into effect, 
so high levels of ZnO as a pharmaceutical compound in pig diets remained wide-spread to 
try and mitigate post-weaning diarrhoea (PWD) in the absence of routine antibiotic 
medicated feed. Case studies reviewed by the European Commission indicated that ZnO 
inclusion at 2500 mg/kg of feed are still commonly used in at least Belgium and Denmark 
(EC, 2015). Other countries such as France and Germany, however, take a different view 
and do not allow the use of ZnO as a Veterinary Medicinal Product (VMP) for pigs, even 
though it is authorised in the EU (FVE, 2014).   
 
In the UK, ZnO is marketed for use in pigs by two companies: DSM Nutritional Products 
(UK) Ltd and Provimi Ltd. It is authorised as a VMP under the trade names PigZin Premix 
(Vm 19108/4000) and ZincoTec® (Vm 03941/4000) to combat PWD (Mounsey, 2016). While 
it is generally recognised as clinically effective against PWD (FVE, 2014) and an effective 
growth promoter (Sales, 2013), it is noted by the VMD (Veterinary Medicines Directorate) 
that the precise action of ZnO in the treatment and control of diarrhea in pigs has not been 
fully determined (VMD, 2000). Reducing the particle size of ZnO to below 100 nm, the so-
called nano-scale, has however been shown to enhance the antimicrobial properties of the 
compound, due to the larger surface area available for surface reactions causing damage 





nanoparticles (ZnO-NP) have potent antibacterial activity against Campylobacter jejuni 
(0.05 mg/ml) but are less effective (8 – 16 fold lower activity) against Escherichia coli 
O157:H7 and Salmonella enterica Serovar enteritidis (Xei et al., 2011). The level for 
complete inhibition of Escherichia coli O157:H7 reported by Xei et al. (2011) of 0.80 mg/ml 
is similar to that previous reported by Liu et al. (2009) of 0.98 mg/ml ZnO-NP, suggesting 
the compound is an effective antibacterial agent, at least in vitro.  
 
Experiments in pigs have also shown that high doses of regular pharmaceutical grade ZnO 
(3000 mg/kg feed) can modulate intestinal bacterial communities (Vahjen et al., 2010) and 
in particular is effective at reducing post-weaning colonisation of enterobacteria for up to 
eight days post-weaning, before levels of bacteria in low zinc diets naturally equalise 
(Vahjen et al., 2016). Similar results have been reported by Jensen-Waern et al. (1998) with 
a significantly lower number of enterococci excreted at three days post-weaning only in 
2500 mg/kg feed ZnO supplemented pigs but no overall difference over the course of the 
63 day study between control and ZnO groups. There is also direct evidence of improved 
growth rates following an Enterotoxigenic Escherichia coli Serotype K88 (ETEC-K88) 
challenge on outdoor reared pigs supplemented with 3100 mg/kg ZnO verses a non-
supplemented control (but no difference between indoor reared pigs under the same 
treatments) and reduced intestinal inflammation (Sargeant et al., 2010).  Zinc oxide also 
has confirmed efficacy both in vitro and in vivo against Campylobacter coli at concentrations 
of 0.21 mg/ml and in feed at 3100 mg/kg ZnO (Bratz et al., 2013), though it shows no action 
against viruses such as PPRSV (Chai et al., 2014). In line with this data, the normal 
recommended use of pharmaceutical ZnO inclusion is on a 14 day program post-weaning 
(FEEDAP, 2014; FVE, 2014).     
 
Despite the effectiveness of pharmaceutical doses of ZnO noted in the majority of studies, 
there are reports of ineffectiveness to reduce the numbers of Enterobacteriaceae and 
Clostridia in both digesta and faecal samples taken post-weaning (Li et al., 2001). Also, not 
every form of zinc shows therapeutic action. For example, Šperling et al. (2014) did not find 
any action of zinc chelate at 250 ml/1000 ml water against a challenge of B. hyodysenteriae 
to which an antibiotic (valnemulin) was effective. In addition, there are risks with continued 
use of ZnO, such as concerns over antimicrobial resistance and environmental issues. 
Recent work by Slifierz et al. (2015) demonstrated that methicillin-resistant Staphylococcus 
aureus (MRSA) can be quite tolerant to therapeutic ZnO in post-weaning pigs, with 
increases in prevalence and persistence in ZnO treated groups verses low zinc controls. 
This may lead to reservoirs of antimicrobial resistant bacteria on farm, posing a risk to public 
health. Furthermore, pharmacological ZnO supplementation may interact with dietary 





increasing dietary phosphorus or including a phytase enzyme in ZnO medicated feeds 
(Walk et al., 2015).  
 
Phytic acid (IP6) is of particular concern in the context of supplemental zinc because it is a 
reactive molecule, normally found as a salt (phytate) chelated to divalent cations, including 
magnesium and especially, zinc. Exogenous phytase activity to hydrolyse phytate needs to 
primarily occur in the stomach, due to the solubility of phytate at low pH (Schlemmer et al., 
2001). If the activity is not enough, phytate complexes may precipitate in the small intestines 
and lock up nutrients. In fact, Zn dependent phytase has been reported to be localised to 
the brush boarder membrane of the duodenum of the rat (Davies and Flett, 1978), 
suggesting this is an important site for phytase and Zn interactions. It is well known that 
phytase addition is effective at releasing chelated zinc from phytate and can therefore be 
used to reduce supplemental zinc inclusion levels at normal phytase doses (Revy et al., 
2006; Schlegal et al., 2013). At therapeutic levels however, there is evidence that 1500 
mg/kg ZnO or zinc chloride can reduce the efficacy of phytase at releasing phytate-P by 
decreasing the availability of phytate for hydrolysis by phytase (Augspurger et al., 2004). 
High levels of ZnO have also been demonstrated to modulate blood serum calcium and 
phosphorus levels, indicating there may be Ca-Zn-P precipitation (Walk et al., 2013), as 
well as reducing P, K and Na apparent total tract digestibility (Walk et al., 2015). Phytase 
has also been shown to significantly interact with pharmaceutical levels of ZnO in the 
intestinal mucosa to increase the relative abundance of metallothionein (MT) mRNA, 
especially at levels of 2000 mg/kg diet ZnO (Martínez et al., 2004). This may in part suggest 
that phytase can modulate the quantities of zinc entering the blood. Routine metaphylactic 
use of ZnO in weaner pigs may therefore not be advisable without due consideration to 
phytase supplementation strategies. 
 
Recent research has suggested that super doses of phytase enzymes may be alternatives 
to high levels of zinc supplementation post-weaning in healthy pigs due to its growth 
promoting effects (Walk et al., 2013). This was certainly shown to be the case in chapter 
five, where extra phosphoric growth rates were 92 % higher in the first week post-weaning 
with a 2000 FTU/kg of feed dose verses a non-phytase supplemented diet (Table 5.8). 
There would be a clear benefit of substituting routine therapeutic ZnO use in weaner pig 
feeds with super doses of phytase from both an environmental and antimicrobial resistance 
where there is no clinical reasoning for medicating the feed. Given the reported interactions 
between pharmaceutical ZnO and phytase supplementation, further research is needed to 





6.1. Objective  
The aim of this chapter is to assess the role of super dosing phytase in conjunction with 
feeding pharmaceutical ZnO to weaned pigs under non-challenge conditions by 
assessment of growth performance and systemic/intestinal health. Furthermore, this 
chapter will investigate the interaction of high levels of ZnO on the requirement for dietary 
digestible phosphorus post-weaning, for optimising growth performance. The general 
hypotheses under test in this chapter are: 
 
1. Increasing dgP from 2.8 g/kg to 5.8 g/kg will not significantly increase growth 
performance above that of those fed the lower rate (confirming the results of chapter 
four).  
2. Increasing phytase supplementation from 0 FTU/kg to 2500 FTU/kg will significantly 
increase the growth performance of weaned pigs up to three weeks post-weaning 
(confirming the results of chapter five). 
3. There will be no significant interaction between the dose of supplemental phytase and 
the level of dgP in the diet, since increasing dgP above 2.8 g/kg diet does not lead to a 
growth response.  
4. The inclusion of pharmaceutical ZnO will not significantly improve pig growth 
performance under non-challenge conditions. 
5. There will be a significant interaction between ZnO inclusion and phytase inclusion on 
pig growth performance, since ZnO has been shown to reduce phytase efficacy.  
6. There will be a significant interaction between ZnO inclusion and dgP level on pig growth 
performance, since ZnO has been shown to precipitate with Ca/P, forming insoluble 
complexes. 
7. There will be a significant dose response to increasing dgP level in ZnO medicated diets 
on pig growth performance parameters, since ZnO has been shown to precipitate with 
Ca/P, forming insoluble complexes. 
8. There will be no significant effects of any treatment or combination of treatments on 
systemic and gut health/immune markers (tested as a null hypothesis).   
 
6.2. Materials and methods 
General materials and methods relating to this section can be found in chapter three. All 
experimental procedures were approved by Harper Adams University Research Ethics 
Committee and in compliance with the Animals (Scientific Procedures) Act 1986. Approval 
for using Quantum Blue phytase in this trial was granted by the Food Standards Agency 





6.2.2. Treatments and trial designs 
The first experiment (designated trial SM3) comprised of a 2 x 2 x 2 factorial design to test 
the main effects of digestible phosphorus (dgP) at 2.8 g/kg of feed (low) and 5.8 g/kg of 
feed (high), effect of phytase at either 0 FTU/kg feed or 2500 FTU/kg feed (super dose) and 
the effect of pharmaceutical ZnO at either 0 mg/kg or 3100 mg/kg feed (medicated) on 
growth performance, and to allow assessment of the interactions (Table 6.2). The two levels 
of dgP selected represented the lowest dose from chapter four (to which there was no 
further increase in growth performance when this level was increased) and the mid-range 
level of 5.8 g/kg feed dgP, which was also the level in the basal diet for chapter five. To test 
the hypothesis that in the presence of high levels of phytase and ZnO there would be a 
dose response to increasing dgP (unlike chapter four when neither were supplied), two 
further treatment groups were included in the design, comprising of 3.8 g/kg dgP of feed 
(with inclusion of 2500 FTU/kg phytase and 3100 mg/kg ZnO) and 4.8 dgP g/kg of feed 
(with inclusion of 2500 FTU/kg phytase and 3100 mg/kg ZnO). This provided an additional 
dose response design with graded levels of dgP (2.8, 3.8, 4.8 and 5.8 g/kg feed) in the 
presence of 2500 FTU/kg phytase and 3100 mg/kg ZnO (Table 6.3). 
 
The main effect of phytase should confirm the data in chapter five, where improvements in 
growth rates for the first two weeks post-weaning should be evident with super dosing. If 
confirmed, this would indicate that Quantum Blue phytase is an efficacious zootechnical 
growth promoter when added at 2500 FTU/kg diet for the first 14 days post-weaning.   
Dietary inclusion of pharmaceutical ZnO should also have growth promoting ability at similar 
or higher levels to super dosed phytase. This may not be the case in healthy pigs not 
suffering from PWD (which should be the norm) but the hypothesis that there should not be 
any adverse effects for ZnO supplementation will be tested. In particular, testing for 
interactions with phosphorus and phytase is of interest in this experiment due to the 
emerging evidence of complex precipitations. Further assessment of super dosing phytase 
and ZnO was assessed in the second experiment. 
 
The second trial (designated trial SM5) was a 2 x 2 factorial design based on the 5.8 g/kg 
dgP diet with and without phytase (0 or 2500 FTU/kg) and with and without pharmaceutical 
ZnO (0 or 3100 mg/kg). The aim of this trial was to assess gut health and immune response. 
Digestible phosphorus in the diets was provided from dicalcium phosphate to the formulated 
levels required. The phytase used in both experiments was a third generation Escherichia 
coli derived 6-phytase enzyme (EC 3.1.3.26) expressed in Trichoderma reesei (Quantum 





supplied as PigZin Premix (Vm 19108/4000) at a dose rate of 3100 mg/kg complete feed, 
to provide 2500 mg/kg zinc.  
 
6.2.1. Animals 
In experiment one (SM3), 400 commercial type pigs (JSR 800 sire line and PIC 337 sire 
line genotypes) from two farrowing batches were sourced from the Harper Adams University 
high health status herd at weaning (~26 days of age) and balanced 50:50 across treatments 
for genotype, sex and selection weight. Animals were housed in pens of five pigs under 
commercial indoor conditions. Each pen represents one experimental unit (replicate). 
Statistical power was assessed prior to the experiment based on the procedure of 
Berndtson (1991), to detect a 10 % difference, with 80 % power, at the 95 % level of 
probability. Treatments were assigned to pens using a random number generator in Excel 
2013 (Microsoft Corporation), to provide a total of eight replicates (pen of five pigs) per 
treatment group.   
 
In experiment two (SM5), 64 commercial type pigs (JSR Genpacker 90 X JSR 900)  were 
weaned at 26 days of age and vaccinated against Mycoplasma hyopneumoniae (M+PAC™, 
Intervet UK Ldt, Milton Keynes, UK) and porcine circovirus virus type 2 (Ingelvac 
CircoFLEX®, Boehringer Ingelheim Vetmedica GmbH, Germany). Pigs were weighed one 
day prior to weaning to establish single sex pens of four pigs (mean weight 8.3±0.1 kg), 
equally split between two buildings (see section 3.1.5.). Treatments were assigned to pens 
using a random number generator in Excel 2013 (Microsoft Corporation), to provide a total 
of four replicates (pen of four pigs) per treatment group (two replicate pens per building).  
 
6.2.3. Diets 
In experiment one (SM3), pigs were fed one of ten treatment diets (Table 6.1) for 22 days. 
All diets were isoenergetic and isonitrogenous. In the second experiment (SM5), pigs were 
fed diets E – J only, for 23 days. All diets were based on the formulation used in experiments 
SM1 and SM2, including 3 g/kg TiO2 as an inert marker. Diets were analysed for their 
nutrient content by Sciantec Analytical (Stockbridge Technology Centre, Cawood, North 










Table 6.1: Composition of raw ingredients (g/kg) for all experimental pig diets fed in 
experiments SM3 and SM5 
Ingredients A B C D E G H J K L 
Micronized barley 76 76 76 76 76 76 76 76 76 76 
Raw whole wheat meal 173 173 173 173 159 159 159 159 169 164 
Micronised wheat meal 173 173 169 168 159 159 155 154 163 159 
Micronised maize 25 25 25 25 25 25 25 25 25 25 
Supertherm oats 50 50 50 50 50 50 50 50 50 50 
Herring meal 31 31 31 31 31 31 31 31 31 31 
Hypro soya  100 100 100 100 100 100 100 100 100 100 
Full fat soyabean 122 122 122 122 122 122 122 122 122 122 
Premix1 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 
Skimmed milk powder 25 25 25 25 25 25 25 25 25 25 
Delactosed whey 25 25 25 25 25 25 25 25 25 25 
Whey powder 123 123 123 123 123 123 123 123 123 123 
Sugar/sucrose 13 13 13 13 13 13 13 13 13 13 
L-lysine HCL 5.1 5.1 5.1 5.1 5.2 5.2 5.2 5.2 5.2 5.2 
Dl-methionine 2.6 2.6 2.6 2.6 2.7 2.7 2.7 2.7 2.6 2.6 
L-threonine 2.7 2.7 2.7 2.7 2.7 2.7 2.7 2.7 2.7 2.7 
L-tryptophan 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 
L-valine 1.2 1.2 1.2 1.2 1.3 1.3 1.3 1.3 1.2 1.3 
Crina 6932 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 
Vitamin E 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 
Titanium dioxide 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 
Quantum blue phytase 0.0 0.5 0.0 0.5 0.0 0.5 0.0 0.5 0.5 0.5 
Sucram®3 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 
Benzoic acid (VevoVitall)  5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 
Pigzin (zinc oxide bp) 0.0 0.0 3.1 3.1 0.0 0.0 3.1 3.1 3.1 3.1 
Limestone flour 5.2 5.2 5.2 5.2 2.6 2.6 2.6 2.6 4.3 3.4 
Dicalcium phosphate 18  0.0 0.0 0.0 0.0 21.8 21.8 21.8 21.8 7.3 14.5 
Soya oil 32.8 33.0 34.2 34.4 41.5 41.7 42.9 43.1 37.3 40.2 
1Premix detailed in chapter three; 2Flavouring made from essential oils manufactured by 
DSM Nutritional Products (UK) Ltd; 3Sweetener manufactured by Pancosma SA 
6.2.4. Statistical analysis 
Data handling and calculations were performed in Excel 2013 (Microsoft Corporation) and 
statistical analysis was performed using GenStat 16th edition (VSN International Ltd) 
statistical software. Summary statistics were used to check data for outliers (<> 3 SD) and 
normality. Statistical significance was accepted at the 95% level and trends were reported 
at the 90 % level. Experiment one (SM3) was analysed as a randomised block (batch) 2 x 
2 x 2 factorial design by ANOVA for treatments A – J (Table 6.2), consisting of eight 






Table 6.2: Factorial experimental design arrangement for experiment one (SM3), with 
digestible phosphorus (dgP g/kg of diet) at two levels, Quantum Blue phytase at two 
levels and PigZin Premix at two levels  
 Diet A Diet B Diet C Diet D Diet E Diet G Diet H Diet J 
DgP 2.8 2.8 2.8 2.8 5.8 5.8 5.8 5.8 
Phytase1 - + - + - + - + 
ZnO2 - - + + - - + + 
 1phytase at either 0 FTU/kg diet (-) or 2500 FTU/kg diet (+); 2PigZin Premix at either 0 
mg/kg diet (-) or 3100 mg/kg diet (+) 
 
Orthogonal polynomial contrasts blocked by batch were then used to test for linear and 
quadratic response to increasing dgP dose in the presence of phytase and ZnO (Table 6.3). 
This was followed by least mean squares regression blocked by batch to ascertain the 
parameters of the response. Eight replicates per treatment were used in the analysis.  
 
Table 6.3: Dose response experimental design parameters for experiment one (SM3), 
with digestible phosphorus (dgP) at four levels, Quantum Blue phytase at 2500 
FTU/kg diet and PigZin Premix at 3100 mg/kg feed 
 Diet D Diet K Diet L Diet J 
DgP (g/kg) 2.8 3.8 4.8 5.8 
Phytase + + + + 
ZnO + + + + 
 
In experiment two (SM5), growth performance and blood data was analysed as a 2 x 2 
factorial design in GenStat 16th Edition (VSN international Ltd). Significance was accepted 
at the 95 % level and trends reported at the 90 % level. For growth performance data, the 
pen of four pigs was considered the experimental unit. For haematology and cytokine 
analysis, the average values of the pair of two pigs from the same pen was considered the 
experimental unit.  
 
6.2.5. Growth performance 
In experiment one, the only parameters for assessing the effects of the treatment groups 
was considered to be growth production performance. Individual pigs were weighed at 
weaning, day seven, 14 and 22 post-weaning, while feed intake was measured on a whole 
pen basis at each of these time points. Feed conversion ratio (FCR), daily liveweight gain 
(DLWG) and daily feed disappearance (DF) were calculated for each of these three periods 
respectively. Period one was regarded as an acclimatisation period and the results 
interpreted appropriately. Growth performance was also assessed in experiment two but 





6.2.6. Haematology  
Assessment of systemic health status was conducted through measurements of total white 
blood cell count (WBC) and subsequent differential quantification of basophils, eosinophils, 
neutrophils, monocytes and lymphocytes. In experiment two only, blood was collected from 
08:00 – 09:00 by jugular venepuncture at day 12 and 13 post-weaning into a 4.0 ml K2EDTA 
coated BD Vaccutainer® from two mean weight pigs per treatment pen. The treatment order 
of blood sampling was randomised but balanced so that two pens per treatment were 
sampled on each day. Whole blood analysis, including WBC differentiation, was performed 
in technical duplicates using an MS45 impedance counter blood analyser (Melet Schloesing 
Laboratories, Osny, France), validated with a normal level control sample (Woodley 
Equipment Company Ltd, Lancashire, UK) (see section 3.4.1 for further details).    
 
6.2.7. Collection of intestinal samples and cDNA preparation 
Over days 22, 23 and 24 post-weaning, two mean weight pigs from each pen were 
euthanized by captive bolt followed by destruction of the brain stem. Following a vertical 
midline incision, the small intestines were clamped at the junction of the stomach/duodenum 
and the terminal ileum/colon, before being removed and carefully spread out on a clean 
surface. Plastic cable ties were used to divide the intestines into three equal sections 
representing the duodenum, jejunum and ileum.  A 2 CM sample was  cut from each section 
and immediately stabilised in RNAlater® (Sigma-Aldrich, St. Louis, Missouri, USA), prior to 
storage at -80 °C for five months. RNA from ~20 mg of whole intestinal samples from the 
duodenum and ileum were extracted, purified and reverse transcribed according to the 
procedure detailed in section 3.6.3. 
  
6.2.8. Determination of reference genes and SYBR green assays 
Reference genes for normalisation of data were selected using the geNorm™ method 
described in section 3.6.1. Immune status of the intestines was assessed by measuring the 
expression levels of key pro-inflammatory cytokines in the duodenum and ileum section of 
the small intestine using RT-qPCR (see section 3.6.3). The cytokines chosen differed from 
those selected in chapter five, since IL-2, IL-4 and IL-17A were designed to indicate the 
response pattern (Th1, Th2 or Th17,) whereas IFN-γ, IL-6 and TNF were selected in this 
chapter as markers of inflammation only. Challenge from bacteria and viruses to the 
intestine should elicit a pro-inflammatory response through the action of cytokines, such as 
the three selected in this chapter. Elevated levels would therefore indicate poor gut health 
and would allow assessment of the dietary treatments, in particular the effectiveness of 
pharmaceutical ZnO and super doses of phytase. For the gene expression assays, eight 





the qPCR stage. These were run under the same conditions as specified in the geNorm 
procedure with the exception that each 20 µl reaction was loaded with 25 ng of cDNA. Two 
reference genes (GSR and GPI) and three genes of interest (IFNG, IL-6 and TNF) were run 
on individual plates, each containing a complete set of samples and controls (Table 6.4). 
 
Table 6.4: Assay details for qPCR primers designed to detect IFNG, IL-6 and TNF 
mRNA transcripts from pig (Sus Scrofa) intestinal tissue in experiment SM5 
Gene 
symbol 








S – AAGAAATAACGATCCTAAAGGACTAT 
A – TGTCACTCTCCTCTTTCCAATT 
108 NM_213948 
IL6 Interleukin 6 
S – CTATGAACTCCCTCCACAAG 






S – TCCCCTGTCCATCCCTTTATTA 
A – TTCTAAGTGTTGCTGTTGTTGTT 
130 NM_214022 
S = Sense primer, A = Anti-sense primer                    (Source: PrimerDesign Ltd, 2014) 
 
In all cases, specificity of the target was confirmed by a unified peak in the melt curve at the 
expected amplicon temperature. The presence of gDNA was excluded by no template 
controls (NTC), and RT-negative controls. geNorm™ analysis was performed using the 
procedure of Hellemans et al. (2007) in qBase+ software (Biogazelle NV, Belgium). For the 
SYBR assays, raw fluorescence data without baseline correction was exported from CFX 
manager (Bio-Rad, Hemel Hempstead, UK) into LinRegPCR (version 2014.2), where Cq 
values were set by amplicon group and PCR efficiencies calculated using a four point 
window-of-linearity (Ramakers et al, 2003; Ruijter et al, 2009). Calculated Cq values were 
converted into normalised (against GPI and GSR) relative quantities (NRQ) to the control 
group, in qBase+ (Hellemans et al, 2007), adjusting for PCR amplicon group efficiency. 
Technical replicates were excluded from data analysis if they were in excess of 0.7 cycles 
apart. NRQ were compared to the control group by comparison contrasts in GenStat (16th 
Edition). 
 
6.3. Results – experiment one 
All live pigs in the first trial were assessed by a qualified veterinary surgeon on completion 
of the trial period and showed no signs of adverse long term effects from treatments. Four 
pigs were removed due to injuries (mostly shoulder problems) or poor growth during the 
course of the trial and one pig died of a suspected heart attack. All data was adjusted based 






6.3.1. Diet analysis 
Feed sample analysis (Table 6.5) confirmed that phytase and zinc were added to the diets 
correctly. Total phosphorus measured was as expected with a step change of ~1 g/kg but 
levels of phytic acid were approximately twice those reported in chapter five. The ratio of 
Ca to tP was slightly higher than formulated at between 1.21 and 1.44 (verses 1.14 to 1.16), 
but still within tolerance. 
 
Table 6.5: Analysis of phytic acid, phytate-P, P, Ca (g/kg as fed basis), phytase 
activity (FTU/kg), zinc (mg/kg) and macro nutrients (%) of experimental diets fed to 
pigs in trials SM3 and SM5 
Diet A B C D E G H J K L 
Measured phytic acid 12.8 12.5 12.3 11.9 13.3 13.1 13.4 13.4 12.4 12.8 
Calculated phytate P 3.6 3.5 3.5 3.4 3.8 3.7 3.8 3.8 3.5 3.6 
Formulated total Ca 5.7 5.7 5.7 5.7 10.3 10.3 10.3 10.3 7.2 8.8 
Measured total Ca 7.2 7.1 7.2 7.1 11.1 10.2 10.9 10.8 8.2 8.7 
Formulated total P 5.0 5.0 5.0 5.0 8.9 8.9 8.9 8.9 6.3 7.6 
Measured total P 5.0 5.3 5.4 5.3 8.4 8.1 8.9 8.9 6.3 7.0 
Formulated Ca:tP 1.14 1.14 1.14 1.14 1.16 1.16 1.16 1.16 1.15 1.15 
Calculated Ca:tP 1.44 1.34 1.33 1.34 1.32 1.26 1.22 1.21 1.30 1.24 
Measured Zn  140 137 3213 2852 147 130 3093 3401 3058 2801 
Expected Zn1 24 24 2524 2524 24 24 2524 2524 2524 2524 
Measured phytase  0 2030 0 2600 0 2560 85 3210 2900 2830 
Expected phytase  0 2500 0 2500 0 2500 0 2500 2500 2500 
Crude Protein, % 18.5 18.9 19.0 18.8 18.8 18.2 18.5 18.5 18.8 18.9 
Crude fibre, % 2.0 2.3 1.9 1.9 1.8 2.1 2 2.3 2.1 1.9 
Moisture, % 8.8 9.0 8.8 8.7 8.6 8.5 8.6 8.8 8.9 8.5 
1Not including native Zn from feed ingredients 
 
6.3.2. Effects of increasing dgP on performance 
Growth rates were good and comparable with those in chapters four and five, with overall 
DLWG between 300 and 400 g. In the first two weeks post-weaning there were no significant 
effects on pig performance observed from increasing dietary phosphorous in the presence 
of exogenous phytase and ZnO. Three weeks post-weaning however, increasing dietary tP 
linearly (p=0.004) improved DF (p=0.012) with a quadratic tendency (p=0.091) (Table 6.6). 
DLWG also increased (p=0.001) in a linear (p=0.002) and quadratic (p=0.01) fashion, while 
FCR was not effected by tP dose (Table 6.6). 
 
Table 6.6: The effects of increasing dietary phosphorus on week three post-weaning 
pig growth performance  
tP (g/kg feed) 5.3 6.3 7.0 8.9 S.E.D. p-value Linear Quadratic 
DLWG (g) 405 466 535 511 31.0 0.001 0.002 0.010 
DF (g) 606 666 713 718 35.1 0.012 0.004 0.091 





The quadratic equations for the lines were best fitted as polynomial models for each batch 
individually. They show that both DLWG and DF could be explained by the level of tP 
(p<0.001 & p=0.002 respectively), accounting for 47.4 % and 41.5 % of the variation 
respectively (adjusted r2). These effects were strong enough that despite no detectable 
dose response in the first two weeks post-weaning, over the whole three weeks, increasing 
dietary phosphorus in the presence of exogenous phytase and zinc increased overall 
DLWG (p=0.017) in a linear (p=0.019) and quadratic (p=0.036) fashion (Figure 6.1).  
 
 
Figure 6.1: The effects of increasing dietary phosphorus in diets containing 2500 
FTU/kg phytase and 3100 mg/kg pharmaceutical ZnO on overall weaner pig 
performance from weaning to three weeks post, split by batch. Data points represent 
mean averages of pens of five pigs. Standard error = 37.6.  
 
There was a clear batch effect but fitting individual lines to each batch only marginally 
improved the adjusted r2 from 43.8 % to 45.2 % compared with fitting parallel lines (Figure 
6.1). Both batches show that with inclusion of both a super dose of phytase and therapeutic 






6.3.3. The effects of phosphorus, phytase and zinc on performance 
Results of the factorial analysis are shown in Tables 6.7, 6.8, 6.9 and 6.10. Increasing 
dietary dgP from 2.8 to 5.8 g/kg improved both overall DLWG (p<0.001) and FCR (p<0.001) 
but only tended to increase DF (p=0.065) (Table 6.7). The addition of phytase was only 
efficacious on DLWG (p=0.04) and FCR (p=0.02) in the low dgP diet, as indicated by a dgP 
x phytase interaction (Table 6.7). Pharmaceutical ZnO depressed both overall DLWG 
(p=0.002) and FCR (p=0.045) as well as a tendency to reduce DF (p=0.096), when 
assessed over the entirety of the three weeks. Performance results taken seven days post-
weaning (Table 6.8) show that ZnO suppressed both DF (p<0.001) and DLWG (p=0.016) 
early on in the trial. If phytase and ZnO were fed in combination, there was an interactive 
effect on FCR (p=0.026) and this also tended to occur with DLWG (p=0.08), with no 
additives giving the worst FCR and both on their own giving the best FCR.  
 
Fourteen days post-weaning, pigs were still responsive to the higher level of dgP, showing 
a 0.05 point lower FCR (p=0.05) and tending to have a higher DLWG (p=0.088) (Table 6.9). 
Those pigs super dosed with phytase showed significantly enhanced DLWG (p=0.032) by 
~20 g and improved FCR (p=0.019) by the end of two weeks post-weaning (Table 6.9). By 
the end of three weeks post-weaning (Table 6.10), DF was increased at the higher level of 
dgP (p=0.015) by ~50 g but phytase was still only effective in the low dgP diet only (dgP x 
phytase, p-value=0.039). Pharmaceutical ZnO inclusion however, tended to have a 
negative effect by the third week post-weaning on DF (p=0.088) but there was a strong 
interaction observed between level of dgP and ZnO (p=0.006), where those fed the low dgP 
diet supplemented with ZnO consumed 92 g/day less feed and grew over 100 g/day less 
(dgP x ZnO, p-value= 0.018) than those on the low dgP without ZnO. FCR was lower at the 
higher dgP inclusion rate compared to the lower dgP diet (p<0.009) independent of ZnO 
















Table 6.7: The effects of low (2.8 g/kg dgP) and high (5.8 g/kg dgP) dietary 
phosphorus, phytase (0 or 2500 FTU/kg) & pharmaceutical ZnO (0 or 3100 mg/kg) on 
overall pig performance up to three weeks post-weaning 
Treatment factor DF (g) DLWG (g) FCR 
Digestible phosphorus    
Low 439.68 336.24 1.32 
High 461.77 375.79 1.23 
Phytase    
+ve 455.59 361.56 1.27 
-ve 445.87 350.47 1.28 
Zinc Oxide    
+ve 440.78 341.47 1.30 
-ve 460.67 370.56 1.25 
Pooled S.E.D. main effects 11.731 9.132 0.025 
DgP vs Phytase    
Low DgP, no phytase 432.96 321.09 1.36 
Low DgP + Phytase 446.40 351.40 1.28 
High DgP, no phytase 458.77 379.85 1.21 
High Dgp + phytase 464.77 371.72 1.25 
DgP vs ZnO    
Low DgP, no ZnO 457.16 357.07 1.29 
Low DgP + ZnO 422.20 315.42 1.35 
High DgP, no ZnO 464.19 384.05 1.21 
High DgP + ZnO 459.35 367.52 1.25 
Phytase vs ZnO    
No phytase, no ZnO 448.91 358.72 1.26 
No phytase + ZnO 442.82 342.23 1.30 
Phytase, no ZnO 472.44 382.40 1.23 
Phytase + ZnO 438.73 340.71 1.30 
Pooled S.E.D. 2-way interactions 16.590 12.914 0.035 
DgP vs Phytase vs ZnO    
Low DgP 436.77 328.23 1.34 
Low DgP + Phytase 477.55 385.91 1.24 
Low DgP + ZnO 429.14 313.96 1.37 
Low DgP + Phytase +  ZnO 415.26 316.88 1.32 
High DgP 461.05 389.20 1.18 
High DgP + Phytase 467.33 378.90 1.23 
High DgP + ZnO 456.50 370.50 1.23 
High DgP + Phytase +  ZnO 462.20 364.55 1.27 
Pooled S.E.D. 3-way interactions 23.462 18.263 0.050 
Probabilities of differences    
DgP 0.065 <0.001 <0.001 
Phytase 0.411 0.230 0.506 
ZnO 0.096 0.002 0.045 
DgP X Phytase 0.752 0.040 0.020 
DgP X ZnO 0.205 0.175 0.791 
Phytase X ZnO 0.244 0.173 0.674 





Table 6.8: The effects of low (2.8 g/kg dgP) and high (5.8 g/kg dgP) dietary 
phosphorus, phytase (0 or 2500 FTU/kg) & pharmaceutical ZnO (0 or 3100 mg/kg) on 
pig performance in the first week post-weaning 
Treatment factor DF (g) DLWG (g) FCR 
Digestible phosphorus    
Low 197.55 154.70 1.36 
High 204.29 160.71 1.33 
Phytase    
+ve 199.21 158.00 1.33 
-ve 202.62 157.40 1.37 
Zinc Oxide    
+ve 180.07 142.69 1.32 
-ve 221.77 172.71 1.37 
Pooled S.E.D. main effects 9.706 12.120 0.055 
DgP vs Phytase    
Low DgP, no phytase 196.64 149.29 1.44 
Low DgP + Phytase 198.46 160.11 1.29 
High DgP, no phytase 208.61 165.52 1.30 
High Dgp + phytase 199.96 155.89 1.36 
DgP vs ZnO    
Low DgP, no ZnO 213.25 160.79 1.45 
Low DgP + ZnO 181.86 148.61 1.28 
High DgP, no ZnO 230.29 184.64 1.29 
High DgP + ZnO 178.29 136.77 1.37 
Phytase vs ZnO    
No phytase, no ZnO 216.79 161.61 1.49 
No phytase + ZnO 188.46 153.20 1.26 
Phytase, no ZnO 226.75 183.82 1.26 
Phytase + ZnO 171.68 132.18 1.39 
Pooled S.E.D. 2-way interactions 13.727 17.140 0.078 
DgP vs Phytase vs ZnO    
Low DgP 205.14 139.71 1.67 
Low DgP + Phytase 221.36 181.86 1.23 
Low DgP + ZnO 188.14 158.86 1.21 
Low DgP + Phytase +  ZnO 175.57 138.36 1.34 
High DgP 228.43 183.50 1.30 
High DgP + Phytase 232.14 185.79 1.29 
High DgP + ZnO 188.79 147.54 1.31 
High DgP + Phytase +  ZnO 167.79 126.00 1.44 
Pooled S.E.D. 3-way interactions 19.413 24.239 0.110 
Probabilities of differences    
DgP 0.491 0.622 0.686 
Phytase 0.727 0.961 0.547 
ZnO <0.001 0.016 0.538 
DgP X Phytase 0.592 0.403 0.174 
DgP X ZnO 0.293 0.147 0.112 
Phytase X ZnO 0.174 0.080 0.026 





Table 6.9: The effects of low (2.8 g/kg dgP) and high (5.8 g/kg dgP) dietary 
phosphorus, phytase (0 or 2500 FTU/kg) & pharmaceutical ZnO (0 or 3100 mg/kg) on 
pig performance in the second week post-weaning 
Treatment factor DF (g) DLWG (g) FCR 
Digestible phosphorus    
Low 443.1 384.6 1.16 
High 448.2 408.5 1.11 
Phytase    
+ve 449.3 411.7 1.10 
-ve 442.0 381.4 1.17 
Zinc Oxide    
+ve 455.0 401.2 1.14 
-ve 436.3 392.0 1.13 
Pooled S.E.D. main effects 14.74 13.77 0.029 
DgP vs Phytase    
Low DgP, no phytase 441.9 366.1 1.22 
Low DgP + Phytase 444.2 403.1 1.11 
High DgP, no phytase 442.1 396.8 1.12 
High Dgp + phytase 454.4 420.3 1.09 
DgP vs ZnO    
Low DgP, no ZnO 428.3 383.5 1.13 
Low DgP + ZnO 457.9 385.7 1.20 
High DgP, no ZnO 444.3 400.4 1.12 
High DgP + ZnO 452.2 416.6 1.09 
Phytase vs ZnO    
No phytase, no ZnO 426.9 376.5 1.15 
No phytase + ZnO 457.0 386.4 1.19 
Phytase, no ZnO 445.6 407.5 1.11 
Phytase + ZnO 453.1 415.9 1.09 
Pooled S.E.D. 2-way interactions 20.85 19.47 0.040 
DgP vs Phytase vs ZnO    
Low DgP 409.5 356.8 1.16 
Low DgP + Phytase 447.0 410.3 1.10 
Low DgP + ZnO 474.2 375.4 1.27 
Low DgP + Phytase +  ZnO 441.5 396.0 1.12 
High DgP 444.4 396.1 1.13 
High DgP + Phytase 444.2 404.7 1.11 
High DgP + ZnO 439.8 397.4 1.11 
High DgP + Phytase +  ZnO 464.6 435.9 1.07 
Pooled S.E.D. 3-way interactions 29.48 27.54 0.057 
Probabilities of differences    
DgP 0.726 0.088 0.051 
Phytase 0.619 0.032 0.019 
ZnO 0.208 0.508 0.545 
DgP X Phytase 0.737 0.625 0.189 
DgP X ZnO 0.466 0.612 0.098 
Phytase X ZnO 0.477 0.957 0.307 





Table 6.10: The effects of low (2.8 g/kg dgP) and high (5.8 g/kg dgP) dietary 
phosphorus, phytase (0 or 2500 FTU/kg) & pharmaceutical ZnO (0 or 3100 mg/kg) on 
pig performance in the third week post-weaning 
Treatment factor DF (g) DLWG (g) FCR 
Digestible phosphorus    
Low 650.12 453.2 1.46 
High 700.36 536.6 1.32 
Phytase    
+ve 687.82 497.3 1.41 
-ve 662.66 492.5 1.37 
Zinc Oxide    
+ve 657.95 463.6 1.45 
-ve 692.53 526.2 1.33 
Pooled S.E.D. main effects 19.938 17.32 0.052 
DgP vs Phytase    
Low DgP, no phytase 633.04 432.4 1.47 
Low DgP + Phytase 667.20 473.9 1.45 
High DgP, no phytase 692.28 552.6 1.27 
High Dgp + phytase 708.44 520.7 1.37 
DgP vs ZnO    
Low DgP, no ZnO 695.88 505.7 1.39 
Low DgP + ZnO 604.37 400.7 1.53 
High DgP, no ZnO 689.19 546.8 1.27 
High DgP + ZnO 711.53 526.5 1.37 
Phytase vs ZnO    
No phytase, no ZnO 671.25 515.7 1.32 
No phytase + ZnO 654.07 469.4 1.42 
Phytase, no ZnO 713.81 536.8 1.35 
Phytase + ZnO 661.83 457.8 1.47 
Pooled S.E.D. 2-way interactions 28.197 24.49 0.074 
DgP vs Phytase vs ZnO    
Low DgP 663.31 468.2 1.43 
Low DgP + Phytase 728.44 543.1 1.36 
Low DgP + ZnO 602.77 396.7 1.52 
Low DgP + Phytase +  ZnO 605.97 404.7 1.54 
High DgP 679.19 563.1 1.21 
High DgP + Phytase 699.19 530.5 1.33 
High DgP + ZnO 705.38 542.1 1.32 
High DgP + Phytase +  ZnO 717.69 510.9 1.41 
Pooled S.E.D. 3-way interactions 39.876 34.64 0.104 
Probabilities of differences    
DgP 0.015 <0.001 0.009 
Phytase 0.212 0.784 0.434 
ZnO 0.088 <0.001 0.034 
DgP X Phytase 0.653 0.039 0.234 
DgP X ZnO 0.006 0.018 0.712 
Phytase X ZnO 0.387 0.348 0.788 





6.4. Results – experiment two 
All pigs completed the second trial, however, two pigs were treated for lameness during the 
first week of the experiment with a three day course of Betamox (Vm 02000/4071) and 
Metacam (Vm EU/2/97/004/041-042). Following post-mortem examination of pigs sacrificed 
for gene expression analysis, one pig was found to have a bladder infection and was 
subsequently excluded from the gene expression analysis.  
 
6.4.1. Growth performance 
All treatment groups were 8.6 SD±0.14 kg at the start of the trial and did not differ 
significantly in BW by three weeks post-weaning (Table 6.11). Dietary ZnO reduced FCR in 
period one (p=0.05) and tended to increase DF in period three (p=0.07). Phytase reduced 
FCR in period two only (p=0.002). Daily liveweight gain in the second trial using the JSR 
900 sire was noticeably better than in the first experiment which used PIC 337 and JSR 800 
sires.  
 
Table 6.11: The effects of super dosing phytase (0 or 2500 FTU/kg) & pharmaceutical 
ZnO (0 or 3100 mg/kg) on pig growth performance in diets containing 5.8 g/kg 
digestible phosphorus over three weeks post-weaning. Replicates are mean 
averages for pens of five pigs.  
Treatment Phytase1 Zinc2 
S.E.D.  (12 d.f.) 
p-values 
Level 0 2500 0 3100 P3 Z4 P X Z5 
Weaning BW (kg) 8.6 8.6 8.6 8.6 0.08 0.54 0.78 0.80 
Day 1 – 7      
   
DLWG (g) 244 244 233 254 24.0 1.00 0.40 0.55 
DF (g) 295 296 295 296 20.0 0.95 0.94 0.51 
FCR 1.22 1.24 1.29 1.17 0.055 0.79 0.05 0.59 
Day 7 – 14         
DLWG (g) 475 521 467 529 35.2 0.22 0.10 0.87 
DF (g) 559 578 533 604 40.5 0.64 0.11 0.70 
FCR 1.18 1.11 1.14 1.15 0.018 0.002 0.80 0.23 
Day 14 – 23      
   
DLWG (g) 553 595 554 594 43.5 0.36 0.38 0.36 
DF (g) 764 824 761 828 33.8 0.10 0.07 0.89 
FCR 1.41 1.40 1.39 1.47 0.080 0.88 0.82 0.15 
Day 1 – 23        
   
DLWG (g) 424 453 418 459 23.6 0.24 0.11 0.78 
DF (g) 539 566 529 576 26.0 0.32 0.10 0.67 
FCR 1.28 1.25 1.27 1.26 0.033 0.45 0.73 0.15 
Final BW (kg) 17.5 18.1 17.4 18.2 0.50 0.21 0.12 0.75 







Individual pigs killed at the end of the three weeks were analysed by treatment group to 
assess representativeness. No significant effects were observed on growth rates of 
individual pigs during any period and they appeared representative of the pen average 
parameters (Table 6.12). Feed intake and FCR could not be calculated on an individual pig 
basis.   
 
Table 6.12: The effects of super dosing phytase (0 or 2500 FTU/kg) & pharmaceutical 
ZnO (0 or 3100 mg/kg) on pig growth performance in diets containing 5.8 g/kg 
digestible phosphorus over a three week post-weaning. Replicates are individual 
pigs.  
Treatment Phytase1 Zinc2 S.E.D. (28 d.f.) p-values 
Level 0 2500 0 3100  P3 Z4 P X Z5 
Weaning BW (kg) 8.5 8.4 8.4 8.5 0.13 0.58 0.59 0.76 
DLWG Day 1 – 7 (g) 231 252 245 237 28.3 0.46 0.78 0.10 
DLWG Day 7 – 14 (g) 452 496 455 493 42.2 0.32 0.37 0.98 
DLWG Day 14 – 23 (g) 552 599 565 586 46.7 0.32 0.65 0.21 
Overal DLWG (g) 411 449 421 439 28.4 0.20 0.54 0.91 
Final BW (kg) 17.1 17.8 17.2 17.7 0.61 0.25 0.48 0.86 
1FTU/kg; 2mg/kg; 3Phytase main effect; 4Zinc main effect; 5Phytase/ZnO interaction 
 
6.4.2. Haematology 
Overall, there were no significant treatment effects on the number of white blood cells/ml 
(Table 6.13). These were slightly elevated (numeric only) above the normal range in the no 
phytase/no ZnO control group (23.42 million/ml), whereby the reference range is 11 – 22 
million/ml (Kahn et al., 2005) but all other treatment groups were within range (Table 6.13). 
There also tended to be an interactive effect of phytase and ZnO in combination, whereby 
the proportion of lymphocytes and neutrophils within the WBC population were increased 
(p=0.091) and decreased (p=0.097) respectively (Figure 6.2). All other average cell 
populations reported in Figure 6.2 were close to normal reference values for healthy pigs in 







Figure 6.2: proportions of white blood cells in whole blood taken from pigs 12 and 13 
days post-weaning, fed a control diet or supplemented with pharmaceutical ZnO at 
3100 mg/kg, phytase at 2500 FTU/kg diet or a combination of both. Ba=basophils, 
Eo=eosinophils, Mon=monocytes, Neu=neutrophils, Lym=lymphocytes.  
 
While Hb and Hct did not significantly differ individually, the calculated MCV revealed a 
significant interation (p=0.04), whereby levels were lower when diets contained neither the 
ZnO nor phytase (either singularly or in combination) (Table 6.13). When expressed on a 
per cell basis (MCHC), only a main effect of ZnO was observed (p=0.05), with a 2.7% 





















































Table 6.13: Haematological parameters of whole blood taken from pigs 12 and 13 days post-weaning, fed a control diet or supplemented with 
















Hb Hct MCV MCHC 
Phytase            
+ve 20.7 11.44 1.008 7.9 0.082 0.22 7.0 12.57 39.0 55.89 32.18 
-ve 23.4 13.00 1.057 9.04 0.090 0.25 6.5 11.59 35.7 54.93 32.43 
Zinc Oxide            
+ve 21.4 12.00 1.038 8.05 0.086 0.24 6.5 11.52 36.2 55.97 31.85 
-ve 22.7 12.44 1.028 8.89 0.087 0.23 7.0 12.63 38.6 54.85 32.76 
Pooled S.E.D. main effects 1.722 1.232 0.084 0.814 0.0134 0.032 0.494 0.984 2.77 1.142 0.419 
Phytase X ZnO            
No phytase, no ZnO 25.03 14.24 1.059 9.43 0.089 0.22 6.55 11.55 34.9 53.02 33.14 
No phytase + ZnO 21.82 11.76 1.055 8.64 0.091 0.27 6.45 11.62 36.6 56.84 31.72 
Phytase, no ZnO 20.31 10.65 0.997 8.35 0.084 0.25 7.47 13.72 42.3 56.69 32.38 
Phytase + ZnO 20.99 12.24 1.02 7.45 0.080 0.20 6.47 11.42 35.8 55.09 31.98 
Pooled S.E.D. 2-way interactions 2.435 1.742 0.1187 1.151 0.0189 0.046 0.698 1.392 3.91 1.615 0.593 
Probabilities of differences            
Phytase 0.13 0.23 0.58 0.19 0.55 0.48 0.36 0.34 0.25 0.42 0.56 
ZnO 0.48 0.73 0.91 0.32 0.93 0.89 0.29 0.28 0.39 0.35 0.05 
Phytase X ZnO 0.28 0.12 0.88 0.95 0.81 0.14 0.38 0.25 0.16 0.04 0.25 
CV% 15.6 20.2 16.3 19.2 31.0 27.7 14.7 16.3 14.8 4.1 2.6 
WBC=White blood cells; Lym=lymphocytes; Mon=monocytes; Neu=neutrophils; Ba=basophils; Eo=eosinophils; RBC=Red blood cells; Hb=haemoglobin; 
Hct=haematocrit; MCV= Mean Corpuscular Hemoglobin; MCHC= Mean Corpuscular Hemoglobin per Cell   
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6.4.3. Intestinal gene expression 
The assay for IL-6 failed repeatedly to give acceptable performance with melt curves 
suggesting a problem with the primers and so results are not reported.  Expression of IFNG 
was up-regulated in the duodenum when zinc and phytase were fed in combination 
(p=0.006) with one outlier in the control group removed, also remaining significant (p=0.047) 
with the outlier included in the analysis (Figure 6.3).      
 
 
Figure 6.3: Duodenal expression of IFN-γ (relative to the control treatment group) in 
pigs three weeks post weaning; Light shaded bars are means including one outlier 
in the control group. Dark shaded bars are means excluding one outlier in the control 
group.  Error bars represent the common standard error of the mean. 
 
There were no significant differences detected in TNF expression (Figure 6.4).  
 
 
Figure 6.4: Duodenal expression of TNF (relative to the control treatment group) in 

















































Both the IFN-γ and TNF assay in the ileum failed the QC, with the DNase treatment at the 
RNA extraction stage not removing all gDNA contamination. Post a second DNase 
treatment directly on to the extracted RNA, the controls (NTC) still failed to pass the QC, 
amplifying within 5 cycles of the main data (Figure 6.5). 
 
   
Figure 6.5: RT-qPCR real-time amplification plots for IFNG, TNF and IL-6 from ileal 
tissue samples and controls (NTC, NC) with a failed DNase treatment during RNA 
extraction, taken from pigs three weeks post-weaning. 
 
6.5. Discussion  
Analysis of the diets confirmed that the levels of all additives were close to those expected 
(Table 6.5), validating the experiments. Levels of zinc in the groups not supplemented with 
pharmaceutical ZnO were just below 150 mg/kg, which is partly from the 110 mg of ZnSO4 
in the premix (24.2 mg elemental zinc) and also from natural zinc contained in feed 
ingredients. Morbidity occurred on four occasions in experiment one and twice in 
experiment two. These largely consisted of shoulder injuries due to mixing at weaning. All 
cases were treated as reported in the relevant results sections and where the animals were 
removed from the trial, performance data was adjusted based on the number of ‘pig days’ 
the animal had completed on trial. For sudden injuries, this is unlikely to have any noticeable 
impacts on pen growth performance or feed intake but if an animal was chronically ill for 
several days prior to removal, then it may not have been eating for 24 hours before being 
removed. One pig died suddenly of a suspected heart attack. A breakdown in herd health 
occurred between the two experiments and so subsequently, all animals on experiment two 







6.5.1. Response to dietary phosphorus level 
In chapter four, dgP was included at levels from just below requirement at 2.8 g/kg dgP 
(Whittemore et al., 2003) up to an excess of 8.8 g/kg dgP. There was no dose response 
over this range, except for a reduction in DF at the highest level (Table 4.7), when tested in 
phytase and ZnO free diets. This was expected since clear growth response in phosphorus 
deficient diets are often reported but not when phosphorus needs are met, typically at 
between 3.3 and 3.5 g/kg dgP (Ekpe et al., 2002). In contrast, a significant quadratic 
response to increasing levels of dgP over the range 2.8 g.kg to 5.8 g/kg was seen in this 
chapter on DLWG and DF, in the third week post-weaning (Table 6.6). This was the 
predicted response to the hypothesis that there may be a zinc-phosphorus interaction in the 
small intestine, possibly due to precipitation. The result of such a condition would then 
require the animal to consume more phosphorus to compensate for that which is 
unavailable. In this case, there were parallel increases in DF and DLWG but no significant 
improvements in FCR (Table 6.6), suggesting that higher levels of dgP encouraged feed 
intake, which in turn, increased DLWG. Voluntary feed intake is a complex mechanism but 
negative and positive feedback stemming from a nutrient imbalance tends to be at play 
when feed intake is modulated in this way (Kyriazakis and Whittemore, 2006).    
 
Interactions between the level of dgP and ZnO inclusion reveal that while there are no 
interferences in the first two weeks post-weaning, inclusion of pharmaceutical ZnO 
significantly reduces DLWG and DF in the third week post-weaning, dramatically in low dgP 
diets (Table 6.10). This is in agreement with the results of the dose response assessment, 
whereby any further growth response to dgP has already plateaued at 5.8 g/kg dgP (Figure 
6.1), so that growth response due to not meeting demand for P is not noticeable in the 5.8 
g/kg dgP group. The ratio of P to Zn in these diets increased from 1.86 in diet D, to 2.06 in 
diet K, 2.50 in diet L and 2.62 in diet J (as measured), having a very strong positive 
correlation (r=0.93, p<0.05) with DLWG in period three. Walk et al. (2013) detected 
significant reductions in serum P and increases in serum zinc with graded levels of ZnO at 
a similar growth period. While the molar ratio of zinc to phytic acid remained constant at 
around 2.5:1 (below the 3.5 - 4.1 precipitation range reported at pH 7.0 by Champagne and 
Fisher (1990)), taken together, there is likely to be phosphorus inhibition by high ratios of 
dietary zinc. This is enough to manifest as reductions in growth performance.    
 
6.5.2. Growth response to phytase 
Similar to chapter five, super dosing phytase was shown to be efficacious at improving 
growth performance and reducing FCR in the first two weeks post-weaning only, in both 





good agreement with data published by Walk et al. (2013), where super dosing phytase 
only increased DLWG and DF in the first three weeks post-weaning. In experiment SM3 it 
was also possible to show that in addition to the independent super dosing effect early on 
post-weaning, phosphorus level becomes more important in the third week post-weaning. 
This was demonstrated by the addition of phytase in the low dgP diet significantly improving 
DF but not in the dgP excessive diet in the third week post-weaning (Table 6.10). The 
implications of this may be that there should be some inclusion of phytase in low dgP diets, 
to ensure animals do not become deficient but that no performance boost should be 
expected in dgP adequate diets.        
 
In the first week post-weaning, the addition of pharmaceutical ZnO in the diet resulted in a 
ZnO x phytase interaction that tended (p=0.08) to reduce DLWG (Table 6.8). Augspurger 
et al. (2004) reported a 2:1 Zn:PA molar ratio (close to the 2.5:1 in these experimental diets) 
in a similar pig experiment and concluded this would be enough to substantially inhibit the 
activity of phytase in releasing iP, based on a reduction in bone ash. This is validated by 
the results of this experiment through the reduction in DLWG and suggests that P should 
be increased in ZnO medicated weaning pig diets from inorganic sources only, rather than 
from phytase. There was no evidence of ZnO x phytase interactions after this period.     
 
6.5.3. Growth response to zinc oxide 
No clinical symptoms of PWD were noted during routine health inspections. Under these 
non-challenge conditions, feeding pharmaceutical ZnO at 3.1 g/kg feed over three weeks 
post-weaning had a negative effect on growth performance, significantly (p<0.05) reducing 
DLWG and FCR by 7.9 % and 3.9 % respectively, and tending (p<0.10) to reduce DF by 
4.3 % by the end of the trial (Table 6.7). The effect was especially pronounced in the first 
week post-weaning (Table 6.8) and was compounded when in combination with phytase, 
increasing FCR (though omitting both was worse than having them in the diet) (Phytase x 
ZnO, p<0.05). Pigs seem to acclimatise to high levels of ZnO in the second week post-
weaning, with no difference in growth performance detectable (Table 6.9) but very 
pronounced negative effects of ZnO inclusion in the third week post-weaning (Table 6.10). 
This is to be expected since it is well documented that post 14 days, high levels of zinc may 
become toxic (FEEDAP, 2014). The reduction in DF was not expected though since several 
studies feeding high levels of zinc have reported increases in feed intake and growth linked 
with increases in hormones that regulate these traits, including Insulin-like growth factor – 
1 (IGF-1) and ghrelin (Li et al., 2006; Yin et al., 2009). There is evidence, however, of ZnO 
being dose dependent, with Walk et al. (2013) reporting quadratic reductions in DLWG 





intestinal microbial communities are also dose dependent to ZnO with distinct clustering 
effects detectable at 50, 150, 250, 1000 and 2500 mg/kg zinc (Pieper et al., 2011). These 
differences may modulate metabolic activity and account for some of the growth effects 
observed. Typically this could be through the reduction of lactate, due to lower Lactobacillus 
numbers in the small intestines (Starke et al., 2014).        
 
In the second experiment (SM5), there was some evidence of ZnO inclusion improving FCR 
in the first week post-weaning (Table 6.11) but this did not translate into any significant 
growth improvement over the three week trial. While ZnO inclusion was not detrimental in 
experiment SM5, compared to experiment SM3, this is likely due to the buffer of phosphorus 
available in the diet used (5.8 dgP) in the second trial (dgP x ZnO interaction observed in 
Table 6.10). Growth response to pharmaceutical ZnO in healthy pigs is often inconsistent 
with reports of little, if any, improved growth during the first few weeks post-weaning (Katouli 
et al.,1999; Piper et al., 2012; Walk et al., 2013), some response detectable (Jensen-Waern 
et al.,1998) and hints of toxicity after a few weeks (Starke et al., 2014). Bigger datasets 
analysed by meta-regression though have concluded that overall there is likely to be growth 
benefits from feeding pharmaceutical ZnO (Sales, 2013). These studies were mostly 
conducted in the USA, where pathogenic challenge and microbiome may differ to the UK. 
This theory is confirmed with data from challenge studies showing ZnO to be effective at 
reducing Coliform numbers in the GI tract or at least reducing PWD post ETEC infection, 
leading to improved growth performance (Slade et al., 2011; Stensland et al., 2015).      
 
6.5.4. General and intestinal health  
Individual pigs for blood sampling and euthanasia were selected to be closest to the mean 
average weight for the pen replicate. This is reflected by the data in Table 6.12 which 
confirms they were consistent with the growth rates in Table 6.11. Systemic WBCs are 
markers of immune system activation and while Zn has not been shown to affect activated 
neutrophils and IFN-γ producing cells post-weaning (Jenson-Waern et al, 1998, Chai et al, 
2014), little is known about the influence of phytase. The effects of high doses of phytase 
and ZnO are more pronounced in the first two weeks post-weaning, so blood analysis to 
assess general health status was conducted at 12 days post-weaning. Analysis revealed 
no effect on total WBC (Table 6.13), with levels within the normal biological range expected 
(Kahn et al., 2005). There is therefore no clinical relevance of this data, which is to be 
expected since the pigs were not challenged in this experiment. 
 
In the group fed the combination of additives, circulating lymphocyte percentage tended to 





6.2). This group also had significantly higher expression of the pro-inflammatory cytokine 
interferon-γ in the duodenum compared to the control group, suggesting intestinal 
inflammation in the anterior section. This was not detectable in the ileum, possibly related 
to a reduced buffering capacity at the stomach/duodenal junction or differences in the upper 
small intestine microbiome (Starke et al., 2014). The addition of 100 mg/kg CS-Zn and 500 
mg/kg ZnO have been shown to rival doses of 3000 mg/kg and 2250 mg/kg ZnO 
respectively for improved small intestine histophysiology and immunity (Han et al., 2014; 
Hu et al., 2013).  In this study, both the control group and the phytase group diets contained 
150 mg/kg Zn. This may have limited the detection of differences expected from the high 
Zn treatment as the basal level of zinc was probably sufficient for optimal gut health and 
growth. Pharmaceutical ZnO supplementation alone did not significantly affect TNF and 
IFN-γ mRNA abundance in this study either and expression levels of both cytokines relative 
to the control were low (<0.5 log10 change), suggesting no major challenge was taking place 
at day 21 post-weaning. Overexpression of pro-inflammatory cytokines have been 
implicated in reduced tight junction protein expression (Hu et al, 2013), thereby leading to 
reduce intestinal integrity. 
 
Many studies rely on only one reference gene (RG) for normalisation of the transcript 
expression of genes of interest (GOI). Often the gene selected has not been assessed for 
stability or suitability and is chosen entirely for historical reasons. Normalising GOI 
expression in this way is prone to error, as using a single RG has been shown to vary greatly 
in stability depending on tissue type (Ryan et al., 2010) and should not be used without 
validation (Bustin et al., 2009). Prior to the GOI expression assays, a geNorm™ experiment 
was conducted to find appropriate reference genes to normalise the cytokine data (see 
section 3.6.2.). The results showed that the best combination in duodenum tissue was GPI 
and GSR, so these were subsequently used to normalise the GOI data. To improve the 
accuracy of the Cq values, PCR efficiency was estimated using regression analysis on a 
four-point-window of linearity of the log-linear phase, by amplicon group (Ramakers et al., 
2003; Ruijter et al., 2009). The NRQ presented in Figures 6.3 and 6.4 are therefore likely to 
be as accurate as currently possible. The addition of no template controls and reverse 
transcription negatives also assisted in stringent quality control. As a consequence, the IL-
6 assay failed the QC by amplifying gDNA (despite a DNase step and a small intron being 
present, the assay was found to “jump”) and the results were therefore not included in this 
chapter. The one pig that was found to have a bladder infection upon post-mortem 
inspection showed highly elevated TNF levels in the intestine and was also excluded from 






In conclusion, the addition of super dosing phytase (2500 FTU/kg feed) was confirmed to 
be efficacious at improving production performance (8 % increase in DLWG and 0.07 point 
decrease in FCR) if fed up to 14 days post-weaning. In this study with pigs showing no 
clinical signs of PWD, medicating feed with pharmaceutical ZnO (3100 mg/kg feed) is 
contraindicated, as it was shown to significantly reduce production performance in this 
chapter, especially in diets containing relatively low levels of digestible phosphorous. Where 
pharmaceutical ZnO is included for seemingly healthy pigs, this should not be in conjunction 
with super doses of phytase, due to potential inhibition of phytase activity. Higher levels of 
dgP from inorganic sources of between 1 – 2 g/kg more than normal may be warranted for 
optimal growth response in ZnO medicated diets. In any case, supplementation with 




General discussion and conclusions on super dosing phytase 
and supplementation of pharmaceutical zinc oxide for enhancing 
the production performance of newly weaned pig 
 
7.0. Introduction 
Pharmaceutical grade ZnO is a widely used replacement to antibiotic growth promoters in 
many EU countries (EC, 2015). There is, however, growing concern about the 
environmental impact of increased zinc usage in the pig industry (SCAN, 2003), lack of 
consistent efficacy and possible development of microbial resistance (Slifierz et al., 2015) 
developing. Research into alternative growth promoters and their implications for use in 
ZnO medicated feeds is therefore of growing interest to the pig industry. A new strategy for 
using phytase enzymes by super dosing at levels beyond that generally required for 
improving P digestibility had emerged as a possible growth promoter but direct evidence of 
‘extra phosphoric’ effects in newly weaned pigs was not well documented. The objective of 
this thesis was therefore to evaluate the efficacy and possible explanatory mechanisms of 
super dosing phytase at enhancing pig performance post-weaning, beyond that attributable 
to increased phosphorus digestibility. In addition, the thesis has assessed the suitability for 
super dosing phytase in ZnO medicated feed.  
   
7.1. Weaning and overall production performance 
Formulating diets that are nutritionally adequate and balanced is only one part of optimising 
pig growth performance. In the typical abrupt weaning systems commonly found in 
commercial pig production, multifactorial stressors can cause an acute growth check and 
increased susceptibility to pathogenic challenge (Lallès et al., 2004). It is therefore important 
to consider the management of stress around weaning, in conjunction with appropriate 
nutritional formulations. With the ban on AMGPs in 2006 (Commission Regulation (EC) No 
1831/2003), alternative control measures against pathogenic challenge are more important 
than ever. Growth performance remained strong throughout the trials detailed in chapters 
four, five and six, with no clinical symptoms of a weaning associated disease observed in 
the 1064 pigs studied. The exception being an unrelated breakdown in herd health, due to 
enzootic pneumonia (EP) during the third experiment (SM3). This was mostly seen in pigs 
that had been weaned for a number of weeks and vaccination against Mycoplasma 
hyopneumoniae and porcine circovirus type 2 proved effective at controlling the disease. 
While pre-weaning growth rates were not available for comparison, DLWG in the first week 





slightly lower than the general herd performance of 193 g/day for this period but this is likely 
to be down to the formulation of a single phase diet, targeted to be optimal in the second 
week post-weaning and the removal of any commercial additives, such as xylanase, acids 
and probiotics, in the experimental diets. 
 
Villus atrophy in the first week post-weaning is normally associated with a reduction of feed 
intake (Kelly et al., 1991; Dong and Pluske, 2007), likely due to the mixing of litters at 
weaning, focusing attention away from feeding to fighting and establishing a new social 
hierarchy. This provides opportunistic pathogens such as Escherichia coli the chance to 
proliferate, resulting in scouring 2 – 3 days post-weaning. Creep feed was provided in all of 
the experiments detailed to help ease the transition from milk to solid feed, thereby 
encouraging feed intake post-weaning. Any growth check should have therefore been 
minimised. In addition, it was recognised that while in semi-natural systems piglets would 
wean at between 11 and 17 weeks after birth (Jensen and Recén, 1989; Bøe, 1991), the 
experiments detailed in this thesis needed to reflect UK commercial practice. For this reason 
piglets were abruptly weaned in the fourth week post farrowing, in line with the EU average 
(AHDB pork, 2015).   
 
7.2. Beyond phosphorus 
Responsible use of non-renewable resources like phosphorous and due consideration of 
the environmental impact through feeding high levels of metals such as zinc and copper are 
high priorities within the animal feed industry. For this reason, guidelines from BSAS 
(Whittemore et al., 2003) and NRC (NRC, 2012) detailing recommended nutrient levels for 
pig feed, in addition to legal limits (Commission Regulation (EC) No 1334/2003) and EU 
scientific reviews (FEEDAP, 2014) are published. The results of chapter four broadly agree 
with the dgP levels currently recommended by Whittemore et al. (2003) and are similar to 
levels published by Ekpe et al. (2002), based on the lack of growth response to increasing 
dgP above 2.8 g/kg feed (Table 4.7). Once P requirements for maintenance and growth 
have been met, some additional P may be incorporated into bone stores but any beyond 
that is excreted in faeces and urine (Fernández, 1995). Supporting the data in chapters four 
and five, P digestibility does not increase when levels of dietary dgP are increased (Table 
4.6), suggesting more P is absorbed as a consequence of the increasing levels in the diet. 
The excess P is then likely regulated by the kidneys and excreted in urine. In contrast, as 
the quantity of Ca increases in the diet, so the level of Ca digested reduces, as measured 
by higher faecal Ca concentrations. This would make sense, as the main route for Ca 





constant (and only modulated by the addition of phytase), then Ca digestibility is largely 
unaffected (Table 5.11).  
 
7.2.1. Phytate destruction 
Phosphorus from inorganic and animal sources is highly digestible (for example dicalcium 
phosphate = 64 %, monosodium phosphate = 90 %, bone precipitate = 61 % and skimmed 
milk powder = 90 % (Lenis and Jongbloed, 1999)). In contrast, the organic P found in plants 
(phytate) is only around 30 % digestible for non-ruminant animals (Lenis and Jongbloed, 
1999). In addition to being a poor source of dgP in non-fermented or phytase supplemented 
diets, there are a number of other reasons for its continued classification as a major ANF. 
These range from chelating minerals (such as calcium, zinc, magnesium, sodium and iron) 
into indigestible complexes (Maenz et al., 1999), to increasing endogenous mineral losses 
(Woyengo and Nyachoti, 2013), binding to protein (Selle et al., 2012) whilst concurrently 
reducing pepsin activity (Yu et al., 2012) and physically changing the gut histomorphology 
by reducing crypt depth – probably due to reduced cell proliferation (Woyengo et al., 2011). 
The effects of this are also confirmed by the results of chapters five and six of this thesis. 
For example, in chapter five, removing phytate by super dosing phytase >2000 FTU/kg (as 
confirmed by the 80% digestibility of phytic acid reported in Table 5.16) significantly 
improved pig growth performance compared to the negative control (Table 5.8). This was 
found not to be a consequence of increasing the level of dgP (Table 5.7 showed no 
difference between the base level of 5.8 g/kg dgP and a higher level of 7.8 g/kg dgP), 
confirming the ‘extra phosphoric’ effects of phytase super dosing. In both experiments SM2 
and SM3, the effects of super dosing phytase (2000 – 8000 FTU/kg of diet) were seen in 
the first and second week post-weaning (Table 5.8 and 6.9) but phosphorus was more 
important in the third week post-weaning. This may have been partly due to the diets being 
nutritionally optimised for pigs at two weeks post-weaning. Super dosing of 2000 FTU/kg as 
part of a “low phytate nutrition program” was also reportedly to be effective at enhancing 
growth performance up to 42 days post-weaning (Wilcock and Walk, 2016). Based on the 
evidence from this thesis and the body of published literature referred to, super dosing 
(>2000 FTU/kg) for phytate removal should be a standard protocol for weaner pig nutrition. 
 
7.2.2. Phytase efficacy 
Phytase acts as the catalyst in the hydrolysis of phytate with the products being free 
inorganic P, any released cations and water (KEGG, 2012). Low phytate diets resulting from 
the super dosing of phytase are only possible with phytases that can dephosphorylate 





experiments is considered third generation (having enhanced intrinsic thermostability and 
substrate affinity over second generation products, which in turn have been modified from 
the first generation “wild type” phytases) and was very effective at phytate destruction, with 
65 % digestibility of IP6 at 500 FTU/kg feed, increasing to over 80 % at super and mega 
doses (Table 5.16). This is in good agreement with Laird et al. (2016) using the same 
Quantum Blue phytase in pig diets, where ileal IP6 concentration reduced from 21616 
nmol/g DM to 7868 nmol/g DM with a dose of 8000 FTU/kg in his study, compared to a 
reduction from 24487 nmol/g DM to 4060 nmol/g DM in this present study (Table 5.16). 
Similarly, the Quantum Blue phytase derived from Escherichia coli (expressed in 
Trichoderma reesei) used in this thesis resulted in a comparable digestibility of IP6, when 
fed at 1000 FTU/kg, as a preparation of 1500 FTU/kg from Aspergillus niger (var. ficuum) 
strain NRRL 3135 (Jongbloed et al., 1992) (68% versus 74%). In this case, both 6-phytase 
and 3-phytase are suitable for use in super dosing strategies despite their differing pH and 
temperature optimums (Table 2.10). The use of these in combination may thus allow for a 
wider range of applications in situations where pH is likely to be variable (e.g. due to the 
buffering effect of feeds). The resulting different species of lower inositol phosphates arising 
from the preferential hydrolysis of carbon in the myo-inositol ring (either starting at the L-6 
position or the D-3 position for 6-phytase and 3-phytase respectively) may be important for 
cellular signalling pathways but this is an area where further research is needed. 
 
7.2.3. Immune modulation and health status  
Biomarkers for stress have been fairly well documented (Martínez-Miró et al., 2016) but are 
of limited use unless specifically defined for the hypothesis under test. In chapters five and 
six, cytokines localised to each section of the small intestine were selected to help describe 
the health of the gut in general. The patterns were assessed through measurements of the 
concentration of mRNA transcripts using RT-qPCR. The technique is very sensitive but can 
be misleading if not carried out or reported correctly (Bustin et al., 2009). Reference genes 
for the normalisation of copy numbers / relative quantities were not taken from the literature 
but instead formed part of a preliminary experiment to assess the suitability of a range of 
candidates specific for the tissue samples used. Those selected (GSR and GPI) were used 
for both experiments reported in chapters five and six (SM2 and SM5) and were validated 
as acceptable. This is interesting since genes such as ACTB and GAPDH are commonly 
used as RG but were shown to be a very poor choice in this situation. The range of controls 
and corrections used to obtain and validate the results of the gene expression analysis 
ensures robustness of the results, however, low expression levels of the cytokines indicate 
only baseline expression was occurring in the gut, with levels often below the quantification 





Several studies in poultry have suggested phytase may be implicated in enhancing 
immunity by boosting the immune response to vaccination (Liu et al. 2008; Ghahri et al. 
2012). While in this study it was attempted to isolate and culture white blood cells from pigs 
to assess cell-mediated immune response, this was unsuccessful in the laboratories (data 
not reported) but could be done to provide further information on this in future experiments. 
In general, there is no evidence though from the trials reported in this chapter that in pigs 
phytase is implicated in any intestinal immune-regulatory pathways, such as those 
described in section 2.2.3. However, studies at the cellular levels reveal that lower inositol 
phosphates (such as IP3) are definitely involved in the regulation of T lymphocyte activation 
(Porciello et al., 2016). This is largely through precursors (such as phosphatidylinositol 4,5-
biphosphate), so it is unclear if dietary derived lower IPs can directly modulate this or 
whether it is exclusively the precursors that have the effect. Further experiments that look 
at stable isotopes of myo-inositol (such as 13C inositol) to differentiate dietary derived IPx 
from that of host cellular origin should be conducted to investigate the tissue cellular 
signalling pathways. The result of this may be a targeted phytase strategy that uses a 
combination of 3-phytases, 5-phytases and 6-phytases for immune-modulation.  
 
7.4. Phosphorus requirement in ZnO medicated feed 
In ZnO medicated diets there was a clear requirement for additional Pi supplementation, as 
indicated by a quadractic growth response of pigs to increasing levels of dgP (Table 6.6). 
Under these conditions, phytase generated Pi (which should have been up to 2.38 g/kg of 
diets based on a phytate P level of 3.5 g/kg (Table 6.5) with a complete dephosphorylation 
of 68% of IP6 (Table 5.16) down to free inositol) appeared not to be as effective at increasing 
growth as supplemental Pi, since providing additional Pi in the diet resulted in further growth 
performance (Table 6.6). It is possible that 2500 FTU/kg releases only some Pi and although 
the phytic acid is removed, it may only have been dephosphylated to lower IPx (Table 5.16). 
There is evidence that IP4 and even IP3 may still have potent ANF properties (Bedford and 
Walk, 2016), so any super dosing strategy needs to make sure it is able to remove these 
lower inositol phosphates. This was shown to be a dose ≥8000 FTU/kg in this thesis (Table 
5.16). This would only need to be the case in diets containing <5.8 g/kg dgP, since the 
growth response to increasing dgP had platued by 5.8 g/kg dgP (Table 6.6), confirmed by 
a phytase x dgP effect, where there was an increase in growth at 2.8 g/kg dgP in phytase 
supplement diets but not in 5.8 g/kg dgP (suggesting dgP was sufficient for maximal growth 
at this higher level) (Table 6.7). Optimising the level of P in ZnO medicated feeds from either 




7.5. General conclusions 
This thesis has evaluated the strategies for using phytase enzymes in weaned pig diets, in 
the context of enhancing production performance beyond that exclusive to increased 
phosphorus digestibility and with relevance for use in ZnO medicated feeds. The findings 
suggest that super dosing Quantum Blue phytase at levels of between 2000 – 8000 FTU/kg 
of feed for the first 14 days post-weaning is efficacious at enhancing growth performance in 
healthy pigs, probably by a more complete removal of dietary phytate than can be achieved 
with doses <2000 FTU/kg feed. Depending on the economic cost of phytase, 
recommendations for phytase supplementation in weaner pig diets based on these results 
would be feeding a super dose of 8000 FTU/kg for the first two weeks post-weaning to 
maximise growth performance and the hydrolysis of phytate in the small intestines; reducing 
to 1000 FTU/kg in the third week post-weaning to facilitate bone mineralisation. If pigs are 
not likely to be pathogen challenged, pharmaceutical ZnO at high levels (3100 mg/kg feed) 
should not be used metaphylactically, as it may inadvertently lead to a reduction of growth 
performance through suppression of feed intake. Where it is used, it should not be fed for 
more than 14 days post-weaning. There may also be justification for a higher inclusion level 

























7.6. Outcomes and practical recommendations 
1. Super dosing of phytase enzymes significantly improved pig growth performance for the 
first two weeks post-weaning, was effective at dephosphylating phytate down to inositol 
and lower IPx, enhanced P digestibility and increased bone mineralisation. Depending 
on the economic cost of phytase, recommendations for phytase supplementation in 
weaner pig diets would be super dosing at 8000 FTU/kg of diet for the first two weeks 
post-weaning to maximise growth performance and the hydrolysis of phytate in the small 
intestines; reducing to 1000 FTU/kg of diet in the third week post-weaning to facilitate 
bone mineralisation.  
 
2. Medicating feed with high levels of ZnO (3100 mg/kg feed) reduced feed intake and 
growth performance in seemingly healthy pigs. Subject to the advice of a veterinarian, 
if pigs are not likely to be pathogen challenged, pharmaceutical ZnO at high levels (3100 
mg/kg feed) should not be used metaphylactically, as it may inadvertently lead to a 
reduction of growth performance through suppression of feed intake. Where it is used, 
it should not be fed for more than 14 days post-weaning. 
 
3. In diets not containing ZnO there was no improvement in growth performance when dgP 
was increased from 2.8 g/kg up to 8.8 g/kg. Conversely, when feed contained ZnO there 
was a quadratic improvement in growth performance when dgP was increased from 2.8 
g/kg up to 5.8 g/kg. There may thus be justification for a higher inclusion level of dietary 



















7.7. Areas for further research 
Several promising areas for further research have been identified in this thesis: 
1. The use of multiple phytase enzyme cocktails for optimising inositol phosphate nutrition 
in the gut. Is it better to have low phytate diets by dephosphorylating phytate down to 
IP1 or even pure inositol, or would generating certain lower inositol phosphate species 
(IP4-3) be of benefit to improve gut health through immune-regulation?  
 
2. What are the chemical interactions between P, Ca and ZnO in the pig and what are the 
practical implications of this for weaner pig nutrition? Do we need to increase Pi levels 
to compensate for P lock-up in ZnO medicated diets, or could we generate comparable 
P from phytate with phytase (how does phytate derived P compaire to inorganic P?) 
which is as effective as inorganic P? What is the effect of high Zn on phytase activity 
and can pharmaceutical ZnO be inhibitory to phytase, preventing adequate release of 
Pi?   
 
3. Would lower doses of pharmaceutical ZnO be more suitable for metaphylactic use in 
weaner pig diets? What is the efficacy of using lower than the current prescription 
requirements on targeted microbes and would supplemental P still be required to 
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